Gastroenterology - McMaster Experts

publication venue for

Development and Validation of an Integrative Risk Score for Future Risk of Crohn's Disease in Healthy First-Degree Relatives: A Multicenter Prospective Cohort Study. 2024
Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis 2023
CLOSTRIDIODES DIFFICILE INFECTION IN MECHANICALLY VENTILATED CRITICALLY ILL PATIENTS: A NESTED COHORT STUDY 2023
A COMPARATIVE STUDY OF DISORDERS OF GUT-BRAIN INTERACTION IN WESTERN EUROPE AND ASIA BASED ON THE ROME FOUNDATION GLOBAL EPIDEMIOLOGY STUDY 2023
A MODEL-BASED META-ANALYSIS OF THE RELATIONSHIP BETWEEN PH CONTROL AND EROSIVE ESOPHAGITIS HEALING RATES 2023
BLOATING IN THE GLOBAL POPULATION: RESULTS FROM THE ROME FOUNDATION GLOBAL EPIDEMIOLOGY STUDY 2023
CHRONIC ORAL EXPOSURE TO THE FOOD-GRADE SILICON DIOXIDE BLOCKS ORAL TOLERANCE INDUCTION IN MICE AND WORSENS FOOD SENSITIVITY 2023
COMPARISON OF THE PREVALENCE AND IMPACT OF DISORDERS OF GUT-BRAIN INTERACTION IN THE FRENCH- AND DUTCH-SPEAKING POPULATIONS IN BELGIUM 2023
EFFECTS OF CHANGES IN THE DIAGNOSTIC CRITERIA FOR IRRITABLE BOWEL SYNDROME (IBS) ON GLOBAL PREVALENCE RATES-RESULTS FROM THE ROME FOUNDATION GLOBAL EPIDEMIOLOGY STUDY 2023
EPIDEMIOLOGICAL AND DIET RELATED DIFFERENCES IN DISORDERS OF GUT-BRAIN INTERACTION (DGBI) IN 4 COUNTRIES OF LATIN AMERICA: RESULTS OF THE ROME FOUNDATION GLOBAL EPIDEMIOLOGY STUDY (RFGES) 2023
FAST TRACK PATHWAY TO ACCELERATED CHOLECYSTECTOMY VERSUS STANDARD OF CARE FOR ACUTE CHOLECYSTITIS (FAST) PILOT TRIAL 2023
GLOBAL PREVALENCE OF FUNCTIONAL ANORECTAL PAIN SYNDROMES 2023
IRRITABLE BOWEL SYNDROME (IBS) IS MORE SEVERE IN INDIVIDUALS SATISFYING ROME IV CRITERIA THAN THOSE WITH ROME III CRITERIA IN JAPANESE POPULATION IN THE ROME FOUNDATION GLOBAL EPIDEMIOLOGICAL STUDY 2023
MICROBIOTA COMPOSITION INFLUENCES ARYL HYDROCARBON RECEPTOR ACTIVITY AND COLITIS SEVERITY 2023
MICROBIOTA FROM PATIENTS WITH CROHN'S DISEASE INDUCES BEHAVIOURAL CHANGES IN MICROBIOTA-HUMANIZED MICE 2023
PREVALENCE AND IMPACT OF DISORDERS OF GUT-BRAIN INTERACTION (DGBI) IN THE SWEDISH GENERAL POPULATION 2023
REVERSAL OF SEVERE GUT DYSFUNCTION FOLLOWING CLOSTRIDIUM DIFFICILE INFECTION BY MICROBIOTA-DIRECTED DIETARY INTERVENTION 2023
ROLE OF GUT MICROBIOTA IN SYMPTOM EPISODES OF IRRITABLE BOWEL SYNDROME 2023
SHORT-TERM POSTOPERATIVE OUTCOMES FOR OBESE VERSUS NON-OBESE INFLAMMATORY BOWEL DISEASE PATIENTS UNDERGOING BOWEL RESECTION: A PROPENSITY SCORE MATCHED ANALYSIS 2023
SIMILAR RATE OF POST-COVID-19 SYMPTOMS IN PATIENTS WITH CELIAC DISEASE AND NON-CELIAC POPULATION: RESULTS OF AN INTERNATIONAL CROSS-SECTIONAL STUDY 2023
THE EFFECTIVENESS OF PEG 3350 COMPARED TO LACTULOSE FOR THE TREATMENT OF ACUTE HEPATIC ENCEPHALOPATHY IN ADULT CIRRHOTIC PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS 2023
THE NATIONAL PREVALENCE OF DISORDERS OF GUT-BRAIN INTERACTION IN THE UNITED KINGDOM IN COMPARISON TO THEIR WORLDWIDE PREVALENCE: RESULTS FROM THE ROME FOUNDATION GLOBAL EPIDEMIOLOGY STUDY 2023
THE RATE OF ADVERSE EVENTS AFTER COVID-19 VACCINATION IS SIMILAR IN PATIENTS WITH CELIAC DISEASE AND NON-CELIAC POPULATION: RESULTS OF A LARGE INTERNATIONAL CROSSSECTIONAL STUDY 2023
TOTAL ABDOMINAL COLECTOMY VERSUS DIVERTING LOOP ILEOSTOMY AND ANTEGRADE COLONIC LAVAGE FOR FULMINANT CLOSTRIDIOIDES COLITIS: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE 2016-2019 2023
ADDING DEAMIDATED GLIADIN PEPTIDE TO TISSUE TRANSGLUTAMINASE ANTIBODIES DOES NOT INCREASE CELIAC DISEASE DETECTION RATES IN IMMUNOGLOBULIN A (IGA) SUFFICIENT PATIENTS 2022
COMORBID DISORDERS OF GUT-BRAIN INTERACTIONS IN INDIVIDUALS WITH SEVERE PSYCHOLOGICAL DISTRESS AND SOMATIC SYMPTOMS: RESULTS FROM A GLOBAL EPIDEMIOLOGY INTERNET STUDY 2022
COMPARISON OF TRADITIONAL TOOLS AND FECAL GLUTEN IMMUNOGENIC PEPTIDE DETECTION TO INVESTIGATE GLUTEN-FREE DIET ADHERENCE IN CELIAC DISEASE 2022
FACTOR ANALYSIS CONFIRMS GLOBAL VALIDITY OF ROME IV CRITERIA FOR MAJOR DISORDERS OF GUT-BRAIN INTERACTION (DGBI) 2022
GASTROINTESTINAL EFFECTS OF CANNABINOIDS: RELATIONSHIP WITH SODIUM CHANNEL FUNCTION 2022
GUT MICROBIOTA MODULATES CGRP PRODUCTION BY DRG NEURONS IN FEMALE MICE 2022
OPTIMIZING STOOL GLUTEN IMMUNOGENIC PEPTIDE TESTS FOR THE MONITORING OF ADHERENCE TO THE GLUTEN-FREE DIET 2022
OPTIMIZING STOOL GLUTEN IMMUNOGENIC PEPTIDE TESTS FOR THE MONITORING OF ADHERENCE TO THE GLUTEN-FREE DIET 2022
PREVALENCE AND ASSOCIATED FACTORS OF BLOATING AND DISTENTION SYMPTOMS IN THE GENERAL POPULATION: FINDINGS OF A SURVEY IN THREE COUNTRIES 2022
PREVALENCE AND BURDEN OF DISORDERS OF GUT-BRAIN INTERACTION IN ROMANIA: A SUBGROUP ANALYSIS OF THE ROME FOUNDATION GLOBAL EPIDEMIOLOGY STUDY 2022
PROCEDURAL INTERVENTION FOR THE MANAGEMENT OF CONSTIPATION FOLLOWING ANTEGRADE ENEMA INSERTION: A POPULATION-BASED STUDY 2022
THE ASSOCIATION BETWEEN DIET AND DISORDERS OF GUT-BRAIN INTERACTION: ANALYSES FROM THE ROME FOUNDATION GLOBAL EPIDEMIOLOGY STUDY 2022
THE BURDEN OF PAIN IN ROME IV GASTROINTESTINAL DISORDERS: A ROME FOUNDATION GLOBAL STUDY 2022
THE. IMPACT OF ANTEGRADE ENEMA INSERTION ON HEALTHCARE UTILIZATION IN PEDIATRIC PATIENTS: A POPULATION-BASED COHORT STUDY 2022
VERY LOW ENERGY DIETS PRIOR TO NON-BARIATRIC SURGERY: A SYSTEMATIC REVIEW 2022
WORLDWIDE PREVALENCE AND BURDEN OF GASTROPARESIS-LIKE SYMPTOMS AS DEFINED BY THE EUROPEAN GASTROPARESIS CONSENSUS: ANALYSIS USING THE ROME FOUNDATION GLOBAL EPIDEMIOLOGY STUDY DATABASE 2022
ANALYSIS OF AUTONOMIC NERVOUS SYSTEM REACTIVITY ASSOCIATED WITH HIGH-AMPLITUDE PROPAGATING PRESSURE WAVES OF THE HUMAN COLON IN HEALTHY SUBJECTS 2021
ASSOCIATION OF PROCESSED FOOD INTAKE WITH RISK OF INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY 2021
COLONIC DYSMOTILITY, AUTONOMIC DYSFUNCTION AND ABNORMAL DEFECATION REFLEXES IN PATIENTS WITH CHRONIC CONSTIPATION 2021
DORSAL ROOT GANGLIA (DRG) NEURONAL RESPONSES AND SUBSTANCE P PRODUCTION ARE HIGHER IN MALE MICE AND SIMILAR BETWEEN CONVENTIONAL AND GERM-FREE MICE 2021
EFFECTS OF SACRAL PHOTOBIOMODULATION ON THE AUTONOMIC NERVOUS SYSTEM IN PATIENTS WITH COLONIC DYSMOTILITY 2021
FECAL IMMUNOCHEMICAL TEST (FIT) VERSUS CY(CY) IN DETECTING ADVANCED COLON NEOPLASIA: A DIAGNOSTIC TEST ACCURACY META-ANALYSIS INCLUDING A HEAD-TO-HEAD COMPARISON OF FIT AND CY 2021
Fr065 FECAL IMMUNOCHEMICAL TEST (FIT) VERSUS CY(CY) IN DETECTING ADVANCED COLON NEOPLASIA: A DIAGNOSTIC TEST ACCURACY META-ANALYSIS INCLUDING A HEAD-TO-HEAD COMPARISON OF FIT AND CY. 2021
INTESTINAL PERMEABILITY IN HEALTHY FIRST-DEGREE RELATIVES OF CROHN'S DISEASE PATIENTS IS ASSOCIATED WITH ENVIRONMENTAL AND DEMOGRAPHIC FACTORS RATHER THAN CROHN'S DISEASE POLYGENIC RISK SCORE 2021
PROINFLAMMATORY EFFECT OF HIGH SALT DIET AND UC MICROBIOTA IN GNOTOBIOTIC MICE 2021
RESULTS OF THE FIRST PILOT RANDOMIZED CONTROLLED TRIAL OF FAECAL MICROBIOTA TRANSPLANT FOR PEDIATRIC ULCERATIVE COLITIS 2021
THE ORAL TISSUE TRANSGLUTAMINASE INHIBITOR ZED1227 PREVENTS GLUTEN-INDUCED ENTEROPATHY IN A TRANSGENIC MOUSE MODEL OF CELIAC DISEASE 2021
IMPROVING PATIENT PARTICIPATION IN LONGITUDINAL RESEARCH: AN INNOVATIVE PATIENT-LED PATIENT-ORIENTED QUALITATIVE RESEARCH PROJECT TO UNDERSTAND THE MOTIVATIONS AND BARRIERS TO GETTING AND STAYING INVOLVED IN THE IMAGINE SPOR STUDY 2021
BIFIDOBACTERIUM INFANTIS NLS-SS SHIFTS FECAL MICROBIOTA IN SYMPTOMATIC CELIAC PATIENTS ON LONG-TERM GLUTEN-FREE DIET 2020
ARYL HYDROCARBON RECEPTOR LIGAND PRODUCTION BY THE GUT MICROBIOTA IN CELIAC DISEASE 2020
CHARACTERISTICS OF SKIN LESIONS ASSOCIATED WITH ANTI-TUMOR NECROSIS FACTOR THERAPY OR OTHER BIOLOGIC AGENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY 2020
EFFECT OF FIBER, OSMOLARITY, AND PROTEIN CONTENT OF ENTERAL NUTRITION ON THE DEVELOPMENT OF DIARRHEA IN CRITICAL ILLNESS 2020
EVALUATION OF GUT MICROBIOTA COMPOSITION IN NAFLD WITH UC PANCOLITIS IN CLINICAL REMISSION: A PILOT STUDY 2020
FEASIBILITY OF THE FIRST PAEDIATRIC RANDOMIZED CONTROLLED PILOT TRIAL OF FAECAL MICROBIOTA TRANSPLANT FOR ULCERATIVE COLITIS 2020
FECAL CALPROTECTIN FOR DETECTING POUCHITIS FOLLOWING ILEAL POUCH ANAL ANASTOMOSIS IN ULCERATIVE COLITIS PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS 2020
LAPAROSCOPIC HEPATECTOMY IS SAFE AND EFFECTIVE FOR COLORECTAL LIVER METASTASES IN A POPULATION-BASED ANALYSIS INONTARIO, CANADA 2020
PREVALENCE AND IMPACT OF FUNCTIONAL DYSPEPSIA ACCORDING TO THE ROME IV DEFINITIONS IN A GLOBAL EPIDEMIOLOGICAL SURVEY 2020
RESULTS OF THE FIRST PAEDIATRIC RANDOMIZED-CONTROLLED TRIAL OF FAECAL MICROBIOTA TRANSPLANT FOR ULCERATIVE COLITIS 2020
ROME IV AND ROME III IRRITABLE BOWEL SYNDROME (IBS) ACROSS THE GLOBE: FINDINGS OF A POPULATION-BASED INTERNET SURVEY OF ADULTS IN 26 COUNTRIES 2020
SACCHAROMYCES BOULARDII CNCM I-745 IMPROVES GUT-BRAIN AXIS DYSFUNCTION IN A HUMANIZED MOUSE MODEL OF IRRITABLE BOWEL SYNDROME WITH CO-MORBID ANXIETY 2020
SAFETY, TOLERABILITY, AND EFFICACY OF ANTI-TL1A ANTIBODY PF-06480605 IN TREATMENT OF ULCERATIVE COLITIS: THE OPEN-LABEL, MULTICENTER, PHASE 2A TUSCANY STUDY 2020
SOMATOSTATIN AND ANALOGUES FOR ACUTE NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED TRIALS 2020
SYMPTOMATIC AND ASYMPTOMATIC CELIAC DISEASE PATIENTS ON LONG-TERM GLUTEN-FREE DIET EXHIBIT DIFFERENCES IN FECAL MICROBIAL TAXA 2020
THE ASSOCIATION BETWEEN INFLAMMATORY BOWEL DISEASE AND CELIAC DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS 2020
THE GEM PROJECT: DIETARY PATTERNS ARE ASSOCIATED WITH MICROBIOME COMPOSITION AND INTESTINAL INFLAMMATION IN HEALHY FIRST-DEGREE RELATIVES OF CROHN'S DISEASE PATIENTS 2020
THE GEM PROJECT: IMPAIRED GUT BARRIER FUNCTION IS ASSOCIATED WITH FUTURE DEVELOPMENT OF CROHN'S DISEASE EVEN IN THE PRESENCE OR ABSCENCE OF PRECLINICAL INFLAMMATION IN ASYMPTOMATIC FIRST-DEGREE RELATIVES OF CROHN'S PATIENTS 2020
THE INFLUENCE OF SEX AND THE GUT MICROBIOTA ON VISCERAL SENSITIVITY IN MICE 2020
THE INTESTINAL MICROBIOTA FROM A PATIENT WITH IBS-C SLOWS MOUSE COLONIC TRANSIT BY DISRUPTING INTERSTITIAL CELL OF CAJAL NETWORK 2020
THE UTILITY OF GLUCOSE HYDROGEN BREATH TEST IN IRRITABLE BOWEL SYNDROME: A SYSTEMATIC REVIEW 2020
TRANSCRIPTIONAL AND MICROBIAL BIOMARKERS OF RESPONSE TO ANTI-TL1A THERAPY IN ULCERATIVE COLITIS: THE PHASE 2A TUSCANY STUDY 2020
WHAT IS THE INCIDENCE OF HERPES ZOSTER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE COMPARED TO THE GENERAL POPULATION: A SYSTEMATIC REVIEW AND META-ANALYSIS 2020
A LONGITUDINAL STUDY EXAMINING THE EFFECT OF ALTERING FODMAP INTAKE ON THE METABOLOME AND PAIN SIGNALLING IN IBS PATIENTS 2019
A RANDOMIZED TRIAL OF PROTON PUMP INHIBITORS VERSUS PLACEBO TO PREVENT UPPER GASTROINTESTINAL BLEEDING IN PATIENTS RECEIVING RIVAROXABAN OR ASPIRIN 2019
ADVERSE EVENTS RELATED TO PROTON PUMP INHIBITOR THERAPY. RESULTS OF A RANDOMIZED TRIAL OF PANTOPRAZOLE VERSUS PLACEBO WITH 53,152 PATIENT YEARS OF FOLLOW-UP 2019
ALTERING DIETARY FERMENTABLE CARBOHYDRATE (FODMAP) CONTENT SHIFTS FERMENTATION PATTERNS BUT DOES NOT IMPACT INFLAMMATION IN PRECLINICAL MODELS OF IBD 2019
COMPLIANCE WITH EARLY POST-OPERATIVE FOLLOW-UP REDUCES RISK OF LATE SEVERE NUTRITIONAL COMPLICATIONS AFTER ROUX-EN-Y GASTRIC BYPASS: A POPULATION BASED STUDY 2019
CRITICAL ROLE OF TOLL-LIKE RECEPTOR 2 IN MEDIATING SEROTONIN PRODUCTION IN GUT 2019
EFFECT OF BIFIDOBACTERIUM INFANTIS NSL SUPER STRAIN IN HIGHLY SYMPTOMATIC CELIAC DISEASE PATIENTS ON LONG-TERM GLUTEN-FREE DIET. A PILOT STUDY 2019
EFFECTS OF PROTON-PUMP INHIBITORS IN PATIENTS RECEIVING CLOPIDOGREL-BASED ANTITHROMBOTIC THERAPY FOR CARDIOVASCULAR PREVENTION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED TRIALS 2019
ELEVATED FECAL CALPROTECTIN IN HEALTHY FIRST DEGREE RELATIVES OF PATIENTS WITH CROHN'S DISEASE IS ASSOCIATED WITH FUTURE DIAGNOSIS OF CROHN'S DISEASE 2019
FECAL MICROBIOTA TRANSPLANTATION: PERCEPTIONS AND EXPERIENCES IN A PEDIATRIC ULCERATIVE COLITIS POPULATION (PEDIFETCH TRIAL) 2019
INCREASED INTESTINAL PERMEABILITY IS A PREDICTOR OF CROHN'S DISEASE DEVELOPMENT IN A LARGE COHORT OF ASYMPTOMATIC FIRST DEGREE RELATIVES 2019
LACK OF EXPERIMENTAL REPRODUCIBILITY IN PRECLINICAL RESEARCH MAY BE INFLUENCED BY THE NUTRITIONAL PROFILE OF STANDARD RODENT CHOWS 2019
MANAGEMENT OF ANTITHROMBOTIC THERAPY AFTER GASTROINTESTINAL BLEEDING: A QUALITATIVE STUDY OF HEALTHCARE PROVIDERS 2019
METABOLISM OF WHEAT AMYLASE TRYPSIN INHIBITORS BY LACTOBACILLI AMELIORATES GUT DYSFUNCTION INDUCED BY WHEAT PROTEINS 2019
MICROBIOTA PLAYS A KEY ROLE IN FORMATION OF NORMAL INTESTINAL MOTOR PATTERNS 2019
PATIENT PERCEPTIONS OF FECAL MICROBIOTA TRANSPLANTATION FOR THE TREATENT OF ULCERATIVE COLITIS 2019
PROTON PUMP INHIBITOR TREATMENT INITIATED PRIOR TO ENDOSCOPY IC DIAGNOSIS IN UPPER GASTROINTESTINAL BLEEDING: AN UPDATED COCHRANE COLLABORATION SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS 2019
REAL LIFE PATTERNS OF GLUTEN-FREE DIET ADHERENCE IN CELIAC PATIENTS USING GIP EXCRETION 2019
SEVERE NUTRITIONAL COMPLICATIONS AFTER BARIATRIC SURGERY IN ONTARIO ADULTS: A POPULATION BASED DESCRIPTIVE STUDY 2019
TARGETING AMPK beta 1 AS A NOVEL STRATEGY TO AMELIORATE COLITIS 2019
UPTAKE AND PATIENT OUTCOMES OF LAPAROSCOPIC LIVER RESECTION FOR COLON CANCER LIVER METASTASES. A POPULATION-BASED ANALYSIS 2019
VALIDATION OF THE BRISTOL STOOL CHART AND THE BLISS STOOL CLASSIFICATION SYSTEM IN THE INTENSIVE CARE UNIT 2019
WEEK 2 ADALIMUMAB LEVEL PREDICTS SHORT-TERM CLINICAL REMISSION IN PATIENTS WITH IBD 2019
384 - Role of Prokinetics in Symptom Improvement of Functional Dyspepsia: Cochrane Collaboration Meta-Analysis of Randomized Controlled Trials 2018
BIOLOGICS FOR THE TREATMENT OF PERIANAL FISTULAS IN CROHN'S DISEASE: A NETWORK META-ANALYSIS 2018
CHARACTERIZING MICROBIOTA COMPOSITION AND FUNCTION THAT PRECEDE DEVELOPMENT OF CLINICALLY RELEVANT INFLAMMATION IN UC PATIENTS 2018
EXCLUSION DIETS AND IRRITABLE BOWEL SYMPTOMS: A SYSTEMATIC REVIEW AND META-ANALYSIS 2018
GLUTEN IMMUNOGENIC PEPTIDE (GIP) EXCRETION SHOWS EVIDENCE OF DIETARY TRANSGRESSIONS IN ASYMPTOMATIC TREATED CELIAC DISEASE PATIENTS 2018
GUT MICROBIOTA DEFINES HOST RESPONSES TO DIETARY FERMENTABLE CARBOHYDRATES IN IBS: THE ROLE OF BACTERIAL HISTAMINE 2018
GUT MICROBIOTA-DIET INTERACTIONS IN A HUMANIZED MOUSE MODEL OF IBS: THE ROLE OF INTESTINAL MAST CELLS 2018
INCIDENCE OF DELAYED VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS UNDERGOING ABDOMINAL AND PELVIC SURGERY FOR CANCER, A SYSTEMATIC REVIEW 2018
INFLUENCE OF MATERNAL SSRI EXPOSURE ON THE DEVELOPMENT OF THE ENTERIC NERVOUS SYSTEM AND ENTEROCHROMAFFIN CELLS 2018
MICROBIAL PROTEASES INCREASE SENSITIVITY TO DIETARY ANTIGEN THROUGH PAR-2 SIGNALING 2018
MICROBIOTA FROM IBS-D PATIENTS INDUCES DYSREGULATION OF INNATE IMMUNITY 2018
Mo1648 - Exclusion Diets and Irritable Bowel Symptoms: A Systematic Review and Meta-Analysis 2018
OVERALL AND DISEASE-FREE SURVIVAL IN COLORECTAL CANCER PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY WITH BIOLOGIC AGENT: A SYSTEMATIC REVIEW AND META-ANAYLSIS 2018
RESUMPTION OF ANTICOAGULANT THERAPY AFTER ANTICOAGULANT-RELATED GASTROINTESTINAL BLEEDING: A SYSTEMATIC REVIEW AND META-ANALYSIS 2018
ROLE OF PROKINETICS IN SYMPTOM IMPROVEMENT OF FUNCTIONAL DYSPEPSIA: COCHRANE COLLABORATION META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS 2018
THE PREVALENCE OF CELIAC DISEASE IS INCREASED IN PATIENTS WITH BARRETT'S ESOPHAGUS AND IS ASSOCIATED WITH EARLY DEVELOPMENT OF DYSPLASIA 2018
ANTIGLIADIN ANTIBODIES PREDICT THE SYMPTOMATIC RESPONSE TO GLUTEN-FREE DIET AND IMPROVEMENT IN GASTROINTESTINAL MOTILITY IN IBS PATIENTS 2017
Activation of Innate Immune Pathways by Bacterial Proteases: Implications for Celiac Disease 2017
Detection of Gluten Immunogenic Peptides in Feces and Urine in Patients with Celiac Disease on a Gluten-Free Diet 2017
Diarrhea and Clostridum Difficile Infection in the ICU: a Multicenter Study 2017
Diet-Microbiota Interactions Underlie Symptoms' Generation in IBS 2017
Early Use of Therapeutic Drug Monitoring to Individualize Infliximab Therapy in Paediatric IBD: A Multicentre Prospective Cohort Study 2017
Endoscopic Findings in Children who are Deamidated Gliadin Peptide Positive and Tissue Transglutaminase Negative 2017
Factors Associated with the Persistence of Symptoms in Celiac Disease Patients on a Gluten-Free Diet. Interim Report of a Multidimensional Assessment 2017
Gluten Free Diet Improves Upper GI Symptoms and Promotes Changes in Gastric Emptying in IBS Patients with Functional Dyspepsia 2017
Influence of Antidepressants in Pregnancy on Intestinal Inflammation and Chemically Induced Colitis Severity of the Offspring 2017
Microbial Modulation of Intestinal Innate Activation Triggered by Wheat Amylase Trypsin Inhibitors (ATIS) in NOD-DQ8 Mice 2017
No Detrimental Effect of Oats on Symptoms, Histological Parameters, Serological Tests, or Quality of Life in Celiac Disease: A Systematic Review and Meta-Analysis 2017
Nutritional Wheat Amylase Trypsin Inhibitors Exacerbate Gluten-Induced Pathology and Alter the Gut Microbiota in Mice 2017
Persistent Symptoms, CRP Elevation and Treatment Changes Over Time in Crohn's Disease Patients are Associated with Bowel Damage Progression as Expressed by Deterioration of Lemann Index Score 2017
Proximal Disease Extension in Limited Ulcerative Colitis: A Systematic Review and Meta-Analysis 2017
Role of Gut Serotonin in the Production of Antimicrobial Peptides 2017
Simultaneous Pressure Waves are an Essential Component of Human Colon Motor Function Assessment, Using High-resolution Manometry 2017
Surgical Outcomes and Costs of Pancreaticoduodenectomy in Octogenarians 2017
The Novel Role of a Serpin-Producing Probiotic in Gluten-Related Disorders 2017
Ulcerative Colitis Patients on Vedolizumab Lacking Response at Induction Phase Continue to Improve Over the First 6 Months of Treatment 2017
258 FODMAPs Alter the Metabolome and Symptoms in Irritable Bowel Syndrome Patients 2016
36 Clinical and Serologic Patterns in a Large Canadian Pediatric Cohort With Celiac Disease at Presentation and Follow-Up 2016
545 Microbiota From an Active Celiac Donor Modulates Intraepithelial Lymphocyte Numbers and Phenotype in the Mouse Small Intestine 2016
616 Metabolomic Profiling Differentiates Irritable Bowel Syndrome Patients From Healthy Controls and Ulcerative Colitis Patients 2016
792 Do Concurrent Gastroprotective Agents Impact Gastrointestinal Bleeding Rates in Edoxaban Users? Results From the ENGAGE-AF TIMI 48 Trial 2016
794 What is the Clinical Profile of “Life-Threatening” Gastrointestinal Bleeding in Anticoagulated Patients? A Sub-Analysis of the RE-LY Trial 2016
843 Validity and Reliability of the Celiac Disease Self-Management Inventory: A Self-Reported Tool to Assess Compliance of the Gluten-Free Diet in Adult Celiac Population 2016
Mo1653 Improvement of Gastrointestinal Symptoms After Gluten-Free Diet in Patients With Irritable Bowel Syndrome Is Dependent on the Presence of Anti-Gliadin Antibodies 2016
Mo1773 Variation in the Treatment of New Onset Pediatric IBD Among Phenotypically Similar Patient Subgroups in Canada: A Cross-Sectional Analysis of the Canadian Children IBD Network Inception Cohort 2016
Sa1085 Telephone vs. Clinic Follow-Up in the Management of Patients With Inflammatory Bowel Disease: A Nurse Practitioner Led Study 2016
Sa1398 Immunogenic Gluten Is Modulated by Small Intestinal Bacterial Hydrolysis 2016
Sa1888 Efficacy and Predictors of Outcomes of Vedolizumab for Ulcerative Colitis in Clinical Practice 2016
Sa1889 Efficacy and Predictors of Outcomes of Vedolizumab for Crohn's Disease in Clinical Practice 2016
Su1012 Canadian Patient and Caregiver Perspectives on Subsequent Entry Biologics/Biosimilars for Inflammatory Bowel Disease 2016
Su1393 Does Giving Pasireotide to Patients Undergoing Pancreaticoduodenectomy Pay for Itself? 2016
Su1891 Colonization of Germ-Free Mice With Human Derived Microbiota Induces Progressive Ultrastructural, Innate, and Functional Changes in the Intestinal Barrier 2016
Su1897 Inflammation-Related Differences in Mucosa-Associated Microbiota and Paracellular Permeability in Crohn's Colitis 2016
Su1901 High Salt Diet Increases Susceptibility to Experimental Colitis: A Putative Role of Gut Microbiota 2016
Su1905 Fecal Microbiome Profiles of Ulcerative Colitis Patients With and Without Anxiety and/or Depression 2016
Tu1068 Diarrhea in the Intensive Care Unit: Epidemiology (The DICE Study) 2016
Tu1908 Safety of Vedolizumab in Inflammatory Bowel Disease in a Multi-Center Real World Consortium 2016
Use of Selective Serotonin Receptor Inhibitors (SSRIs) Is Not Associated With Increased Risk of Endoscopy-Refractory Bleeding, Rebleeding or Mortality in Patients With Peptic Ulcer Bleeding 2016
A Cluster Randomized Trial of Directly Mailed gFoBT Kits to Previous Responders Being Recalled for Screening 2015
Adrenergic Innervation Regulates Intestinal Microbiota Diversity and Richness via Cholinergic Th17 Lymphocytes 2015
Anxiety and Depression Increase in a Step-Wise Fashion in Parallel With Multiple FGIDs 2015
Clinical Impact of Routine Anti-Tumour Necrosis Factor (Anti-TNF) Therapeutic Drug Monitoring (TDM) in Management of Inflammatory Bowel Disease (IBD) Patients 2015
Discovery of an Epithelial Form of Elastase in the Intestine That Participates to Mucosal Inflammation in IBD 2015
Functional Dyspepsia Treatment Trial (FDTT): Association of Adequate Relief Response and Psychological Measures 2015
Functional Dyspepsia Treatment Trial (FDTT): Effect of Antidepressants on Mood Response in Functional Dyspepsia 2015
Gastric Physiology Test Correlations in Functional Dyspepsia 2015
How Often Does Major Gastrointestinal Bleeding in Patients Receiving Warfarin or Dabigatran Uncover Cancer? The US Experience From the RE-LY Trial 2015
Increased Risk of Functional Gastrointestinal Disorders (FGIDs) in Obesity Patients 2015
Is Proton Pump Inhibitor Use Associated With Delayed Gastric Emptying in Functional Dyspepsia Subjects? 2015
Loss of IL-10 Receptor Signaling in Patients With Infantile IBD Results in Aberrant Th17 Responses and Enhanced T-Cell Proliferation 2015
Reflux Symptoms in Patients With Celiac Disease Are Associated With Alkaline or Weakly Acid Reflux 2015
Small Vessel Hepatic Arteriopathy and Cholangiopathy in Chronic Renal Disease and Dialysis: A 'Hidden' Cause of Cholestatic Liver Disease 2015
A randomized, placebo controlled trial of fecal microbiota therapy in active ulcerative colitis. 2014
Adalimumab Monotherapy Versus Combination Therapy With Adalimumab and Immunomodulators for Crohn's Disease: A Meta-Analysis 2014
Anti-TNF alpha Therapies Are Safe During Pregnancy in Women With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis 2014
Colonic Motor Patterns in Patients With Chronic Constipation Assessed by High Resolution Manometry 2014
Dependence of Colonic Motor Patterns on 5-HT3 and 5-HT4 Receptor Activation in the Rat 2014
Dermatological Complications of Anti-TNF-alpha Therapy in Crohn's Disease 2014
Factors Associated With Large Increases in Self-Reported Health Status in Infliximab-Treated IBD Patients 2014
Faecalibacterium prausnitzii Prevents Irritable Bowel Syndrome-Like Symptoms in Both Murine Low Grade Chronic Inflammation and Acute Stress Models 2014
GI Bowel Symptom Comorbidity in Functional Dyspepsia 2014
Gluten-Induced Responses in NOD/DQ8 Mice Are Influenced by Bacterial Colonization 2014
How Does Specific Serology Match With Esphgan Serologic Guidelines for Diagnosis of Celiac Disease in a Prospective Cohort of Adults With High Pretest Probability? 2014
Impact of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas After Pancreaticoduodenectomy 2014
In Functional Dyspepsia, Are Meal-Related Symptoms Linked to Less Drinking Capacity? 2014
Increased Prevalence of Gluten Related Disorders in Patients With Barrett's Esophagus: The Impact on the Development of Dysplasia 2014
Investigating the microbiome pre and post fecal microbiota therapy from active ulcerative colitis patients in a randomized placebo controlled trial 2014
Larazotide Acetate, a First In-Class, Novel Tight Junction Regulator, Meets Primary Endpoint and Significantly Reduces Signs and Symptoms of Celiac Disease in Patients on a Gluten-Free Diet: Results of a Multicenter, Randomized, Placebo Controlled Trial 2014
Morbidity and Morality Rates After Bariatric Surgery in a Regionalized Surgical Care Program: the Ontario Experience 2014
Patients With Active Celiac Disease Have Altered Intercellular Spaces and Tight Junction Structure of the Lower Esophagus That May Explain the High Prevalence of Reflux Symptoms in These Patients 2014
Squalamine Reverses Age and Loperamide Associated Dysmotility in a Mouse Biomarker Model of Constipation 2014
The Adoptive Transfer of Anxiety and Gut Dysfunction From IBS Patients to Axenic Mice Through Microbiota Transplantation 2014
The Critical Role of Gut Microbiota in Determining Behavioral Changes and Susceptibility to Inflammation in a Model of Depression 2014
The Effect of High Fat Diet on Human Microbiota Transfer Into Gnotobiotic Mice 2014
The Functional Dyspepsia Treatment Trial (FDTT): 5-HTT LPR and Gn beta 3 825C > T Are Not Pharmacogenetic Markers for FD Antidepressant Treatment Response 2014
The intestine switches between propulsion and segmentation through a nutrient- or neurally-induced transient pacemaker 2014
Transplantation of Dysbiotic Microbiota Derived From UC Patients Promotes a Pro-Inflammatory Phenotype and Increased Susceptibility of Gnotobiotic Mice to Colitis 2014
A Population-Based Assessment of the Burden of Acute Pancreatitis in the United States 2013
Bifidobacterium Breve NCC2950 Induces Expression of Antimicrobial Regiii in Colonic Epithelial Cells Through MYD88-Ticam Pathway 2013
Burden of Clostridium difficile-Associated Hospitalizations in the United States 2013
Can Prophylactic PPI Help Reduce Marginal Ulcers After Gastric Bypass Surgery? A Systematic Review and Meta Analysis 2013
Clinico-Pathological Features of Solid Pseudopapillary Neoplasms of the Pancreas 2013
Clostridium difficile Infection Emergency Department Visits in the United States: Patterns of Care, Admission and Mortality 2013
Endogenous Microbiota Influence the Postnatal Development of Intestinal Motility 2013
Impact of the Commensal Bacterium Faecalibacterium prausnitzii in a Non Active Inflammation Murine Model 2013
Intestinal Mucosal Calprotectin (IMC) : Defining Remission and Prediction of Disease Course in Ulcerative Colitis (UC) Patients 2013
Intestinal Volvulus in the United States: A Population-Based Assessments of Emergency Departments Visits From the Nationwide Emergency Department Sample 2013
Optimal Care in Crohn's Disease and Ulcerative Colitis: How Aligned With Patients' Needs and Expectations Are Health Care Providers? 2013
Optimization of the Use of Probiotics to Prevent and Treat Colitis 2013
Psychosocial Characteristics of Patients With IBD: Experience From the Mcmaster Interdisciplinary Clinic 2013
Risk-Benefit Assessment of the Use of Intraperitoneal Drainage After Pancreaticoduodenectomy 2013
Specific Crohn's Disease (CD) Associated Risk Alleles Are Associated With the Composition of the Intestinal Microbiota in Healthy First Degree Relatives (FDR) of CD Subjects 2013
Suppression of Gluten-Induced Enteropathy by the Copolymer Bl-7010 in NOD/DQ8 Transgenic Mice, an Animal Model of Celiac Disease (CD) 2013
The Functional Dyspepsia Treatment Trial (Fdtt) Key Results 2013
The Impact of Diet on Post-Operative Recurrence Following Ileal Resection in Crohn's Disease 2013
The Relationship Between Common IBD-Associated Risk Alleles and Intestinal Permeability in a Cohort of Healthy First Degree Relatives of Individuals With Crohn's Disease 2013
1078 Risk of Serious Upper Gastrointestinal (UGI) Complications in Patients Receiving Non-Selective NSAIDs for at Least 4 Weeks: A Series of Systematic Reviews of Randomized Controlled Trials (RCT), Cohort Studies and Case Control Studies 2012
A Novel In Vivo Method to Measure Gastrointestinal Transit in Mice 2012
Antimicrobial-Induced Dysbiosis Excerbates Colitis in NOD1(-/-);NOD2(-/-) Mice 2012
Communicating Gastrointestinal (GI) Symptoms: the Patient's Challenge 2012
Disordered Eating Behaviors in Functional Dyspepsia Patients 2012
Immediate Effects of Infliximab Infusion on Mood in Patients With Inflammatory Bowel Disease 2012
Postnatal Patterning of the Enteric Nervous System is Dependent on the Presence of Endogenous Microbiota 2012
Protective and Curative Effect of Faecalibacterium prausnitzii in a Chronic DNBS-Induced Murine Colitis 2012
Risk of Serious (UGI) Complications With Concomitant use of Non-Selective NSAIDs and Low-Dose Aspirin: A Series of Systematic Reviews of Randomized Controlled Trials (RCT), Cohort Studies and Case Control Studies 2012
Risk of Serious Upper Gastrointestinal (UGI) Complications With Concomitant Non-Selective NSAID and Anticoagulation Therapy for at Least 4 Weeks: A Series of Systematic Reviews of Randomized Controlled Trials (RCT), Cohort Studies and Case Control Studies 2012
Risk of Serious Upper Gastrointestinal (UGI) Complications With Concomitant use of Non-Selective NSAIDs and Clopidogrel for at Least 4 Weeks: A Series of Systematic Reviews of Randomized Controlled Trials (RCT), Cohort Studies and Case Control Studies 2012
Risk of Serious Upper Gastrointestinal (UGI) Complications With use of Non-Selective (NS) NSAIDs for at Least 4 Weeks Among Patients With a History of Peptic Ulcer (PU) or PU Complications: A Series of Systematic Reviews and Meta-Analyses 2012
Risk of Serious Upper Gastrointestinal (UGI) Complications in Patients Receiving Multiple Non-Selective NSAIDs for at Least 4 Weeks: A Series of Systematic Reviews and Meta-Analyses of Randomized Controlled Trials (RCT), Cohort and Case Control Studies 2012
Risk of Serious Upper Gastrointestinal (UGI) Complications in Patients Receiving Non-Selective NSAIDs for at Least 4 Weeks: A Series of Systematic Reviews of Randomized Controlled Trials (RCT), Cohort Studies and Case Control Studies 2012
The Role of Microbiota in the Maternal Separation Model of Depression 2012
Alzheimers Disease Affects the Enteric Nervous System 2011
Are Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Associated With Esophageal Injury? A Systematic Review of Case-Control Studies 2011
Barrett's Dysplasia Cancer Task Force - Bad Cat: A Global, Multidisciplinary, Consensus on the Management of High Grade Dysplasia and Early Mucosal Cancer in Barrett's Esophagus 2011
Characterizing the Neural Pathways of Communication Within the Microbiota-Gut-Brain Axis 2011
Comparing the Quality of Reporting in Randomized Controlled Trial Abstracts at Two International Gastroenterology Meetings in 2010 2011
Critical Role of Gliadin for Both Enteropathy and Insulitis Development in NOD-DQ8 Mice 2011
Effect of Proton Pump Inhibitors (PPIs) Treatment on the Length of Barrett's Esophagus: A Systematic Review of Cohort Studies 2011
Effect of Proton Pump Inhibitors (PPIs) Treatment on the Length of Barrett's Esophagus: A Systematic Review of Cohort Studies 2011
Efficacy of Antidepressants in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis Controlling for Depression 2011
Empirical Rescue Eradication Regimen for H. pylori Infection Following Two Treatment Failures: A Systematic Review and Meta-Analysis 2011
Helicobacter pylori Eradication and Change in Body Weight: A Systematic Review 2011
Helicobacter pylori Eradication and Change in Body Weight: A Systematic Review 2011
Influence of Interleukin-13 in 5-HT Synthesis and Severity of Experimental Colitis 2011
Irritable Bowel Syndrome Causes Increased Partner Burden: A Comparative Study 2011
Medical and Surgical Therapy in Barrett's Esophagus (BE): Meta-Analyses Using Various Outcomes 2011
Microbial Perspectives in Very Low Birth Weight Infants Expressing High Calprotectin Levels 2011
Narcotic Bowel Syndrome: Characterization of 30 Patients and Preliminary Results After Detoxification 2011
Origin of Rhythmic Calcium Transients in the ICC-MP of the Mouse Small Intestine 2011
Proton Pump Inhibitors and Low-Dose Aspirin Markedly Exacerbate NSAID-Induced Small Intestinal Injury: A Link to Dysbiosis? 2011
ROME III Criteria for Functional Gastrointestinal Disorders: Too Much Overlap to Be Useful? 2011
The Anxiolytic Effect of Bifidobacterium Longum Ncc3001 Requires Vagal Integrity for Gut-Brain Communication 2011
The Intestinal Microbiota Determines Mouse Behavior and Brain BDNF Levels 2011
The Role of Intestinal Bacteria and Bifidobacterium Breve NCC2950 in Barrier Homeostasis and Intestinal Injury in NOD1 and 2 Knockout Mice 2011
A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication (LNF) Versus Proton Pump Inhibitors for Treatment of Patients With Chronic Gastro-Esophageal Reflux Disease (GERD) Who Complained of Cough 2010
A Validation Study of the Italian Short-Form Leeds Dyspepsia Questionnaire 2010
Conjoint Analysis of Patient Preferences for 5ASA Maintenance Therapy in Ulcerative Colitis 2010
Developmental Associations Between Vagal Afferent Intramuscular Arrays and Interstitial Cells of Cajal 2010
Efficacy and Optimum Dose of Amino-Salicylic Acid (ASA) in Ulcerative Colitis (UC): A Meta-Analysis of Randomized Controlled Trials Inducing Remission in Active Disease and Preventing Relapse Rates in Quiescent Disease 2010
Efficacy of Amino-Salicylic Acid (ASA) in Crohn's Disease (CD): A Meta-Analysis of Randomized Controlled Trials Inducing Remission in Active Disease and Preventing Relapse Rates in Quiescent Disease 2010
Efficacy of Anti-TNF alpha Therapy in Ulcerative Colitis (UC): A Meta-Analysis of Randomized Controlled Trials Looking at Inducing Remission in Active Disease and Preventing Relapse Rates in Quiescent Disease 2010
Efficacy of Antibiotics at Inducing Remission in Active Ulcerative Colitis (UC): A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs) 2010
Efficacy of Antibiotics in Crohn's Disease (CD): A Meta-Analysis of Randomized Controlled Trials (RCTs) Looking at Inducing Remission in Active Disease and Preventing Relapse Rates in Quiescent Disease 2010
Efficacy of Biologics in Crohn's Disease (CD): A Meta-Analysis of Randomized Controlled Trials Looking at Inducing Remission in Active Disease and Preventing Relapse Rates in Quiescent Disease 2010
Efficacy of Budesonide in Crohn's Disease (CD): A Meta-Analysis of Randomized Controlled Trials (RCTs) Assessing Remission Induction in Active Disease and Relapse Prevention in Quiescent Disease 2010
Improving Adherence to Guidelines When Managing Non-Variceal Upper Gastrointestinal Bleeding: A National Cluster Randomized Trial of a Multifaceted Strategy 2010
Incidence of Inflammatory Bowel Disease Following the Walkerton Outbreak of Waterborne Bacterial Gastroenteritis 2010
Intragastric pH Holding Time of pH < 4 Predicts Low Erosive Esophagitis (EE) Healing Rate 2010
Is There a Relationship Between H. pylori Prevalence and Overweight? A Systematic Review of Observational Studies 2010
Pain and Abuse History Predict Days in Bed and Physician Visits in African American Women With Functional Bowel Disorders (FBD) 2010
Partner Burden in Irritable Bowel Syndrome (IBS) 2010
Patients With IBS Commonly use Narcotics 2010
Placebo Response Rates in Trials of Pharmacological Therapies for Irritable Bowel Syndrome: Systematic Review and Meta-Analysis 2010
Predictors of Satisfaction With Care Among Patients With Irritable Bowel Syndrome (IBS) 2010
Preliminary Study on Predictors of Health Status in African-Americans With Functional Bowel Disorders (FBD) Using an NIH Funded Database 2010
The Gamma-Aminobutyric Acid (GABA) Receptor Agonist Baclofen in the Treatment of Gastroesophageal Reflux Disease (GERD): A Systematic Review 2010
The Practice of North-American Gastroenterologists in Treating IBD Patients With C.Difficile: Antibiotics Alone or Combined Antibiotics-Immunomodulators? 2010
The Utility of the Digital Rectal Exam (DRE) Amongst Physicians and Students: A Multi-Center Study 2010
An Updated Model of Intragastric pH and Erosive Esophagitis (EE) Healing Using 24-Hour Intragastric pH Values to Predict EE Healing: Validation By Data from TAK-390MR 2009
Antibiotic-Induced Intestinal Dysbiosis Results in Altered Behavior in BALB/C Mice 2009
Development and Validation of a Risk Score for Post Infectious Irritable Bowel Syndrome 2009
Does Proton Pump Inhibitor (PPI) Treatment Initiated Before Endoscopy Work in Unselected Upper Gastrointestinal Bleeding? A Cochrane Systematic Review Update 2009
Early Depression-Like Behaviour in Maternal Separation Mice Is Associated with Altered Microbiota 2009
Effect of Validation Status and Type of Dyspepsia Questionnaire On the Prevalence of Dyspepsia: Systematic Review and Meta-Analysis 2009
Episodes of Irritable Bowel Syndrome - A Quantitative Examination of IBS-D, C & M Symptoms Using Ecological Momentary Assessment 2009
Examination of the Depressed Gut Reveals Changes in Microbiota and Serotonin Levels 2009
Fine Mapping of the Genetic Risk Factors for Post-Infectious Irritable Bowel Syndrome (PI-IBS) in the Walkerton Outbreak of Waterborne Gastroenteritis (GE) 2009
IL-13 Plays a Critical Role in Development of Enterochromaffin Cell Hyperplasia and Production of Serotonin 2009
Improvement in Sleep Disturbance in Patients with Persistent GERD Symptoms After a Change in Therapy: EncomPASS - a Cluster-Randomized Study in Primary Care 2009
Infliximab-Induced Psoriasis in Pediatric Crohn Disease; Experience of This Paradoxical Skin Manifestation At a Tertiary Centre and a Potential Association with a Variation in the IL-23r Gene 2009
Information Needs of Digestive Disease Patients: the Patient Education Needs Survey (PENS) 2009
Intragastric pH Holding Time pH < 3 At Steady State in Healthy Volunteers (HV) After Once Daily PPIs: A Predictor for Low Erosive Esophagitis (EE) Healing Rates? 2009
Neonatal Stress Induces Changes in the Enteric Nervous System and Gut Microflora 2009
Non-Healed Rate of Moderate-Severe (LA Classification Grade C and D) Erosive Esophagitis After 4-8 Weeks Proton Pump Inhibitors (PPIs): Evidence of An Unmet Need 2009
Pain and Bloating Symptoms Decrease After Bowel Movements in IBS: A Reaffirmation of ROME Criteria 2009
Pantoprazole 20mg Versus 40mg Once Daily for Two Weeks for Heartburn or Reflux Symptoms Relief: A Meta-Analysis 2009
Post-Infective Dyspepsia Eight Years After the Walkerton Outbreak of Waterborne Gastroenteritis (GE) 2009
Prevalence of Clinically Significant Endoscopic Findings in Individuals with and Without Dyspepsia: Systematic Review and Meta-Analysis 2009
Prevalence of Irritable Bowel Syndrome in Individuals with Dyspepsia: Systematic Review and Meta-Analysis 2009
Prevalence of Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis 2009
Prognosis of Post-Infectious Irritable Bowel Syndrome (PI-IBS) Eight Years After the Walkerton Outbreak of Waterborne Gastroenteritis (GE) 2009
Psychological Factors Are More Important Than Disease Activity in Determining Health Status in Celiac Disease 2009
Resolution of Persistent GERD Symptoms After a Change in Therapy: EncomPASS - a Cluster-Randomized Study in Primary Care 2009
Risk Factors for Dyspepsia: Systematic Review and Meta-Analysis 2009
Risk of Development of Gastric Cancer in Relatives of Patients with Non-Hereditary Gastric Cancer: A Meta-Analysis 2009
The Gain in Quality-Adjusted Life Years By Switching to Esomeprazole in Those with Persistent GERD Symptoms in Primary Care: EncomPASS - a Cluster-Randomized Trial 2009
The Ontario Crohn's & Colitis Cohort: Validation of An Algorithm to Identify Children Diagnosed with Inflammatory Bowel Disease Using Health Administrative Data 2009
The Worldwide Prevalence of Dyspepsia: Systematic Review and Meta-Analysis 2009
Validation of Genetic Risk Factors for Post-Infectious Irritable Bowel Syndrome (IBS) in Patients with Sporadic IBS 2009
What Is the Optimum Duration of Proton Pump Inhibitor (PPI)-Based Triple Therapy for Helicobacter pylori? 7, 10, or 14 Days? 2009
Yield of Diagnostic Tests for Celiac Disease in Dyspepsia: Systematic Review and Meta-Analysis 2009
A novel, oral 5HT3 partial agonist, DDP733, improves overall response in patients with irritable bowel syndrome and constipation (IBS-c): A randomized, double blind, placebo-controlled, parallel-group, dose-ranging study 2008
A population-based study of surgical treatment of colon cancer in Ontario, Canada 2008
A randomized, double-blind, placebo-controlled trial with a novel dual noradrenergic reuptake inhibitor (NARI) and 5-HT3 antagonist: Results of a phase II 8-week study in female patients with diarrhea predominant irritable bowel syndrome (D-IBS) 2008
Altered intestinal paracellular permeability in H-pylori infected mice is restored by bacterial eradication and probiotic treatment 2008
Critical role of the alpha-7 nicotinic acetylcholine receptor in the development of colitis 2008
Depression reactivates inflammatory bowel disease in mice 2008
Dose-effect of S-tenatoprazole-Na in healthy volunteers: A meta-analysis of individual subject data from four pharmacodynamic studies 2008
Effect of a community screening and eradication program for Helicobacter pylori infection on consultations for dyspepsia: Seven year follow-up of the Bristol Helicobacter project 2008
Effects of probiotics on gut-brain axis during chronic H-pylori infection 2008
Effects of synthetic Zot peptide analog AT-1002 and inhibitor AT-1001 on gluten induced alterations in barrier function and macrophage recruitment in HLA-HCD4/DQ8 mice 2008
Empirical proton pump inhibitor therapy or Helicobacter pylori "test and treat" in the initial management of dyspepsia? An individual patient data meta-analysis 2008
Endoscopic gastroduodenal ulcers (Gdus) in NSAID arms in randomized placebo-controlled NSAID trials (Rcts): A meta-analysis 2008
Fluctuation of gastrointestinal symptoms in the community: A 10-year longitudinal survey 2008
Genetic risk factors for post-infectious IBS in the walkerton outbreak of waterborne gastroenteritis 2008
Guidance of vagal sensory axons in the fetal gut: Long-range netrin-mediated attraction terminated by laminin in the target microenvironment 2008
Helicobacter pylori eradication reduces the incidence of gastric cancer: Results of a systematic review of randomized controlled trials 2008
Hemeoxygenase-1 is induced in peripheral blood mononuclear cells of patients with acute pancreatitis: A potential therapeutic target 2008
Male predominance of adenocarcinoma of upper gastrointestinal tract is related to intestinal histological subtype not tumour location 2008
NOTES-assisted Roux-en-Y gastric bypass 2008
Natural orifice translumenal endoscopic surgery for Roux-en-Y gastric bypass: An experimental surgical study in a human cadaver model 2008
Predictors of bowel preparation quality in patients undergoing colonoscopy - a preliminary analysis 2008
Role of intestinal barrier modulation by non-steroidal anti-inflammatory drugs in gluten-induced epithelial damage in HLA-Dq8/Hcd4 transgenic mice 2008
Systematic review and meta-analysis of the saftey of bismuth 2008
Systematic review of the utility of the manning and ROME criteria in the diagnosis of irritable bowel syndrome 2008
The development of HIS, abdominal pain and constipation following elective hysterectomy 2008
The proportion of patients who are free of reflux symptoms during the initial days of treatment with proton pump inhibitors (PPIs) in GERD trials: A meta-analysis 2008
The relative effects of clinical and psychosocial factors on health care utilization and disability in women with Functional Bowel Disorders 2008
Up-regulation of hemoxygenase-1 provides a novel therapeutic approach in early acute experimental pancreatitis 2008
5-aminosalicylic acid selectivity modulates bacterial gene expression at concentrations which are not inhibitory to growth 2007
A cross-sectional survey to assess the usefulness of the Rome III dyspepsia symptom subgroups in a large community sample 2007
Attenuation of colitis by a tricyclic anti-depressant is mediated via the vagus nerve 2007
Compromised parasympathetic response to colorectal distension in patients with irritable bowel syndrome 2007
Current prescribing practices of domperidone exposed hospitalized patients to unnecessary increased cardiac risks: A Canadian tertiary centre evaluation 2007
Does suppression of 24-hour intragastric pH predict healing of erosive esophagitis with antisecretory treatment; A meta-analysis 2007
Effect of lactobacillus SP (Lb) probiotic ingestion on membrane properties of intrinsic sensory neurons in rat colon 2007
Effect of placebo in PPIs or H2ras controlled trials of patients with functional dyspepsia: A meta-analysis 2007
Effect of placebo in controlled trials of patients with functional dyspepsia: A meta-analysis 2007
Esomeprazole for treatment of unexplained chest pain in primary care: A prospective, randomized, double-blind, placebo-controlled multicenter study 2007
Evaluation of symptom relief after 1 week of esomeprazole therapy as a predictor of relief after 4 weeks in patients with unexplained chest pain: A randomized, double-blind, placebo-controlled, multicenter study 2007
Gastrointestinal symptom-specific anxiety: An important predictor for health outcome and symptom severity in patients with irritable bowel syndrome 2007
Gliadin-dependent neuromuscular and epithelial secretory responses in the gut 2007
Hemoclip combined with epinephrine injection for bleeding ulcer, a meta-analysis of randomized controlled trials 2007
Herbal medicine for the treatment of functional dyspepsia: A systematic review of the literature and meta-analysis 2007
Inhibition of acid secretion by a novel proton pump inhibitor (PPI) 2007
Irritable bowel syndrome after intestinal infection: A systematic review and meta-analyses 2007
Lack of agreement for irritable bowel syndrome subtypes for Rome III between retrospective questionnaire and prospective diary cards 2007
Netrin biosynthesis by enteric neurons: Roles in normal guidance of vagal sensory axons and their mislocation in aganglionic gut 2007
Placebo effect in the treatment of gastroesophageal reflux disease (GERD); considerations for objective and subjective endpoints in proton pump inhibitors (PPI) trials 2007
Poor quality of life predicts the new onset of irritable bowel syndrome. A longitudinal ten-year follow-up study 2007
Prognosis of post-infectious irritable bowel syndrome (PI-IBS) six years after the Walkerton outbreak of waterborne gastroenteritis (GE) 2007
Psychosocial factors predict the development of abdominal pain following gynecologic surgery 2007
Response to proton pump inhibitor (PPI) therapy in different grades of erosive esophagitis 2007
S-tenatoprazole-na 30 Mg, 60 Mg and 90 Mg versus esomeprazole (Eso) 40 Mg in healthy male volunteers (Hmvs) 2007
Small bowel carcinoid (ECCell) neoplasia exhibits TGF B1-mediated regulatory abnormalities including up-regulation of C-myc and Mta1 2007
The development of a valid, reliable and responsive pediatric ulcerative colitis activity index (Pucai): A prospective multicenter study 2007
What is the placebo effect in eradication trials of H-pylori-positive functional dyspepsia? 2007
A randomized controlled trial of laparoscopic Nissen fundoplication (LNF) versus proton pump inhibitors for treatment of patients with chronic gastro-esophageal reflux disease (GERD) 2006
A survey assessing attitudes towards privacy and research 2006
A ten-year natural history of gastro-esophageal reflux disease 2006
Accelerate reversal of helicobacter pylori-induced gastric dysfunction by specific probiotics through an anti-inflammatory effect 2006
Adoptive transfer of Th2 polarized CD4+T cells up-regulates 5-HT production in gut 2006
An exploratory, randomised, controlled, parallel-group, open-label study to evaluate different dosing regimens of rabeprazole in controlling nocturnal heartburn (NT HB) symptoms in uninvestigated symptomatic gastroesophageal reflux disease (s-GERD) 2006
Baroreceptor sensitivity in irritable bowel syndrome patients and healthy volunteers during colorectal distension 2006
Effect of sibling number and birth order on prevalence of Helicobacter pylori a cross-sectional survey 2006
Failure of vagal sensory axons to innervate aganglionic (Ret-deficient) bowel: Relationship to enteric expression of Netrin-1 2006
H-pylori eradication v empirical acid suppression in uninvestigated H-pylori positive dyspepsia: A Cochrane Collaboration individual patient data meta-analysis 2006
Helicobacter pylori infection confers an increase in ten-year mortality from all causes: Data from a community screening and treatment program 2006
Impact of esophagitis classification in evaluating healing after therapy with proton pump inhibitors (PPIs) 2006
In vivo goblet cell responses to an enteric bacterial pathogen in a mouse model of infectious colitis 2006
Intragastric acidity after H.pyori eradication: Is more suppression needed? 2006
Is eradication of H-pylori infection ever followed by GERD? A meta-analysis 2006
Maintenance therapy with continuous and on-demand rabeprazole (RAB) 20mg in uninvestigated gastroesophageal reflux disease 2006
Minimally important difference (MID) for health related quality of life (HRQOL) measures in functional bowel disorders (FBD) 2006
Night-time heartburn as a possible indicator of degree of heartburn severity, frequency and response to standard acid suppressive regimens 2006
Nighttime acid suppression with proton pomp inhibitor (PPIs) : Are all nights the same? 2006
Post-infective changes in behavior: A model of functional dyspepsia in the mouse 2006
Prognosis of post-infectious irritable bowel syndrome (PI-IBS) four years after the walkerton outbreak of waterborne gastroenteritis (GE) 2006
Proteomic analysis of potential mechanisms involved in the Lactobacillus paracasei-mediated restoration of enteric muscle dysfunction induced by Trichinella spiralis infection 2006
Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in unselected upper gastrointestinal bleeding: A cochrane systematic review and meta-analysis 2006
Systematic review of adenocarcinoma risk in Barrett's esophagus with particular reference to short segment Barrett's esophagus and intestinal metaplasia 2006
Targeted esophageal biopsies: What you see is what you get (WYSIWYG) - Or not? 2006
Tonic inhibitory influence of the vagus in chronic experimental colitis 2006
Trichinella spiralis infection alters quality of mucins in previously H. pylori (HP) infected gerbils 2006
Vagal blocking for obesity control (VBLOC): Concordance of effects of very high frequency blocking current at the neural and organ levels using two preclinical models 2006
What determines the compromised quality of life in patients with irritable bowel syndrome (IBS)? 2006
What is the annualized risk of gastrointestinal bleeding from aspirin use? The results of pooled RCT trials 2006
What is the relationship between H-pylori and esophageal infection and esophageal malignancy? 2006
What patients with irritable bowel syndrome (IBS) expect from their health care providers. National survey on IBS educational needs and expectations 2006
Who consults with dyspepsia? A ten-year cross-sectional survey 2006
The GIST of a stromal tumor 2005
A community screening and treatment programme for H-pylori saves money: Ten-year follow-up of a randomized controlled trial 2005
A systematic review of the diagnosis of functional dyspepsia 2005
Baroreceptor sensitivity in IBS patients during colorectal distension 2005
Chemorepulsion in the guidance of vagal sensory axons that innervate the fetal gut: Expression of slit-1 in the gut and its receptor, robo-1 in nodose ganglia 2005
Chronic cough is a typical symptom of gastroesophageal reflux disease 2005
Depression enhances vulnerability to experimental colitis in maternally deprived mice. 2005
Differential regulation of colonic muscle contractility in Th1 and Th2 dominant environments 2005
Hypercontractility of intestinal muscle can be adoptively transferred by Th2 polarized lymphocytes 2005
Immune cells modulate visceral pain by endogenous opioid production. 2005
Intramural overexpression of monocyte chemoattractant protein-1 in mouse colon induces fibrosis via T-cell-depenclent mechanism 2005
Long term outcomes following laparoscopic surgery for rectal cancer 2005
Long-term gastrointestinal symptoms after Laparoscopic Nissen Fundoplication 2005
Post-infectious irritable bowel syndrome (IBS) after the walkerton outbreak of waterborne gastroenteritis (GE). 2005
Prospective study of functional bowel disorders two years after a food borne outbreak of acute viral gastroenteritis 2005
Proton pump inhibitor (PPI) treatment for peptic ulcer (PU) bleeding: An updated cochrane collaboration (CC) meta-analysis of randomized controlled trials (RCTs) 2005
Rectal 5ASA to maintain remission of distal ulcerative colitis (UC): a cochrane collaboration meta-analysis 2005
Symptom relief improves patients lives:: the Canadian feeling thermometer study in patients with uninvestigated reflux disease 2005
The diagnostic value of alarm features in predicting upper gastrointestinal malignancy in dyspeptic patients: Systematic review and meta-analysis. 2005
The effect of CYP2C19 polymorphisms on H-pylori eradication rates with PPI dual and triple first line therapies - a meta-analysis. 2005
The impact of reflux disease on health-related quality of life: Results from the GERD Feeling Thermometer Study 2005
The relationship of gut dysfunction and chronic parasitic infection; Implications for the pathogenesis of IBS 2005
What characterizes a pill placebo responder in a functional bowel clinical trial? 2005
What characterizes a response to cognitive-behavioral treatment in a functional bowel clinical trial? 2005
A retrospective case-control study to determine the risk of Barrett's esophagus according to ethnic origin 2004
Conjoint analysis (CA) of patient preferences for colorectal cancer (CRC) screening strategies 2004
Effect of H-pylori eradication on development of gastric and duodenal ulcers (GDU) in NSAID users: A meta-analysis 2004
Enteric netrins are chemoattractants for deleted in colorectal cancer (DCC)-expressing vagal sensory axons in the fetal gut 2004
Epidemiology of pediatric IBD in the Greater Toronto area 2004
Evidence that altered motility contributes to host defense in nematode infection 2004
Immunodeficiency and visceral hyperalgesia: A putative mechanism for abdominal pain in AIDS patients 2004
Increased intestinal permeability (IP) in subjects with irritable bowel syndrome (IBS) two years after the Walkerton outbreak of waterborne gastroenteritis 2004
Induction of colonic fibrosis in mice by intramural gene transfer of monocyte chemoattractant protein-1 2004
Inflammation of mouse jejunum induces long term excitation in DRG neurons projecting to the viscera 2004
Lactobacillus paracasei normalizes post-infective dysmotility in vivo and induces a sustained attenuation of inflammatory mediators 2004
Mast cells induce epithelial barrier dysfunction by activation of protease-activated receptor 2 (PAR2) 2004
Methodologic quality of trials affects estimates of treatment efficacy in functional (non-ulcer) dyspepsia: A meta-analysis based on two methodologic criteria scores 2004
Na-v 1.9 but not 1.8 current is augmented in DRG neurons innervating the viscera 3-5 weeks after transient inflammation of mouse jejunum 2004
Post infectious irritable bowel syndrome (PI-IBS) is transient following a foodborne outbreak of acute gastroenteritis attributed to a viral pathogen 2004
Previous Helicobacter pylori (Hp) infection and functional dyspepsia; a role for cellular rather than humoral immune activation in the maintenance of gastric motor dysfunction 2004
Prompt endoscopy versus a 'test and treat' strategy in the initial management of dyspepsia: An individual patient data meta-analysis of randomized controlled trials 2004
Robotically-assisted radiofrequency ablation of liver tumors: Comparison with standard manual techniques 2004
Role of supplemental calcium in the recurrence of colorectal adenomas: A meta-analysis of randomized controlled trials 2004
Screening for anal cancer in HIV-infected men 2004
Selective serotonin reuptake inhibitors (SSRIs) and risk of upper gastrointestinal bleeding: Confusion or confounding? 2004
The long-term natural history of dyspepsia, and the importance of the irritable bowel syndrome 2004
The role of CDId1 in host defense in intestinal nematode infection 2004
Ultrastructural injury to ICC is evident in the early stages of achalasia and is associated with mast cell infiltration 2004
Upper GI bleeding in Canada: 1993-1994 and 2002-2003 2004
Videofluoroscopy and image analysis: A new method for the simultaneous assessment of gastric emptying and upper gastrointestinal (GI) motility in humans 2004
A systematic review and economic analysis of the cost-effectiveness of proton pump inhibitor therapy in non-ulcer dyspepsia 2003
A systematic review of Helicobacter pylori eradication therapy in duodenal and gastric ulcer healing and maintenance 2003
A systematic review of the efficacy of proton pump inhibitors (PPIs), H2 receptor antagonists (H2RAs) and prokinetics in maintenance therapy of esophagitis 2003
Afferent intestinal mechanosensitivity during postoperative ileus in the mouse jejunum 2003
Behavioral abnormalities and increased local and systemic inflammatory responses in adult mice following maternal deprivation as neonates 2003
Can Canadian endoscopists predict lesions at uper Gi endoscopy (EGD)? An evaluation of the 'PAGE' program 2003
Cancer risk and inflammatory bowel disease in a Canadian populationȁa population-based study 2003
Commensal bacteria evoke production of the chemokine interleukin-8 from gut epithelia under metabolic stress 2003
Cortical evoked responses (CEP) to esophageal electrical stimulation before, and after, acid sensitization of viscero-afferent neural pathways 2003
Detrending fluctuation analysis of gastric pH reveals long-term correlations accentuated by acid suppression 2003
Early diagnosis or prevention of gastric cancer with H.pylori ȁTest and treatȁ? A discrete event simulation model 2003
Endoplasmic reticulum stress in mucosal smooth muscle cells upregulates hyaluronan deposition and leukocyte adhesion 2003
Enteric sensory neurons in the mouse: Identification, electrophysiology and morphology 2003
Gastroesophageal reflux is more prominent in western dyspeptics: A prospective comparison study of British and South East Asian patients with dyspepsia 2003
Home parenteral nutrition is cost-saving with low consumption of acute care resources 2003
How best to assess symptomatic outcomes of therapy in gastro-oesophageal reflux disease trials: A systematic review 2003
Interaction between CD40 and CD40 ligand is required in the development of intestinal muscle contractility and host immunity during nematode infection 2003
Is MRI colonography an appropriate alternative to screening colonoscopy? 2003
MCP-1 gene transfer enhances intestinal muscle contractility during nematode infection 2003
Magnet-tracing (MT) in the gastrointestinal (GI) tract: a new technique for non-invasive verification of nasogastric tube (NGT) placement 2003
Mood disorders and disease severity are the strongest predictors of health-related quality of life (HRQOL) in Crohn's disease and ulcerative colitis 2003
Neuronal remodeling and immune activation maintains gut dysfunction in a model of post-infective IBS 2003
Orocecal transit times (OCTT) in healthy subjects assessed by magnet-tracing (MT) and lactulose breath hydrogen test (LBHT) 2003
Outcome of laparoscopic approach for resection of rectal cancer 2003
Practice audit in gastroenterology - The PAGE program or upper GI endoscopy (EGD) 2003
Predictors of early versus late mortality after resection of hepatocellular carcinoma 2003
Risk factors for the onset of abdominal pain in children: A prospective population based study 2003
Role of calcium channels in extrinsic afferent sensitivity in the mouse jejunum 2003
Role of interstitial cells of cajal in the regulation of gastric compliance 2003
Smoking affects accuracy of lipid index as a marker of silent aspiration in GERD patients 2003
Socioeconomic burden of digestive disorders in Canada: A retrospective and descriptive analysis 2003
Strain-dependent effects of probiotics on intestinal muscle dysfunction in an animal model of post-infective irritable bowel syndrome 2003
Synergy of high salt diet and infection with the sydney strain of Helicobacter pylori infection results in gastric mucosal dysplasia in mongolian gerbils 2003
TGFB-induced changes in muscarinic receptor affinity and in the contractility of intestinal smooth muscle cells 2003
The ROME II definition of dyspepsia does not exclude patients with gastroesophageal reflux disease (GERD) in primary care 2003
The effects of gene transer of soluble TFG-β type II receptor and soluble VEGF type I receptor (Flt-1) in peritoneal fibrosis model of mice; balance between inflammation and fibrosis 2003
The prevalence of Barrett's esophagus in primary care patients with uninvestigated dyspepsia 2003
Validation of the short-form leeds dyspepsia questionnaire (SF-LDQ) in a community setting 2003
Variation in estimates of cost-effectiveness for colorectal cancer (CRC) screening: A systematic review 2003
Does laparoscopic Nissen fundoplication cause regression of Barrett's esophagus? 2002
Does laparoscopic anti-reflux surgery lead to chronic bowel dysfunction? 2002
Adenoviral-based gene delivery in the lower GI tract induces antigen-specific immune responses in the colonic mucosa 2002
Altered cerebral evoked response and esophageal sensory function in normoglycemic diabetes patients with visceral neuropathy 2002
Chloride channels in interstitial cells of Cajal play a major role in intestinal pacemaker activity 2002
Early life traumatic events increase the susceptibility of adult mice to experimental colitis 2002
Effect of high salt diet on the colonization and pathological changes of gastric mucosa in Mongolian gerbils infected with the Sydney strain of Helicobacter pylori 2002
Estrogen increases the severity of dextran sodium sulfate colitis through a mechanism that is independent of macrophage colony stimulating factor-1 (M-CSF-1) 2002
Extrinsic visceral afferent responses to luminal stimuli in mouse small bowel 2002
Health care use increases in inflammatory bowel disease with severe disease and mood disturbance 2002
High dose intravenous proton pump inhibition improved outcomes in unselected patients who undergo endoscopy for acute non-variceal upper GI bleeding 2002
Immunization against interleukin-9 impairs host protection in nematode infection 2002
Interleukin-9 enhances intestinal muscle contractility during nematode infection 2002
Long term alteration of intestinal muscle function following surgical manipulation in mice 2002
On the relationship of IBS and IBD: Estrogen induces a sustained increase in colonic substance P levels post DNB colitis. 2002
Patients with ulcerative colitis (UC) demonstrate abnormalities of autonomic function which are correlated with measures of anxiety 2002
Persistence of sensory and eating disturbances after H-pylori eradication in mice 2002
Proteases regulate intestinal epithelial barrier function by PAR-2 specific and non-specific mechanisms 2002
Psychosocial and environmental determinants of post-infective gut dysfunction in the mouse 2002
Reciprocal modulation of muscarinic receptors on smooth muscle cells by Th1 and Th2 cytokines 2002
Role of interstitial cells of Cajal as mechano-sensory receptors in the activation of gastric vagal afferent pathways 2002
Signal transducer and activator of transcription 6 (STAT6)-independent changes in muscarinic receptor properties in the inflamed murine intestine 2002
Smoking and inflammatory bowel disease: An effect of disease or disease location: A meta-analysis 2002
The burden of illness on families of pediatric patients with inflammatory bowel disease 2002
The effect of reduced duality of life on the subsequent development of dyspepsia and irritable bowel syndrome: A prospective cohort study 2002
The impact of functional gastrointestinal disorders on health-related quality of life: A population-based case-control study 2002
The influence of antibiotics on irritable bowel syndrome: A randomised controlled trial 2002
The relationship between chronic colonic inflammation and mechanosensitivity. 2002
Use of double blind randomized Bernstein test in diagnosis of functional heartburn 2002
6-mercaptopurine (6-MP) is more cost-effective than 5-aminosalicylates (5-ASA) for post-operative prophylaxis in Crohn's disease (CD). 2001
Altered and distinct cardioautonomic responses to esophageal stimulation (ES) in patients with GERD or with non-cardiac chest pain (NCCP) 2001
CD23 Fc epsilon RII (low affinity IgE receptor) is expressed on human epithelial cells and upregulated by IL-4 and LPS 2001
COX-2 specific inhibition with MK-0663 120 mg q.d. over 4 weeks did not increase fecal blood loss: A controlled study with placebo and ibuprofen 800 mg t.i.d. 2001
Ca+2-dependent Cl- secretion in T84 epithelia: Role of SOCs and Na+-K+ ATPase. 2001
Cancer risk and Crohn's disease in a Canadian population 2001
Characterization of early and late cerebral evoke responses (CEP) to stimulation of afferent esophageal pathways in humans 2001
Chronic H. pylori interaction induces functional and morphological changes in the neural system 2001
Chronic psychological stress inducer mucosal inflammation in the neum and colon of naive rats: Role of mast cells 2001
Chronic psychological stress induces epithelial barrier disruption, bacterial penetration, and mucosal inflammation in ileum and colon of naive rats 2001
Cortical evaked petential response (EP) to esophageal stimulation (ES) in healthy controls and patients with GERD or non-cardiac chest pain (NCCP) 2001
Early maternal deprivation predisposes adult rats to colonic mucosal barrier dysfunction in response to mild stress 2001
Effectiveness of prompt endoscopy in the management of dyspepsia: A systematic review. 2001
Estrogen decreases the acute inflammatory response in DNB-induced colitis in C57 BL/6 mice 2001
Evidence for cytokine-induced activation of signal transducer and activator of transcription 6 (STAT6) in human intestinal muscle cells 2001
Five year comprehensive follow-up on 181 patients after laparoscopic Nissen fundoplication 2001
Gastroesophageal reflux disease (GERD) symptoms (GS) in 5 European countries: a common and poorly understood condition 2001
Hepatic leukocyte recruitment in Inflammatory Bowel Disease 2001
IL-4 enhances transepithelial antigen transport by stimulating CD23/Fc epsilon RII (low affinity IgE receptor) expression on enterocytes of sensitized mice. 2001
Improvement in chronic gastroesophageal reflux disease related cough five years after laparoscopic fundoplication 2001
In Vivo motility disturbances in a model of post-infective IBS 2001
Intravenous acid suppression - Appropriateness of use in a tertiary care setting 2001
Intravenous proton pump inhibitors (IV PPI) for peptic ulcer hemorrhage (PUH): Meta-analysis of randomized controlled trials (RCTs) allowing endoscopic treatment 2001
Is prompt endoscopy necessary in uninvestigated dyspeptics? Prevalence of upper gastrointestinal abnormalities - The CADET-PE study. 2001
Laboratory proficiency in susceptibility testing of Helicobacter pylori using Agar Dilution and E test methods. 2001
Long-term follow up of Rigiflex pneumatic dilatation in the treatment of achalasia 2001
Long-term follow up on the surgical treatment of upper gastrointestinal neoplasms in familial adenomatous polyposis patients. 2001
Low frequency presynaptic stimulation selectively excites S neurons with descending axons in the guinea pig ileum 2001
Meta-analysis analysis of medical therapies for chronic anal fissure 2001
Modulation of experimental colitis in mice by the STAT6 pathway 2001
Mood disorders (MD) worsen health related quality of life (HRQOL) in inflammatory bowel disease (IBD) 2001
Neuro-immune interactions in the stomach of H. pylori infected mice: Role of lymphocytes 2001
PKC alpha antagonizes PKC epsilon-mediated cytoskeletal and membrane remodeling: Role of basolateral Ca+ entry. 2001
Prospective comparison of ileoscopy and biopsy (ICB) vs small bowel meal with pneumocolon (SBMP) in ileal Crohn's disease (CD). 2001
Rectal pain thresholds are higher, not lower in IBS patients with history of sexual/physical abuse. 2001
Risk factors for the onset of abdominal pain: A prospective population based study 2001
Safe home-care administration of infliximab 2001
Significant and rapid HRQoL improvement correlates with symptom relief in GERD patients using pantoprazole (Panto) as compared to nizatidine (Niza). 2001
Sustained increase of the pseudoaffective visceromotor response (VMR) to colorectal distention (CRD) in NIH/SWISS mice (NIH/SWISS) following Trichinella spiralis (Tsp.) enteritis 2001
The appropriateness of measuring the benefit of dyspepsia management in terms of quality adjusted life years 2001
The host specific differences in physiology of acid secretion related to prostaglandins may bias toward Helicobacter related mucosal injury. 2001
The role of TGF β in muscle hyper-contractility in a murine model of post-infectious irritable bowel syndrome 2001
“Test and treat” strategy for management of uninvestigated dyspepsia: A meta-analysis 2001
"Topical" phase effects of acetylsalicylic acid on human small bowel epithelium: Inhibition of oxidative phosphorylation and increased tight junction permeability 2000
A systematic review and economic analysis of the cost-effectiveness of H pylori eradication therapy in non-ulcer dyspepsia (NUD) 2000
A systematic review of pharmacological therapies in non-ulcer dyspepsia 2000
Activation and recruitment of mast cells are critical for stress-induced increased permeability of the rat colon 2000
Alternative medicine (AM) is widely used by ambulatory gastroenterology (GI) patients 2000
Association of family history of gastric cancer, intestinal metaplasia and high gastric juice ammonia in patients with Helicobacter pylori infection 2000
Both stress and colitis alter autonomic function in flinders rats 2000
Can symptoms be used to diagnose lactose intolerance? 2000
Chemokine expression and lymphocyte subsets in patients with idiopathic myenteric ganglionitis (IMG) 2000
Cholinergic nerve dysfunction in a model of murine intestinal inflammation is mediated by macrophage-colony stimululating factor (M-CSF)-dependent macrophages 2000
Chronic cough and gastroesophageal reflux — 5 year follow up after laparoscopic nissen fundoplication 2000
Colorectalert: A novel test for colorectal cancer screening 2000
Correlation of changes in clinical pain and abnormal stools with changes in visceral pain thresholds following treatment 2000
Corticotropin-releasing hormone-like peptides stimulate colonic epithelial physiology 2000
Cost analysis and quality of life assessments of palliation of malignant dysphagia by Nd:YAG laser 2000
Cost-effectiveness of strategies for managing dyspepsia in primary care: A discrete event simulation 2000
Diagnosis of helicobacter pylori infection in acute upper gastrointestinal haemorrhage; what is the best diagnostic test? 2000
Does regression of fundic gland polyps depend on stopping omeprazole use? 2000
Effect of purified forms of lipopolysaccharide from various strains of Helicobacter pylori and Helicobacter felis on acid secretion in vitro 2000
Endoscopy study comparing risedronate andalendronate in postmenopausal women 2000
Enhanced uptake of specific antigen by epithelial cells in sensitized mice: Role of IL-4, IgE and CD23 2000
Esomeprazole 40mg and 20mg is efficacious in the long-term management of patients with endoscopy-negative gerd: A placebo-controlled trial of on-demand therapy for 6 months 2000
Establishing patient preferences for one-stop gastrointestinal clinics using conjoint analysis 2000
Helicobacter pylori infection delays gastric emptying in mice 2000
Helicobacter pylori infection induces in vitro evidence of neural dysfunction in the murine gastric antrum 2000
How much are patients with dyspepsia willing to pay for endoscopy compared with an H pylori "test and treat" service? 2000
Hyperalgesic colonic sensory afferent pathways following T. spiralis enteritis: Involvement of NK1 receptors 2000
IL-10 and TGFB correct IL-4 enhanced uptake of macromolecules by human colonic epithelium. 2000
Immune requirements and inflammatory mediators in a murine model of post-infectious irritable bowel syndrome 2000
Immunohistochemical assessment of the interstitial cells of Cajal (ICC)in chronic intestinal pseudoobstruction (CIIP) 2000
Increased intestinal permeability precedes Crohn's disease (CD) in a subject with familial risk. 2000
Interleukin-4 induced hyper-contractility of human intestinal muscle cells is mediated via stat-6; Implications for motility changes in Crohn's disease 2000
Knowledge of a negative C-13-urea breath test reduces health care utilisation for dyspepsia in a population H pylori test and treat program. 2000
Long-term effects of acute trichinella spiralis (T.sp) infection on substance P levels in NIH swiss mice 2000
Managing dyspepsia in primary care: A systematic review 2000
Novel system for enhanced specific transepithelial antigen transport in sensitized rats is mediated by IgE/CD23 2000
Objective assessment of cognitive factors involved in visceral perception by using event-related cerebral evoked responses to esophageal target stimulation in man 2000
On the mechanisms underlying the protective role of M-CSF dependent macrophages in experimental colitis in mice 2000
Parasympathetic modulation of the severity of the acute inflammatory response to colonic acetic acid administration in rats 2000
Poor responders to proton pump inhibitors: Five year outcome after laparoscopic anti-reflux surgery 2000
Pseudo-obstruction associated with ICC abnormalities, hyperplasia and lymphocyte infiltration 2000
Self-reported accuracy of international classification of disease (ICD-9) coding of inflammatory bowel disease (IBD) by ontario physicians 2000
Severe colonic injury induced by local over-expression of the IL-12 gene in the mouse 2000
Supine duodeno-gastro-oesophageal bile reflux measured with the Bilitec-2000 appears to protect against the presence of microscopic intestinal metaplasia at the cardia 2000
Temporal separation of the dual effects of TGFB1 on epithelium: Early disruption in ion transport is followed by delayed increase in barrier function 2000
The cost-effectiveness of population H pylori screening and treatment to reduce mortality from gastric cancer and peptic ulcer complications: A Markov model using randomized controlled trial data. 2000
The disparity between mucosal inflammatory changes and muscle hyper- contractility in hapten-induced colitis in mice; implications for the relationship between inflammatory and functional bowel disorders in man 2000
The essential role of stat-6 in the development of muscle hypercontractility and worm expulsion in trichinella spiralis-infected mice 2000
The influence of psychosocial factors on health care utilization in patients with functional bowel disorders (FBD) 2000
The influence of psychosocial factors on health status in patients with functional bowel disorders (FBD) 2000
The role of macrophages in experimental colitis is dependent upon the manner in which the inflammation is induced 2000
The roles of interleukins-4 and −13 and STAT-6 in inflammation-induced hypercontractility of murine smooth muscle cells 2000
The severity of infectious gastroenteritis is not related to patient anxiety and depression 2000
The test and treat strategy for dyspepsia: Cost-effectiveness of the order of eradication strategies 2000
“Step-up” or step-down? A 4-week comparison of pantoprazole, 40 mg daily and nizatidine, 150 mg bid in symptomatic gastroesophageal reflux disease (GERD) 2000
Adaptation of rat colonic epithelial responses to acute stress involves opioid pathways. 1999
Addition of metronidazole to omeprazole and amoxicillin for second line H pylori eradication does not influence eradication rate: Results of a single-blinded randomised trial 1999
Adenoviral gene transfer of active TGF-beta to the colonic epithelium causes fibrosis and strictures 1999
Altered cerebral processing of perceived esophageal stimuli in non-cardiac chest pain (NCCP). 1999
Bismuth-based quadruple therapy with colloidal bismuth subcitrate plus tetracycline plus metronidazole (M) plus omeprazole in eradication of M sensitive and M resistant Helicobacter pylori 1999
Bone marrow reconstitution of WWv mice: Non myeloid C-kit dependent cells contribute to host defence against enteric infection 1999
C-13-urea breath test or H-pylori serology for the initial evaluation of young patients with ulcer-like dyspepsia: A decision analysis 1999
Causes of reoperation after laparoscopic Nissen Fundoplication. 1999
Changing patterns of H pylori gastritis in long-standing acid suppression 1999
Cholinergic modulation of intestinal inflammation. 1999
Chronic administration of glucagon-like peptide-2 (GLP-2) alters murine intestinal enterocyte form and function 1999
Chronic stress induces mast cell dependent epithelial changes in the rat jejunum and colon. 1999
Cost-effectiveness of acid suppression versus misoprostol in the prevention of non-steroidal antliinflammatory drug (NSAID)-induced ulcers 1999
Dexanabinol enema reduces the severity of experimental colitis in rats 1999
Differential effect of Th1 vs Th2 cytokines on acid secretion in mouse gastric glands: Possible significance in Helicobacter infection? 1999
Direct mechanosensory responses of myenteric neurons in the guinea pig duodenum 1999
Disturbed in vivo motor patterns in Trichinella spiralis infected mice 1999
Does eradication of Helicobacter pylori influence the recurrence of symptoms in patients with symptomatic gastro-oesophageal reflux disease? A randomised double blind study 1999
Effective inhibition of immune-mediated epithelial abnormalities by novel glucocorticoids. 1999
Endothelial-derived nitric oxide is an important mucosal defensive mechanism against bacterial invasion in experimental colitis 1999
Esophageal shortening in idiopathic achalasia and Chagas disease 1999
Evaluation of the use of botulinum toxin in children with achalasia 1999
Evidence for a nitrergic link in the opiate inhibition of stimulated acetylcholine (ACH) release from canine heal deep muscular plexus (DMP) nerve terminals 1999
Excellent outcome of first attack of ulcerative colitis in three regional cohorts 1999
Five year comprehensive follow-up of laparoscopic Nissen Fundoplication. 1999
Flexible sigmoidoscopy: Is it the best tolerated endoscopic procedure? 1999
Gastroesophageal reflux disease (GERD): Is the "acid test" sufficient? 1999
H pylori screening and treatment reduces dyspepsia in the community 1999
Helicobacter pylori (HP) infection does not affect gastric emptying in patients with functional dyspepsia (FD). 1999
Impact of chronic liver disease on patients' utilities 1999
Incidence of Crohn's disease (CD) and ulcerative colitis (UC) in three regional centers in England 1999
Increased gut epithelial apoptosis and mucosal atrophy after burn 1999
Increased pseudoaffective cardiac response and substance P immunoreactivity following Trichinella spiralis enteritis in rats with cholinergic hyperresponsiveness. 1999
Intestinal smooth muscle produces the intracellular and secrted forms of IL-15 protein in health and Crohn's disease. 1999
Lipid-laden macrophages in sputum is a marker of acid microaspiration 1999
Low mortality rate in Crohn's disease (CD and ulcerative cloitis (UC) in three regional centres in England 1999
Macrophages mediate the impairment of cholinergic nerve function during nematode infection in mice: Role for macrophage-colony stimulating factor 1999
Macrophages play a protective role during experimental colitis in the mouse 1999
Mucosal inflammation induced changes in smooth muscle contraction are a property of the muscle cell rather than the syncitium 1999
Nerve-mast cell interactions regulate acute corticotropin releasing hormone (CRH) induced abnormalities in rat colonic epithelium. 1999
Oral administration of intestinalflora antigens consisting of anaerobes reduces the severity of experimental acute colitis in BALB c mice 1999
Oral treatment with ethanol aggravates experimental colitis in mice 1999
Pathophysiology of the small intestinal epithelium during the late phase allergic reaction 1999
Population H pylori screening and treatment reduces dyspepsia costs. 1999
Positron emission tomography in the investigation of pediatric inflammatory bowel disease. 1999
Preliminary experience with cryotherapy (CTx) for liver metastases 1999
Rat colonic epithelial responses to antigen challenge are blunted by preceding stress and corticotropin releasing-hormone (CRH). 1999
Reproducibility, validity and responsiveness of a GERD specific symptom score 1999
Responsiveness of the IBS-QOL: Further validation of a disease specific quality of life measure for IBS 1999
Role of IL-4 in enhanced transepithelial uptake of specific antigen in intestine of sensitized mice. 1999
Role of bacterial products in activation of intestinal immune cells in Crohn's disease 1999
Second-line eradication for H-pylori after failure of therapy with proton pump inhibitor (PPI), clarithromycin and metronidazole: Results of a case series 1999
Seven days of omeprazole and clarithromycin with either amoxicillin or metronidazole for H-pylori eradication - Results of a single-blinded randomised trial in the community 1999
Small bowel meal with pneumocolon (SBMP) versus standard small bowel meal for the diagnosis of terminal ileal Crohn's disease: Incremental yield of double-contrast imaging 1999
Spontaneous exocrine pancreatitis in C2d MHC II deficient mice is accompanied by enteric nerve and muscle dysfunction 1999
Stress induced enhancement and reactivation of colitis involve different underlying immunological mechanisms 1999
Th cell cytokine profile in the Muscularis externa in Crohn's disease differs from that of the mucosa; implications for pathophysiology 1999
The autonomic response to esophageal stimulation is enhanced by rhythmic stimulation and decreased by irregular stimulation. 1999
The congnitive processing associated with perception of esophageal stimulation is enhanced in patients with non-cardiac chest pain (NCCP) 1999
The cortical evoked response associated with perception of an unpredictable esophageal stimulus is greater than with a regularly occurring stimulus. 1999
The cost-effectiveness of an H pylori screen and treat strategy in dyspeptic patients presenting in primary care 1999
The critical role of nitric oxide in the maintenance of colonic goblet cells 1999
The immuno-modulation of motility: The TH2 cytokine basis for increased intestinal muscle contractility in the nematode-infected mouse 1999
The neurogenic component of inflammation in experimental colitis is mediated by the NK-1 receptor 1999
The prevalence and severity of irritable bowel syndrome (IBS) in the community in those with and without a primary care diagnosis 1999
Variability in feeding practices of preterm infants <= 1.5kg 1999
What determines severity among patients with functional bowel disorders (FBD)? 1999
Why do irritable bowel syndrome (IBS) sufferers visit a primary care physician? 1999
Case cost and resource utilization for bleeding peptic ulcers: The Ontario GI bleed study. 1998
Determinants of case cost for non-variceal upper gastrointestinal hemorrhage at a Canadian community hospital. 1998
Early diagnosis of aspiration in patients with Steinert's disease by videofluoroscopy. 1998
Evidence of inflammatory pathogenesis in post-infectious irritable bowel syndrome. 1998
Manometric characteristics of pharyngeal peristalsis in patients with chronic neurologic diseases. 1998
Pain thresholds measured by the barostat predict the severity of clinical pain in patients with irritable bowel syndrome. 1998
Profound reduction in health-related quality of life in patients with chronic liver disease. 1998
The effectiveness and side effects of omeprazole, clarithromycin and tinidazole used in a community Helicobacter pylori eradication programme. 1998
The influence of dyspepsia, Helicobacter pylori status and irritable bowel syndrome on quality of life in the community. 1998
What proportion of dyspepsia in the general population is attributable to Helicobacter pylori? 1998
A GERD specific symptom score responsive to the effects of both medical and surgical therapy 1998
A systematic overview of the use of diary cards, quality of life questionnaires and psychometric tests in the treatment trails of Helicobacter pylori positive and negative non-ulcer dyspepsia 1998
Altered epithelial barrier function in a sensitized host is present in the absence of inflammation 1998
Bone marrow reconstitution of MHC II deficient mice: Defining the role of class II antigen presentation and CD4+VE T cells in intestinal inflammation and enteric muscle dysfunction 1998
Can pets ACT as a vector for Helicobacter pylori transmission? 1998
Changes in calcitonin gene-related peptide (CGRP) and substance P/tachykinin (SP/TK) immunoreactivity (IR) in sensory nerves of rats chronically infected with H. pylori (HP) 1998
Cortical and autonomic responses to perceived versus non-perceived esophageal stimuli in humans 1998
Expression of interleukin-15 (IL-15) by human intestinal muscle cells and in the Muscularis externa during disease states 1998
Focused cross-chimeric analysis of secretin/VIP ligand-receptor interactions 1998
Glucagon-like peptide-2 (GLP-2) reduces intestinal epithelial permeability of both the paracellular and transcellular pathway 1998
Health-related quality of life in pediatric inflammatory bowel disease: A comparison of parent and child reports 1998
Hospital procedure volume and hospital teaching status do not influence operative mortality or long-term survival for rectal cancer in a large general population: An outcomes study 1998
Immunomodulation of Helicobacter felis colonization of the mouse stomach 1998
Improvement in chronic cough two years after laparoscopic fundoplication 1998
Increased expression of the chemokines MCP-1 and eotaxin within the Muscularis externa during intestinal inflammation 1998
Increased tension generation by intestinal smooth muscle is mediated in part by leukotrienes and prostaglandins 1998
Increased worm expulsion and vagal response to gastric distention (GD) following T. Spiralis infection in a rat model of cholinergic hyperresponsiveness 1998
Inflamation-induced impairment of cholinergic nerve function is CD-4 independent in nematode-infected mice 1998
Inhibition of inflammation and anorexia by the novel anti-inflammatory drug dexanabinol (HU-211) 1998
Laparoscopic resection of inflammatory bowel disease 1998
Local over-expression of IL-5 within murine small bowel induces local and mucosal eosinophilia without alterations in muscle function 1998
Macrophages infiltrate intestinal muscle layers and myenteric plexus during T. Spiralis infection in mice 1998
Mobilization of epithelial stat-1 in response to mediators released from bacterial superantigen-activated immune cells 1998
Novel corticosteroids inhibit immune-mediated epithelial pathophysiology in a co-culture model of inflammation 1998
On the mechanism underlying post-infective intestinal dysfunction 1998
Optimizing gene transfer to the intestine: A comparison of three different techniques 1998
Oral administration of intestinal flora sonicate reduces severity of DDS-induced acute colitis in BALB/C mice 1998
Palliation of esophageal and colorectal cancer with YAG laser: Quality of life assessments 1998
Peripheral corticotropin releasing-hormone increases colonic permeability and ionic secretion through nicotinic pathways and mast cells 1998
Response to pantoprazole is an effective diagnostic test for gastro-esophageal reflux disease: Results of a randomised double-blinded placebo-controlled pilot study 1998
Spontaneous exocrine pancreatitis in MHC II deficient mice: Transferrable by autoreactive CD8+ve T cells 1998
Steroid sensitive motility failure 1998
Subchronic mild acoustic stress enhances the in vitro small intestinal permeability to intact protein in rats by increased endocytic transport 1998
Sumatriptan, a 5HT1 agonist, increases gastro-oesoph-ageal refflux 1998
Sustained increases of excitability of guinea pig myenteric AH neurons following their synaptic activation 1998
TGF-β and TGF-β receptor type II are not increased in colonic adenocarcinomas with Crohn's-like infiltrate 1998
TGFα over expression result in in vivo progression of a weakly tumorigenic colon cancer cells 1998
The effect of Helicobacter pylori infection on gastric emptying in patients with non-ulcer dyspepsia 1998
The facilitative role of epithelial barrier disruption in successful gene transfer to the colon 1998
The late phase reaction in rat intestine: Persistent pathophysiology after a single oral dose of antigen 1998
The onset and chronicity of experimental colitis is modulated by pro-inflammatory peptides 1998
The responses to nematode infection in a model of cholinergic hypersensitivity 1998
The role of pro-inflammatory peptides in the onset of intestinal inflammation 1998
The susceptibility to stress-induced reactivation of colitis requires CD4+ve but not CD8+ve T lymphocytes 1998
Two-lumen tubing is required for accurate barostat studies 1998
Validation of a disease specific health-related quality of life (HRQOL) instrument for pediatric inflammatory bowel disease (IBD) 1998
A comparative study of iNOS, nNos and eNOS inhibition in dinitrobenzene sulfonic acid-induced colitis in rats. 1997
A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group 1997
Adult social class as an independent risk factor for Helicobacter pylori. 1997
Alosetron slows colonic transit in patients with irritable bowel syndrome (IBS) 1997
Amelioration of experimental colitis by IL-4 gene transfer. 1997
Apparent increase in acid output during omeprazole (OME) after cure of H-pylori infection (HpI). 1997
Assessment of functional status in children and adolescents with inflammatory bowel disease (IBD). 1997
Barostat-controlled, rectal distention modifies heart rate variability in healthy subjects. 1997
Beneficial effects of IL-10 in ameliorating immune-mediated epithelial (T84) dysfunction depends on the type of immune cells and immune stimulus. 1997
C-kit receptor: Its role in the intestinal response to infection and inflammation. 1997
Changes in neurokinin 1 receptor (NK1-R) expression and its preferred ligand substance P (SP) immunoreactivity (IR) in a model of intestinal inflammation 1997
Cholinergic hypersensitivity is responsible for predisposition to stress and stress-induced intestinal transport abnormalities in Wistar Kyoto rats. 1997
Cholinergic modulation of gastric electrical activity in rats 1997
Cigarette smoking aggravates experimental colitis in the rat. 1997
Cognitive P300 evoked potential responses to esophageal stimulation in man. 1997
Convergence of stress and intestinal lumenal exposure to hapten are required for the reactivation of colitis in the mouse. 1997
Cooperation between neural and myogenic mechanisms in the control of distention induced peristalsis comparison with W-mutant mice. 1997
Correlation of electrophysiology, morphology, chemistry and projections of myenteric neurons in the duodenum of the guinea pig. 1997
Distribution of peptidergic nerves in the enteric nervous system of MHC II knockout mice in the absence and presence of pancreatitis. 1997
Dyspepsia and irritable bowel syndrome in the community. 1997
Early invasion of lymphocytes and macrophages into the musculature may mediate changes in interstitial cells of Cajal and intestinal peristaltic activity after a Trichinella spiralis infection. 1997
Effects of lipids on antropyloric motility and gastric emptying are mediated through both CCKA and CCKB receptors. 1997
Esophageal and lower esophageal motor function after laparoscopic Nissen fundoplication. 1997
Expression of two isoforms of neuronal nitric oxide synthase in the intestine of rats; Selective down-regulation during inflammation. 1997
FDG-PET: An investigative tool in pediatric inflammatory bowel disease 1997
Further evidence that sumatriptan induced chest pain is oesophageal in origin: Effect on oesophageal visceral sensation. 1997
Gastrointestinal bleeding in Canadian osteo and rheumatoid arthritis patients. 1997
Gene transfer to monocytes & macrophages: Potential target for gene therapy of intestinal inflammation. 1997
Increased T84 epithelial monolayer permeability induced by enterohemorrhagic Escherichia coli involves the activation of protein kinase C. 1997
Influence of siblings on risk of Helicobacter pylori infection. 1997
Inhibition of intestinal food allergic reactions by treating sensitized mice with mPEG-conjugated antigen via the intragastric (IG) route. 1997
Interleukin-10 gene therapy prevents the occurrence but doesn't reverse experimental colitis. 1997
Laparoscopic fundoplication provides an excellent symptom control and improvement in QOL in poor responders to omeprazole. 1997
Mutations in distinct domains of the secretin receptor lead to constitutive activation. 1997
Need for monitoring of swallowing during ambulatory esophageal manometry. 1997
Neural involvement in the bivalent action of nicotine on experimental colitis in rats. 1997
One week clarithromycin 500 mg bid is better than 250 mg bid for eradicating Helicobacter pylori (H pylori) infection when combined with proton pump inhibitor (P) and metronidazole (M) or amoxicillin (A): A meta-analysis 1997
Optimal electrical stimulus for esophageal evoked potentials: Transmural or intraesophageal? 1997
Prevalence of Helicobacter pylori in patients presenting with bleeding peptic ulcers. 1997
Reciprocal interactions between T cells and intestinal muscle cells; Role of IL-4 in host defense. 1997
Regional differences in the effects of neuropeptides on the proliferation of smooth muscle cells from rabbit antrum and colon. 1997
Resource utilization for non-variceal upper gastrointestinal hemorrhage (UGIH): Profile at a Canadian community hospital. 1997
Role of extracellular cysteines in secretin receptor structure and function. 1997
Spontaneous exocrine pancreatitis in C2D MHC II deficient mice: Mediation by CD8+ve T lymphocytes 1997
Stress-induced epithelial pathophysiology in the colon: Increased uptake of bacterial products and antigenic proteins may be responsible for symptoms in IBD. 1997
Substance P (SP) mediated plasma extravasation in the gastrointestinal tract due to activation of the neurokinin 1 receptor (NK1-R) and does not occur in NK1-R knockout mice. 1997
The autonomic response to esophageal stimulation is enhanced by the involvement of cortical pathways. 1997
The brain gut axis in IBD: Stress reactivation of experimental colitis in rats requires concomitant luminal hapten challenge. 1997
The magnitude of the cerebral evoked response to mechanical stimulation in the esophagus depends on stimulation frequency. 1997
The modulation of intestinal smooth muscle contraction by interleukin-5 (IL-5) and eosinophils; Studies in nematode-infected IL-5 knockout mice. 1997
The optimum 5 day therapy against Helicobacter pylori. 1997
Two phases of transepithelial antigen transport in sensitized intestine demonstrated by studies in mast cell deficient rats. 1997
Two year comprehensive follow-up in 108 patients after laparoscopic Nissen fundoplication. 1997
Which combination therapy can eradicate >=90% Helicobacter pylori (H-pylori) infection?: A meta-analysis of amoxicillin, metronidazole, tetracycline and clarithromycin containing regimens. 1997
Zinc sulphate induces healing in two models of experimental colitis in rats by a mechanism other than superoxide dismutase activity. 1997
A Canadian multi-centre survey of gastrointestinal bleeding: Economic considerations. 1996
A low resting vagal tone predicts response to acid perfusion in patients with esophageal symptoms. 1996
A novel component of the neuro-immune axis in the gut: Neural modulation of cytokine production by intestinal smooth muscle. 1996
A psychobiophysiological model for the irritable bowel syndrome (IBS). 1996
Altered neuro-muscular function in the inflamed murine intestine 1996
Autonomic response to esophageal acid perfusion in patients with esophageal symptoms. 1996
Barostat-controlled esophageal balloon distension produces a pressure-dependent heart rate decrease in healthy subjects 1996
Characterization of 5-HT and H+ sensitive sensory pathways within the guinea-pig ileum 1996
Characterization of myenteric P-2X-purinoceptors: Evidence for a new subtype. 1996
Corticosteroid-induced down-regulation of IL-6 gene expression in rat intestinal smooth muscle and splenic adherent cells 1996
Differences in acid secretory response and serology in H-pylori positive patients after successful and failed triple therapy 1996
Do younger patients with Helicobacter pylori (HP) infection have a higher risk of gastric cancer? A meta analysis of the relationship between HP seropostivity and gastric cancer (GC) 1996
Effect of curing H-pylori (Hp) infection on the pH-raising effect of ranitidine (RAN) in duodenal ulcer (DU) patients 1996
Enterohemorrhagic Escherichia coli infection alters tight junction permeability through a protein kinase C-dependent pathway and stimulates ion secretion in infected T84 epithelial cells. 1996
Gastritis and enterocolitis with altered colonic muscle function in MHC II knockout mice. 1996
H-pylori related increase in omeprazole (OME) effect is associated with ammonia production. 1996
How would Canadian physicians manage dyspepsia if an H-pylori (Hp) test were readily available. 1996
Interleukin-4 gene transfer to the intestine causes inflammation and muscle dysfunction in the mouse 1996
Intestinal inflammation induced by non-pathogenic non-toxigenic E-coli. 1996
Intestinal smooth muscle cells (ISMCs) modulate interleukin-4 (IL-4) synthesis by T cells. 1996
Intestinal smooth muscle cells attenuate T-cell apoptosis in vitro 1996
Intragastric pH and omeprazole (OME): Role of Helicobacter pylori (HP) and HP-associated gastritis. 1996
Irreversible fall of efficacy of omeprazole (OME) after cure of H-pylori (Hp) infection in duodenal ulcer (DU) patients 1996
Laparoscopic vs open intra-operative ultrasound of the liver. 1996
Low pressure, unperceived, barostat-controlled esophageal distension decreases heart rate in healthy subjects 1996
Nitric oxide regulates gastric tone through a central or presynaptic action on cholinergic nerves 1996
Opossum peritoneal mast cells are insensitive to acid. 1996
Production of volatile amines by Helicobacter pylori (HP) is not relevant in vivo. 1996
Proinflammatory cytokines impair enteric nerve function through the action of leukemia inhibitory factor (LIF). 1996
Prospective randomized control trial to evaluate the use of bupivacaine in laparoscopic cholecystectomy port sites 1996
Rapid transcellular antigen uptake mechanism delivers antigen to effector cells in < 2 min in intestine 1996
Rectal corticosteroids (CS) are not the best therapy for distal ulcerative colitis (UC). 1996
Selective distribution of changes in substance P tachykinin (SP/TK) and calcitonin gene-related peptide (CGRP) containing neurons within and outside the gut during intestinal inflammation. 1996
Sensory neuropeptide modulation of T cell activation by intestinal smooth muscle cells (ISMCs). 1996
Spontaneous pancreatitis leads to selective exocrine pancreas loss in MHC II knockout mice. 1996
Steroid resistant inflammation in an excluded inflamed loop of bowel in the rat. 1996
Sumatriptan at a therapeutic dose alters oesophageal motility. 1996
T lymphocyte activation by anti-CD3 disrupts small bowel propulsive activity. 1996
T-lymphocyte reconstitution in athymic rats restores stress-induced reactivation of colitis. 1996
TH-1 and TH-2 cytokines differ in their effect on smooth muscle contractility in the rodent gut. 1996
The amplitude of the cerebral evoked response to electrical stimulation of the esophagus is intensity-dependent. A dose-response study. 1996
The diagnosis of Helicobacter pylori infection in a tertiary care centre by detection of salivary antibodies 1996
The effect of cisapride on gastric emptying in the critically ill patient. 1996
The enteric nervous system in a murine model of postinfectious irritable bowel 1996
The role of VIP in the control of motor patterns of the rat ileum in vitro 1996
The use of prokinetic agents in diabetic gastroparesis: A meta-analysis 1996
A PREDICTIVE MODEL OF MUCOSAL DAMAGE IN GERD USING AREA-UNDER-THE-CURVE ESTIMATION OF HYDROGEN-ION ACTIVITY (AUC H+) 1995
ACTIVATED MONOCYTES/MACROPHAGES STIMULATE ION SECRETION OF T84 EPITHELIUM AND IMPAIR ITS BARRIER FUNCTION 1995
AN ORALLY-ACTIVE NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONIST (BOSENTAN) MARKEDLY REDUCES INJURY IN A RAT MODEL OF COLITIS 1995
Budesonide inhibits immune cell activation and epithelial pathophysiology in co-culture studies 1995
CHANGES IN ENTERIC NEURAL FUNCTION IN EXPERIMENTAL COLITIS ARE NOT T-LYMPHOCYTE DEPENDENT 1995
COST-EFFECTIVENESS OF ALTERNATIVE STRATEGIES FOR THE LONG-TERM MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE (GERD) 1995
COST-EFFECTIVENESS OF HELICOBACTER-PYLORI (HELICOBACTER-PYLORI) ERADICATION IN THE LONG-TERM MANAGEMENT OF DUODENAL-ULCER 1995
Differential Ca2+ sensitivity of two pacemaking networks in the canine ileum 1995
EFFECT OF GLP-1 ON ANTROPYLORIC MOTILITY, TRANSPYLORIC FLOW AND GASTRIC-EMPTYING OF NONNUTRIENT LIQUIDS IN CONSCIOUS DOGS 1995
EFFECT OF REVERSIBLE VAGOTOMY ON ANTRAL AND PYLORIC REGULATION OF TRANSPYLORIC FLOW 1995
Effect of curing Helicobacter pylori (HP) infection on intragastric pH during omeprazole treatment 1995
Efficacy of ten days of clarithromycin, amoxicillin and omeprazole in eradicating Helicobacter pylori infection 1995
Enteroglial cells (EGC) are an integral part of the neuroimmune axis in the enteric nervous system (ENS) 1995
GENETIC SUSCEPTIBILITY TO INTESTINAL HYPERSENSITIVITY IS RELATED TO INCREASED CHOLINERGIC ACTIVITY 1995
IMMUNE CELL-INTERACTIONS IN T-CELL-INDUCED EPITHELIAL PATHOPHYSIOLOGY 1995
IMMUNE REGULATION BY INTESTINAL SMOOTH-MUSCLE CELLS (ISMCS) 1995
INCIDENCE OF DYSPHAGIA FOLLOWING LAPAROSCOPIC NISSEN FUNDOPLICATION 1995
INTERLEUKIN-1-BETA (IL-1-BETA) AND TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) POTENTIATE IMMUNE ACTIVATION BY INTESTINAL SMOOTH-MUSCLE CELLS (ISMCS) 1995
INTERPLAY OF VIP, NITRIC-OXIDE AND MOTOR PATTERNS OF THE RAT ILEUM IN-VITRO 1995
INTESTINAL AND COLONIC MUSCLE DYSFUNCTION AN ANIMAL-MODEL OF POSTINFECTIOUS IRRITABLE BOWEL 1995
INTESTINAL INFLAMMATION AND MUSCLE DYSFUNCTION IN MHC-II KNOCKOUT MICE 1995
MODULATORY EFFECT OF T-LYMPHOCYTES ON EXPERIMENTAL COLITIS IN RATS 1995
MUCOSAL MAST-CELLS (MMC) NUMBERS ARE NORMAL IN BIOPSIES OF PATIENTS WITH IRRITABLE-BOWEL-SYNDROME (IBS) 1995
ON THE IMMUNOLOGICAL BASIS FOR STRESS-INDUCED REACTIVATION OF COLITIS IN THE RAT 1995
OPPOSING EFFECTS OF NEUROPEPTIDE-Y AND SUBSTANCE-P IN THE REGULATION OF INTESTINAL HYPERSENSITIVITY REACTIONS 1995
PROTRACTED GASTRIC-ACID SECRETION IN HELICOBACTER-PYLORI POSITIVE DU PATIENTS FOLLOWING ERADICATION 1995
PSYCHOLOGICAL-FACTORS PRECEDE THE ONSET OF IRRITABLE-BOWEL-SYNDROME 1995
Role of laparoscopic nissen fundoplication in control of cough in patients with gastroesophageal reflux 1995
STRESS-ENHANCED EPITHELIAL PERMEABILITY TO ANTIGENIC PROTEINS IS MEDIATED BY CHOLINERGIC MECHANISMS AND OCCURS VIA BOTH TRANSCELLULAR AND PARACELLULAR PATHWAYS 1995
THE EFFECT OF ERADICATION OF HELICOBACTER-PYLORI (HP) ON SYMPTOMS OF NONULCER DYSPEPSIA (NUD) - A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL 1995
When should the position of Z-line and hiatus be measured during upper gastrointestinal endoscopy (UGE)? 1995
ENTEROGLIAL CELLS - PUTATIVE PLAYERS IN THE IMMUNOMODULATION OF NEURAL FUNCTION IN THE INFLAMED INTESTINE 1994
CARDIAC EFFECTS OF ESOPHAGEAL STIMULATION IN HEALTHY-VOLUNTEERS 1994
CHOLINE-ACETYLTRANSFERASE (CHAT) IMMUNOREACTIVITY IN PARAFFIN SECTIONS OF HIRSCHSPRUNGS INTESTINES 1994
COMPARISON OF WHOLE CRYPT DISSECTION TO PCNA IMMUNOHISTOCHEMISTRY TO MEASURE RECTAL MUCOSAL PROLIFERATION 1994
CYTOKINE-INDUCED CLASS-II MAJOR HISTOCOMPATIBILITY ANTIGEN COMPLEX AND INTRACELLULAR ADHESION MOLECULE EXPRESSION ON MURINE INTESTINAL SMOOTH-MUSCLE CELLS 1994
DOWN-REGULATION OF SUBSTANCE-P RECEPTOR, NK-1 IN TRICHINELLA-SPIRALIS INFLAMED INTESTINE OF RAT 1994
DUODENAL-ULCER RECURRENCE AFTER HELICOBACTER-PYLORI (HP) ERADICATION - A METAANALYSIS 1994
EFFECT OF L-NNA ON ANTROPYLORIC MOTILITY, TRANSPYLORIC FLOW AND GASTRIC-EMPTYING OF NONNUTRIENT LIQUIDS IN CONSCIOUS DOGS 1994
ENTEROGLIAL CELLS FROM RAT MYENTERIC PLEXUS EXPRESS INTERLEUKIN-1-BETA AND INTERLEUKIN-6 MESSENGER-RNA 1994
ENTEROPATHOGENIC ESCHERICHIA-COLI INFECTION ALTERS T84 EPITHELIAL-CELL BARRIER AND TRANSPORT-PROPERTIES 1994
ERADICATION OF HELICOBACTER-PYLORI (HP) - A METAANALYSIS 1994
IDENTIFICATION OF AREAS INDUCING RHYTHMIC MYOGENIC ACTIVITY BY IMAGE-ANALYSIS OF RAT ILEUM IN-VITRO 1994
IMMUNE RECONSTITUTION OF MYCOBACTERIUM-PARATUBERCULOSIS (MPTB) INFECTED SCID BG MICE ENHANCES INTESTINAL PATHOPHYSIOLOGY 1994
INCREASED INTESTINAL IMMUNOPHYSIOLOGICAL RESPONSES IN RATS WITH A GENETIC PREDISPOSITION TO REACTIVE DEPRESSION 1994
INCREASED MUSCLE-CONTRACTION IN THE NEMATODE-INFECTED MOUSE - AN IMMUNOLOGICALLY MEDIATED ADAPTIVE RESPONSE TO INFECTION 1994
INTERLEUKIN-1-BETA INDUCES THE EXPRESSION OF INTERLEUKIN-6 IN INTESTINAL SMOOTH-MUSCLE CELLS 1994
INTERLEUKIN-1-BETA INHIBITS SODIUM-PUMP ACTIVITY IN THE SMALL-INTESTINE OF RAT 1994
IS THERE AN INFLAMMATORY BASIS FOR A SUBSET OF PATIENTS PRESENTING WITH DIARRHEA IN THE IRRITABLE-BOWEL-SYNDROME 1994
LANSOPRAZOLE AND OMEPRAZOLE, AT THERAPEUTIC DOSES, PRODUCE EQUIVALENT RISES IN GASTRIC PH IN HELICOBACTER-PYLORI (HP) POSITIVE SUBJECTS 1994
LAPAROSCOPIC NISSEN FUNDOPLICATION - AN ALTERNATIVE TO LONG-TERM OMEPRAZOLE THERAPY FOR GERD 1994
LONG-TERM STRATEGIES TO PREVENT DUODENAL-ULCER (DU) - A METAANALYSIS 1994
MAPPING OF CEREBRAL RESPONSE TO VAGAL AND ESOPHAGEAL STIMULATION USING POSITRON EMISSION TOMOGRAPHY (PET) AND TOPOGRAPHIC EEG IN HUMANS 1994
MAST CELL-DEPENDENT AND INDEPENDENT COMPONENTS IN INTESTINAL HYPERSENSITIVITY 1994
MULTIDISCIPLINARY MULTIMODALITY TREATMENT OF ESOPHAGEAL CANCER 1994
MURINE TRICHINOSIS - A MODEL OF POST-INFECTIVE SMOOTH-MUSCLE DYSFUNCTION 1994
PHYSICAL-ACTIVITY AND THE RISK OF COLORECTAL ADENOMAS 1994
PROSTAGLANDINS AND MACROPHAGE-LIKE CELLS ARE INVOLVED IN SYNERGISTIC INTERACTIONS OF CYTOKINES IN RAT MYENTERIC PLEXUS (MP) 1994
RAPID ATTENUATION OF CORTICAL EVOKED-POTENTIALS TO ELECTRICAL AND MECHANICAL ESOPHAGEAL STIMULATION 1994
REDUCED GASTRIC-ACID SECRETION IN THE HELICOBACTER-FELIS-INFECTED MOUSE 1994
RELATIONSHIP OF INTESTINAL MUCOSAL MAST-CELLS (IMMC) WITH NERVES IN AGANGLIONIC (HIRSCHSPRUNGS) COLON 1994
REPRODUCIBILITY AND VARIABILITY OF RECTAL MUCOSAL PROLIFERATION INDEX USING PCNA 1994
ROLE OF CHOLINERGIC MECHANISMS IN STRESS-INDUCED INTESTINAL SECRETION AND PERMEABILITY ABNORMALITIES IN THE RAT 1994
SHORT-TERM EFFECT ON ACID SECRETORY RESPONSE AND PARIETAL-CELL SENSITIVITY IN HELICOBACTER-PYLORI POSITIVE DU PATIENTS FOLLOWING ERADICATION 1994
STRESS-INDUCED REACTIVATION OF EXPERIMENTAL COLITIS IS ASSOCIATED WITH AN EXAGGERATED ALTERATION IN MYENTERIC NEURAL FUNCTION IN THE RAT 1994
SUPPRESSION OF FOOD-INTAKE DURING EXPERIMENTAL COLITIS - EFFECT OF SYSTEMIC INHIBITION OF NITRIC-OXIDE SYNTHESIS 1994
T-LYMPHOCYTE DEPENDENCE OF PERSISTENT INTESTINAL MUSCLE DYSFUNCTION - POSTINFECTION BY TRICHINELLA-SPIRALIS IN THE MOUSE 1994
THE ROLE OF NITRIC-OXIDE IN INTESTINAL INFLAMMATION IN RATS IS DEPENDENT ON THE MANNER IN WHICH INFLAMMATION IS INDUCED 1994
THE SELECTIVE BENEFICIAL-EFFECTS OF NITRIC-OXIDE INHIBITION IN EXPERIMENTAL COLITIS 1994
TNF-ALPHA CAUSES EPITHELIAL (T84) PERMEABILITY AND SECRETORY ABNORMALITIES IN A COCULTURE MODEL OF INFLAMMATION 1994
TOPICAL AMINOSALICYLATE (ASA) THERAPY FOR DISTAL ULCERATIVE-COLITIS - A METAANALYSIS 1994
VERAPAMIL INHIBITS INTERLEUKIN-1-BETA MEDIATED HYPERPLASIA OF HUMAN INTESTINAL SMOOTH-MUSCLE 1994
A COMPARISON OF 2 METHODS FOR THE ENDOSCOPIC ASSESSMENT OF REFLUX ESOPHAGITIS (RO) 1993
A NEW STUDY DESIGN EXPLAINS LACK OF TREATMENT EFFICACY IN IRRITABLE-BOWEL-SYNDROME (IBS) 1993
ACTION OF PINAVERIUM BROMIDE ON ACTION-POTENTIAL GENERATION IN CIRCULAR AND LONGITUDINAL COLONIC SMOOTH-MUSCLE 1993
ACTIVATION OF MAST-CELLS BY SUBSTANCE-P IN THE REGULATION OF ION SECRETION IN MOUSE SMALL-INTESTINE 1993
ACTIVATION OF T-LYMPHOCYTES CAUSES INCREASED PERMEABILITY OF T84 EPITHELIAL MONOLAYERS AND REDUCES RESPONSES TO SECRETAGOGUES 1993
ALTERED MYENTERIC PLEXUS FUNCTION IN EXPERIMENTAL COLITIS IN THE RAT 1993
ANOREXIA IN EXPERIMENTAL COLITIS IS MEDIATED BY INTERLEUKIN-1 AT BOTH A PERIPHERAL AND CENTRAL LEVEL 1993
AUTOINDUCTION OF INTERLEUKIN-1-BETA GENE-EXPRESSION IN ENTERIC SMOOTH-MUSCLE CELLS 1993
BUDESONIDE ENEMAS PREVENT EXTENSIVE CHANGES IN THE ENTERIC NERVOUS-SYSTEM IN RATS WITH EXPERIMENTAL COLITIS 1993
CHOLINE ACETYLTRANSFERASE-IMMUNOREACTIVITY IN PARAFFIN SECTIONS OF RAT AND HUMAN INTESTINES 1993
CHRONIC INFLAMMATION, ALTERED FUNCTION AND STRUCTURE OF DISTAL SMALL-INTESTINE APPEAR DOSE DEPENDENT IN MYCOBACTERIUM-PARATUBERCULOSIS INFECTED SCID BG MICE 1993
DISTAL COLITIS CAUSES CHANGES IN ENTERIC NERVE FUNCTION AT DISTANT NONINFLAMED SITES IN THE GUT 1993
DOES RAPID HEALING OF PEPTIC-ULCER PREDISPOSE TO EARLIER RELAPSE 1993
DOWN-REGULATION OF DIPEPTIDYL PEPTIDASE-IV (DPPIV, EC 3.4.14.5) IN THE INFLAMED INTESTINE OF RATS INFECTED WITH TRICHINELLA-SPIRALIS 1993
DUODENOGASTRIC REFLUX (DGR) MONITORING - IS GASTRIC PH-METRY ADEQUATE 1993
EFFECT OF REGION, TEMPERATURE AND NEURONAL BLOCKADE ON THE MOVEMENT OF SODIUM AND CR-51 EDTA ACROSS CANINE GASTROINTESTINAL MUCOSAE 1993
EXPRESSION OF SMOOTH-MUSCLE SPECIFIC ISOFORMS OF ACTIN MESSENGER-RNA IN THE INFLAMED INTESTINE OF RAT 1993
EXPRESSION OF SUBSTANCE-P MESSENGER-RNA IN THE INFLAMED INTESTINE OF RAT 1993
FACTORS THAT INFLUENCE SUBSTANCE-P EXPRESSION IN RAT MYENTERIC NERVES 1993
GASTRIC AND PYLORIC MOTOR RESPONSE TO INTRADUODENAL LIPID INFUSION AFTER VAGOTOMY AND PYLOROPLASTY 1993
GASTRIC-JUICE IMMUNOGLOBULINS - IMMUNOPHYSIOLOGICAL INTERACTION IN HELICOBACTER-PYLORI INFECTION 1993
INCREASED CHOLINERGIC EXCITATION OF COLONIC SMOOTH-MUSCLE BY SEROTONIN IS MEDIATED BY 5HT1C AND OR 5HT2 RECEPTORS 1993
INFLUENCE OF PERSONALITY-CHARACTERISTICS (PC) AND STRESS (S) ON DUODENAL-ULCER (DU) RECURRENCE (R) 1993
INTERLEUKIN-8 SECRETION BY GASTRIC EPITHELIUM FOLLOWING HELICOBACTER-PYLORI INFECTION INVITRO 1993
LUMINAL DISTENSION, MOTILITY PATTERNS AND LUMINAL TRANSPORT IN ISOLATED ARTERIALLY PERFUSED RAT ILEUM 1993
MECHANICAL CORRELATES OF INTESTINAL FLUID-FLOW IN AN ISOLATED ARTERIALLY PERFUSED RAT ILEUM 1993
NSAID AND PEPTIC-ULCER THERAPY IN PATIENTS WITH GASTRODUODENAL ULCER (GU DU) 1993
PARIETAL-CELL SENSITIVITY - THE EFFECTS OF ERADICATING HELICOBACTER-PYLORI IN DU PATIENTS VS NORMAL VOLUNTEERS (NV) 1993
PATTERN OF ANTROPYLORODUODENAL MOTOR-ACTIVITY AFTER VAGOTOMY AND PYLOROPLASTY IN FED STATE 1993
POTENTIATING INTERACTIONS BETWEEN INTERLEUKIN-1 AND INTERLEUKIN-6 IN RAT MYENTERIC PLEXUS - EFFECTS ON H-3 NORADRENALINE (H-3-NA) RELEASE 1993
PRESERVATION OF ANTRAL INTRAMURAL NEURAL PATHWAYS BY USE OF A MUSCLE BRIDGE 1993
RATES OF DUODENAL-ULCER (DU) HEALING BY DRUG CLASSES - A METAANALYSIS 1993
RECURRENT ABDOMINAL-PAIN (RAP), LACTOSE-INTOLERANCE AND INTESTINAL PERMEABILITY (IP) IN BLASTOCYSTIS HOMINIS (BH) INFECTION 1993
SEASONAL ULCERS - GASTRIC-ACID SECRETION UNALTERED BY MELATONIN 1993
SEMIELEMENTAL (S-E) DIET VS PREDNISONE IN PEDIATRIC CROHNS-DISEASE 1993
STRESS INCREASES INTESTINAL EPITHELIAL PERMEABILITY, STIMULATES ION SECRETION, AND ALTERS ENTERIC NERVE FUNCTION IN THE RAT 1993
STRESS-INDUCED EXACERBATION OF EXPERIMENTAL COLITIS IN THE RAT 1993
THE CORTICAL EVOKED-RESPONSES PRODUCED BY BALLOON DISTENSION AND ELECTRICAL-STIMULATION OF THE ESOPHAGUS INVOLVE DIFFERENT AFFERENT VAGAL FIBERS 1993
THE ROLE OF TRANSRECTAL ULTRASOUND (TRUS) IN THE FOLLOW-UP OF ENDOCAVITARY RADIATION (RT-50) TREATED RECTAL-CANCER 1993
WATER-QUALITY AND TRANSMISSION OF BLASTOCYSTIS HOMINIS (BH) 1993
Electrical communication in areas with and without gap junctions in canine colon 1992
Gradient of membrane potential in circular muscle of canine colon is caused by electrical interaction between different cell types 1992
Immunohistochemical localization of a gap junction protein in muscularis externa of murine, canine and human intestine 1992
Methylene blue and light selectively lesioned interstitial cells of Cajal in canine colon 1992
INTERSTITIAL-CELLS OF CAJAL MEDIATE QUINIDINE AND QUININE EFFECTS ON THE CIRCULAR MUSCLE OF THE DOG COLON 1988
MECHANISMS OF PACEMAKER GENERATION IN COLONIC CIRCULAR MUSCLE .1. ROLE OF THE SODIUM-PUMP 1988
MECHANISMS OF PACEMAKER GENERATION IN COLONIC CIRCULAR MUSCLE .2. IONIC BASIS 1988
PSYCHOLOGICAL STRESS AS A PROVOCATION TEST FOR NONCARDIAC CHEST PAIN 1988
A COMPARATIVE-STUDY OF INTESTINAL PERMEABILITY IN PEDIATRIC AND IN ADULT PATIENTS WITH INFLAMMATORY BOWEL-DISEASE 1988
ABNORMAL NERVOUS REGULATION OF INTESTINAL ION-TRANSPORT IN MAST CELL-DEFICIENT WBB6F1-W/WV MICE 1988
ADAPTIVE RESPONSE TO SLOW INTRAESOPHAGEAL ACID INFUSION 1988
CHANGES IN MAST-CELLS, NERVES AND THE EPITHELIUM CONTRIBUTE TO ION-TRANSPORT ABNORMALITIES DURING PARASITE-INDUCED INTESTINAL INFLAMMATION IN THE RAT 1988
DETERMINANTS OF SYMPTOM REPORTS IN PATIENTS WITH IBS - THE ROLE OF PSYCHOLOGICAL DISPOSITION AND RESPONSES TO PAIN 1988
EFFECT OF DIETARY FIBER ON SYMPTOMS AND COLONIC MOTILITY IN PATIENTS WITH IBS - A CROSSOVER STUDY 1988
ION-TRANSPORT ABNORMALITIES IN RESPONSE TO LUMINAL ANTIGEN (AG) AND OTHER SECRETAGOGUES IN JEJUNUM FROM SPECIFICALLY SENSITIZED RATS 1988
IS IRRITABLE BOWEL SYNDROME THE ASTHMA OF THE GUT 1988
MAST CELL-INDUCED MUCOSAL DAMAGE DURING EXPERIMENTAL ANAPHYLAXIS IN THE RAT 1988
NONSPECIFIC INDUCTION OF MAST-CELL HYPERPLASIA IN INTESTINAL SMOOTH-MUSCLE 1988
OPIOID RECEPTORS IN LONGITUDINAL MUSCLE MYENTERIC PLEXUS IN COMPARISON TO DEEP MUSCULAR PLEXUS AND SUBMUCOUS PLEXUS IN CANINE ILEUM 1988
POSTPRANDIAL PLASMA CHOLECYSTOKININ (CCK) AND FOOD-INTAKE IN LEAN AND OBESE SUBJECTS 1988
PREDNISONE AND BONE-MINERAL MASS IN ADOLESCENT CROHNS-DISEASE (CD) 1988
PRIMARY ENTERIC NEURAL CULTURE OF NEONATAL HAMSTER - SELECTION AND GROWTH OF VIP-CONTAINING NEURONS 1988
QUALITY OF LIFE INDEX FOR INFLAMMATORY BOWEL-DISEASE (IBD) 1988
RELATIONSHIP OF CIRCULATING CHOLECYSTOKININ (CCK) AND PYLORIC MOTOR RESPONSE AFTER INTRADUODENAL TRIGLYCERIDE INFUSION IN HUMANS 1988
SERUM GAMMA-GLUTAMYL-TRANSFERASE TRANSPEPTIDASE (GGT) AS A PREDICTOR OF CHOLEDOCHOLITHIASIS 1988
STRESS INDUCTION OF NON-CARDIAC CHEST PAIN 1988
SYSTEMIC FACTORS ARE RESPONSIBLE FOR ALTERED SMOOTH-MUSCLE FUNCTION IN THE INFLAMED GUT 1988
THE IMMUNOMODULATION OF GUT MOTILITY - FACTORS THAT DETERMINE THE PROLIFERATION OF MAST-CELLS IN THE SENSITIZED GUT 1988
THE RELATIVE GASTROTOXICITY OF DUODENAL JUICE COMPONENTS - ACUTE STUDIES IN THE RAT 1988
TRICHINELLA-SPIRALIS INFECTION IN THE RAT ALTERS ACETYLCHOLINE-RELEASE FROM THE MYENTERIC PLEXUS 1988
EFFECT OF NALOXONE ON LIPID INDUCED PYLORIC MOTOR-RESPONSES IN HUMANS 1987
EFFECTS OF PLATELET-ACTIVATING-FACTOR (PAF) ON RAT JEJUNAL MUCOSA 1987
EVIDENCE FOR CENTRAL-NERVOUS-SYSTEM CONTROL OF THE LOWER ESOPHAGEAL SPHINCTER FROM ITS RESPONSE TO VESTIBULAR STIMULATION 1987
FLEXIBLE SIGMOIDOSCOPY (S) PLUS DOUBLE CONTRAST BARIUM ENEMA (DCBE) VS COLONOSCOPY (CS) IN RECTAL BLEEDING 1987
FURTHER EVIDENCE FROM ANTIBODY STUDIES FOR SUBSTANCE-P AS A NEUROTRANSMITTER REGULATING ION-TRANSPORT 1987
IMMUNOLOGICAL CONTROL OF MOTILITY - 5-HT MEDIATES ANTIGEN-SPECIFIC CONTRACTION OF SMOOTH-MUSCLE IN THE SENSITIZED GUT 1987
INTESTINAL MACROMOLECULAR PERMEABILITY CORRELATES WITH URINARY RECOVERY OF CR-51 EDTA DURING INFLAMMATION IN THE RAT 1987
INVESTIGATION OF CAUSES OF FALSE POSITIVES IN THE USE OF ORALLY-ADMINISTERED CR-51 EDTA TO MEASURE GUT PERMEABILITY 1987
MOTOR-RESPONSES OF THE UPPER ESOPHAGEAL SPHINCTER TO PHYSICAL STRAINING 1987
NEUROENDOCRINE CELL-CULTURE OF HAMSTER INTESTINE - MORPHOLOGY AND PEPTIDE-HORMONE CONTENT 1987
PIGMENTATION OF TERMINAL ILEUM RESULTS FROM EXOGENOUS PIGMENT DEPOSITS IN PEYER PATCHES 1987
POTENTIATION OF HISTAMINE RESPONSES IN CANINE COLONIC MUCOSA BY HYDROXYLAMINES 1987
RELATIONSHIP OF PYLORIC MOTILITY TO TRANSPYLORIC FLOW IN HEALTHY-SUBJECTS 1987
STUDIES OF THE MECHANISMS OF INTESTINAL EPITHELIAL-CELL INJURY IN NIPPOSTRONGYLUS-BRASILIENSIS (NB) INFECTION AND GRAFT-VERSUS-HOST DISEASE (GVHD) 1987
THE EFFECT OF GLUCAGON ON ESOPHAGEAL PERISTALSIS AND CLEARANCE 1987
THE INFLUENCE OF STRESS ON SYMPTOMS AND UPPER ESOPHAGEAL SPHINCTER PRESSURE IN PATIENTS WITH GLOBUS SENSATION 1987
Effect of electrode configuration and time constant on colonic in-vitro slow waves 1986
Electrical control activity in human and dog colon longitudinal muscle 1986
Electrical correlates of relaxation, tone, and phasic contractile activity in the lower esophageal sphincter of the dog 1986
Inhibition of human colon circular muscle and its blockade by 9-amino-acridine 1986
Measurement of upper esophageal sphincter pressure: The effect of stress 1986
A COMPARISON OF COSTS OF PERFORMING DOUBLE CONTRAST BARIUM ENEMA PLUS FLEXIBLE SIGMOIDOSCOPY VS COLONOSCOPY TO EXAMINE THE LARGE-BOWEL 1986
ALTERATIONS IN COLONIC TRANSPORT DURING INTESTINAL ANAPHYLAXIS - INVIVO AND INVITRO STUDIES 1986
CALCIUM-METABOLISM AND CORTICOSTEROIDS IN CHILDREN AND ADOLESCENTS WITH INFLAMMATORY BOWEL-DISEASE (IBD) 1986
COLONIC TRANSPORT - EVALUATING NEURONAL CONTRIBUTIONS TO INFLAMMATORY MEDIATORS 1986
CONTROLLED-STUDY OF PEER SUPPORT GROUP IN ADOLESCENT IBD 1986
DIFFERENCES IN MUSCARINIC RECEPTOR SPARENESS IN ISOLATED CELLS, PLASMA-MEMBRANES AND MUSCLE STRIPS FROM CANINE STOMACH 1986
DIFFERENTIAL RESPONSES OF LONGITUDINAL AND CIRCULAR MUSCLE TO INFLAMMATION INDUCED IN THE RAT BY TRICHINELLA-SPIRALIS 1986
DOES ACUTE EMOTIONAL-STRESS INFLUENCE FREQUENCY OR DURATION OF GASTROESOPHAGEAL REFLUX IN HUMAN-SUBJECTS 1986
EFFECT OF TIME CONSTANT ON COLONIC SLOW WAVES AND THEIR POWER SPECTRA 1986
EVIDENCE FOR SUBSTANCE-P (SP) AND ACETYLCHOLINE (ACH) AS FUNCTIONAL NEUROTRANSMITTERS IN GUINEA-PIG JEJUNAL MUCOSA 1986
HISTAMINE CHANGES MYOGENIC CONTROL OF HUMAN-COLON MOTILITY 1986
IRRITABLE-BOWEL-SYNDROME (IBS) PATIENTS HAVE HIGHER CUTANEOUS PAIN THRESHOLDS THAN NORMALS 1986
MEASUREMENT OF COLONIC MOTILITY - VALIDATION AND COMPARISON OF EXISTING TECHNIQUES 1986
MYOGENIC ELECTRICAL CONTROL ACTIVITY IS PRESENT IN HUMAN AND DOG COLON LONGITUDINAL MUSCLE 1986
PROLONGED BURSTS OF SPIKING ACTIVITY AND HIGH-FREQUENCY SLOW WAVES ARE INDUCED BY A MEAL IN THE HUMAN-COLON 1986
THE ABSENCE OF A FREQUENCY GRADIENT IN ELECTRICAL SLOW WAVES IN THE HUMAN-COLON 1986
THE EFFECT OF LEUKOTRIENE D4 ON GASTROINTESTINAL MOTILITY 1986
THE RELATIONSHIP BETWEEN PERSONALITY, STRESS AND DISEASE-ACTIVITY IN ULCERATIVE-COLITIS 1986
THE ROLE OF THE PYLORUS IN THE REGULATION OF FOOD-INTAKE 1986
A COMPARATIVE-STUDY OF MUSCARINIC RECEPTOR CHARACTERISTICS ON CANINE GASTRIC SMOOTH-MUSCLE USING ISOLATED CELLS, MUSCLE STRIPS AND PLASMA-MEMBRANES 1985
ALTERED UTILIZATION OF CALCIUM BY SMOOTH-MUSCLE FROM THE INFLAMED GUT 1985
MUSCARINIC RECEPTOR SIZE BY RADIATION-INACTIVATION ON ENZYMATICALLY ISOLATED SMOOTH-MUSCLE CELLS AND PLASMA-MEMBRANES FROM THE CANINE STOMACH 1985
ON THE APPLICABILITY OF FOURIER-ANALYSIS TECHNIQUES TO GASTROINTESTINAL MYOELECTRIC ACTIVITY 1985
PROLONGATION OF THE DEPOLARIZATION PLATEAU IN COLONIC CIRCULAR MUSCLE 1985
THE ACTION OF TRIMEBUTINE ON GASTROINTESTINAL MOTILITY IN HUMANS IS MEDIATED BY OPIATE RECEPTORS 1985
THE FIDELITY OF RECORDING TECHNIQUES AND INTRASUBJECT VARIABILITY IN HUMAN COLONIC MOTILITY STUDIES 1985
TUBE-MOUNTED STRAIN-GAUGES ARE INFERIOR TO PERFUSED TUBES IN RECORDING GASTROINTESTINAL MOTOR-ACTIVITY 1985
ALTERATIONS IN ELECTRICAL-ACTIVITY OF HUMAN-COLON SMOOTH-MUSCLE BY CHOLINERGIC AND ADRENERGIC-STIMULATION, INVITRO 1984
EFFECT OF IGE-MEDIATED REACTIONS ON RAT INTESTINAL EPITHELIUM - GOBLET CELL REACTION AND ENTEROCYTE DAMAGE 1984
GENERATION OF MUCOSAL MAST-CELLS INVITRO FROM THE MESENTERIC LYMPH-NODE 1984
GUT INFLAMMATION ALTERS CALCIUM HANDLING PROPERTIES OF INTESTINAL SMOOTH-MUSCLE 1984
MECHANISM UNDERLYING THE POTENTIATING INTERACTION BETWEEN PENTAGASTRIN AND CARBACHOL IN CANINE GASTRIC CIRCULAR MUSCLE 1984
SUDDEN POTENTIAL DROP (SPD) IN GASTRIC-MUCOSA - POSSIBLE RELATION TO STRESS-ULCER 1984
THE EFFECT OF A CHOLECYSTOKININ ANTAGONIST ON SATIETY IS INDEPENDENT OF GASTRIC-EMPTYING 1984
THE RELATIONSHIP BETWEEN SLOW ELECTRICAL OSCILLATORY ACTIVITY, SPIKES, AND CONTRACTIONS IN HUMAN COLONIC CIRCULAR MUSCLE 1984
ABNORMAL COLONIC MOTILITY IN PNEUMATOSIS CYSTOIDES INTESTINALIS 1983
CHARACTERIZATION OF NEUROTENSIN BINDING TO ISOLATED RAT GASTRIC FUNDUS MUSCLE PLASMA-MEMBRANE 1983
IDENTIFICATION OF PUTATIVE MUSCARINIC RECEPTORS IN ISOLATED SMOOTH-MUSCLE CELLS FROM CANINE GASTRIC CORPUS BY CONTRACTION STUDIES AND BY [H-3]-LABELED QUINUCLIDINYL BENZILATE BINDING 1983
INTESTINAL DYSFUNCTION DURING IGE-MEDIATED REACTIONS - THE ROLE OF MAST-CELL MEDIATORS 1983
PROGLUMIDE IS A SPECIFIC ANTAGONIST OF THE ACTION OF CHOLECYSTOKININ ON ISOLATED SMOOTH-MUSCLE CELLS FROM GUINEA-PIG STOMACH 1982
SITES AND MECHANISMS OF ACTION OF NEURO-PEPTIDES ON GUT MOTILITY DIFFER INVIVO AND INVITRO 1982
IMPAIRED NA+-DEPENDENT BRUSH-BORDER D-GLUCOSE TRANSPORT IN EXPERIMENTAL VIRAL DIARRHEA 1981
LONG-TERM MEDICAL THERAPY IN ZOLLINGER-ELLISON SYNDROME (ZES) 1981
THE RELATION BETWEEN SYMPTOMS AND GASTRIC-ACID SECRETION IN MEDICALLY TREATED PATIENTS WITH ZOLLINGER ELLISON-SYNDROME (ZES) 1981
A CONTROLLED-STUDY OF THE EFFICACY OF COHERIN IN REGIONAL ENTERITIS 1980
IMMUNOREACTIVE PROLACTIN (IPR) AND GROWTH-HORMONE (IGH) IN THE GASTROINTESTINAL TRACTS (GIT) OF INTACT AND HYPOPHYSECTOMIZED (HYPOX) RATS 1980
COLONOSCOPY FOR UNEXPLAINED RECTAL BLEEDING 1979
MOTILIN RELEASE, DIFFERENCES BETWEEN MAN AND DOG AND RELATIONSHIP TO MIGRATING MOTOR COMPLEXES (MMC) 1979
INITIATION OF MIGRATING MYOELECTRIC COMPLEXES (MMC) BY INTRA-DUODENAL ACID 1978
NEW MODEL OF MALNUTRITION IN WEANLING RABBIT - INTESTINAL FUNCTION AND STRUCTURE 1978
RELEASE OF MOTILIN 1978
HETEROGENEITY OF RAT-LIVER PARENCHYMAL-CELLS STUDIED USING SEDIMENTATION-VELOCITY ANALYSIS 1977
PATHOGENESIS OF PORPHYRIA CUTANEA-TARDA (PCT) 1977
RELATIONSHIP OF SERUM LYSOZYME AND SERUM IMMUNOGLOBULIN LEVELS TO INFLAMMATORY BOWEL-DISEASE 1976
Adverse Events Associated With Endoscopic Retrograde Cholangiopancreatography: Systematic Review and Meta-Analysis.. S0016-5085(24)05657-9. 2024
AGA Clinical Practice Update on Integrating Potassium-Competitive Acid Blockers Into Clinical Practice: Expert Review.. 167:1228-1238. 2024
Placebo Rates in Crohn's Disease Randomized Clinical Trials: An Individual Patient Data Meta-analysis.. S0016-5085(24)05571-9. 2024
Healthy First-Degree Relatives From Multiplex Families vs Simplex Families Have a Higher Subclinical Intestinal Inflammation, a Distinct Fecal Microbial Signature, and Harbor a Higher Risk of Developing Crohn's Disease.. S0016-5085(24)05414-3. 2024
Gluten-Dependent Activation of CD4+ T Cells by MHC Class II–Expressing Epithelium. 167:1113-1128. 2024
Relative Efficacies of Interventions to Improve the Quality of Screening-Related Colonoscopy: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. 167:560-590. 2024
Molecular Mechanisms Underlying Loss of Vascular and Epithelial Integrity in Irritable Bowel Syndrome. 167:1152-1166. 2024
Two Years Gone. 167:204-205. 2024
Celiac Disease Moves Into the Current Era of Modern Medicine. 167:1-3. 2024
Non-Host Factors Influencing Onset and Severity of Celiac Disease. 167:34-50. 2024
16 INFLAMMATORY BOWEL DISEASE (IBD)-ASSOCIATED MICROBIOTA ALTER VISCERAL SENSITIVITY AND BEHAVIOUR IN MICROBIOTAHUMANIZED MICE.. 166:S-5. 2024
240 DIFFERENCES IN DIETARY INTAKE PATTERNS CONTRIBUTE TO VARIATIONS IN THE WORLDWIDE PREVLANECE OF ROME IV IRRITABLE BOWEL SYNDROME. 166:s-53-s-54. 2024
794 GLUTEN DEPENDENT ACTIVATION OF CD4+ T CELLS BY MHC CLASS II EXPRESSING INTESTINAL EPITHELIAL CELLS. 166:S-196. 2024
Effect of Brain-Gut Behavioral Treatments on Abdominal Pain in Irritable Bowel Syndrome: Systematic Review and Network Meta-Analysis. 167:934-943.e5. 2024
Mo1125 LATENT CLUSTER ANALYSIS OF GASTROINTESTINAL SYMPTOMS, DIET, PSYCHOSOCIAL AND QUALITY OF LIFE PARAMETERS IN PEOPLE WITH BLOATING AND/OR DISTENSION REVEALED 6 DISTINCT CLUSTERS. 166:s-940-s-941. 2024
Mo1127 SEX DIFFERENCES IN GASTROINTESTINAL SYMPTOMS AND HEALTHCARE UTILIZATION AMONG INDIVIDUALS WITH DGBI IN THE GLOBAL POPULATION. 166:s-941-s-942. 2024
Sa1136 RELATIVE EFFICACIES OF INTERVENTIONS TO IMPROVE THE QUALITY OF SCREENING-RELATED COLONOSCOPY: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. 166:S-355. 2024
Sa1716 DIAGNOSTIC CLASSIFICATION SYSTEMS FOR DISORDERS OF GUT-BRAIN INTERACTION SHOULD INCLUDE PSYCHOLOGICAL SYMPTOMS. 166:s-489-s-490. 2024
Su1324 EFFECT OF AN-PEP PROTEASE INTHE REAL-LIFE OF PATIENTS WITH CELIAC DISEASE ON A LONG-TERM GLUTEN-FREE DIET.. 166:S-729. 2024
Su1338 FOOD INSECURITY NEGATIVELY IMPACTS GLUTEN-FREE DIET ADHERENCE AND IS ASSOCIATED WITH PERSISTENT SYMPTOMS IN ADULT PATIENTS WITH CELIAC DISEASE.. 166:S-735. 2024
Su1629 CHARACTERIZATION OF THE GUT VASCULAR BARRIER IN IRRITABLE BOWEL SYNDROME. 166:S-773. 2024
Su1653 PREVALENCE AND RISK FACTORS OF EPIGASTRIC PAIN SYNDROME (EPS) AND HEARTBURN OVERLAP, AND CORRELATION WITH H.PYLORI PREVALENCE.. 166:s-783. 2024
Taking Microbiome Science to the Next Level: Recommendations to Advance the Emerging Field of Microbiome-Based Therapeutics and Diagnostics. 167:1059-1064. 2024
The Microbiome in Early Biomarker Discovery for Neurodevelopmental Disorders: A Novel Research Roadmap?. 167:813-814. 2024
Tu1029 EFFECT OF MENOPAUSE AND MENSES ON GASTROINTESTINAL SYMPTOMS AMONG INDIVIDUALS WITH DGBI IN THE GLOBAL POPULATION. 166:s-1228-s-1229. 2024
Tu1414 FACTORS ASSOCIATED WITH PHYSICAL SYMPTOM BURDEN AMONG PATIENTS WITH PANCREATIC ADENOCARCINOMA. 166:S-1331. 2024
Tu1655 DISCLOSURE OF DIET TRIGGERS DOES NOT ALTER DIETARY CHOICES IN PATIENTS WITH IRRITABLE BOWEL SYNDROME (IBS) AND SELFREPORTED GLUTEN SENSITIVITY. 166:S-1367. 2024
Tu1670 BACTERIAL LYSOPHOSPHATIDYLCHOLINE (LPC) AND LYSOPHOSPHATIDIC ACID (LPA) INDUCE VISCERAL HYPERSENSITIVITY AND LOW-GRADE COLONIC INFLAMMATION IN IRRITABLE BOWEL SYNDROME (IBS). 166:S-1373. 2024
Nutrition Assessment and Management in Celiac Disease. 167:116-131.e1. 2024
Integrating Evidence to Guide Use of Biologics and Small Molecules for Inflammatory Bowel Diseases. 166:396-408.e2. 2024
Standardizing Randomized Controlled Trials in Celiac Disease: An International Multidisciplinary Appropriateness Study. 166:88-102. 2024
Gut Microbiome Composition Is Associated With Future Onset of Crohn’s Disease in Healthy First-Degree Relatives. 165:670-681. 2023
Prevalence and Associated Factors of Bloating: Results From the Rome Foundation Global Epidemiology Study. 165:647-655.e4. 2023
Factor Analysis of the Rome IV Criteria for Major Disorders of Gut-Brain Interaction (DGBI) Globally and Across Geographical, Sex, and Age Groups. 164:1211-1222. 2023
1247 REVERSAL OF SEVERE GUT DYSFUNCTION FOLLOWING CLOSTRIDIUM DIFFICILE INFECTION BY MICROBIOTA-DIRECTED DIETARY INTERVENTION. 164:s-258-s-259. 2023
1291 FINANCIAL TOXICITY AMONG PATIENTS UNDERGOING SURGERY FOR INFLAMMATORY BOWEL DISEASE IN THE UNITED STATES. 164:s-1521-s-1522. 2023
19 CHRONIC ORAL EXPOSURE TO THE FOOD-GRADE SILICON DIOXIDE BLOCKS ORAL TOLERANCE INDUCTION IN MICE AND WORSENS FOOD SENSITIVITY. 164:S-6. 2023
458 MICROBIOTA FROM PATIENTS WITH CROHN'S DISEASE INDUCES BEHAVIOURAL CHANGES IN MICROBIOTA-HUMANIZED MICE. 164:S-87. 2023
537 LONG-TERM OUTCOMES FOLLOWING DOR, TOUPET, AND NISSEN FUNDOPLICATION: A NETWORK META-ANALYSIS OF RANDOMIZED TRIALS. 164:S-1486. 2023
683 INVESTIGATING MECHANISMS THAT DRIVE SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME AND PERCEIVED GLUTEN SENSITIVITY. 164:S-136. 2023
INVESTIGATING MECHANISMS THAT DRIVE SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME AND PERCEIVED GLUTEN SENSITIVITY. 164:S136-S136. 2023
MICROBIAL PHOSPHOLIPIDS AS TRIGGERS OF VISCERAL HYPERALGESIA IN IRRITABLE BOWEL SYNDROME. 164:S1075-S1075. 2023
Mo1107 A COMPARATIVE STUDY OF DISORDERS OF GUT-BRAIN INTERACTION IN WESTERN EUROPE AND ASIA BASED ON THE ROME FOUNDATION GLOBAL EPIDEMIOLOGY STUDY. 164:s-757. 2023
Mo1110 EPIDEMIOLOGICAL AND DIET RELATED DIFFERENCES IN DISORDERS OF GUT-BRAIN INTERACTION (DGBI) IN 4 COUNTRIES OF LATIN AMERICA: RESULTS OF THE ROME FOUNDATION GLOBAL EPIDEMIOLOGY STUDY (RFGES). 164:s-759. 2023
Mo1111 PREVALENCE AND IMPACT OF DISORDERS OF GUT-BRAIN INTERACTION (DGBI) IN THE SWEDISH GENERAL POPULATION. 164:s-759. 2023
Mo1814 PROTEOLYTIC CROHN'S DISEASE MICROBIOTA ENHANCES INFLAMMATION THROUGH PROTEASE-ACTIVATED RECEPTOR 2 PATHWAY. 164:S-921. 2023
PROTEOLYTIC CROHN'S DISEASE MICROBIOTA ENHANCES INFLAMMATION THROUGH PROTEASE-ACTIVATED RECEPTOR 2 PATHWAY. 164:S921-S921. 2023
Sa1103 THE NATIONAL PREVALENCE OF DISORDERS OF GUT-BRAIN INTERACTION IN THE UNITED KINGDOM IN COMPARISON TO THEIR WORLDWIDE PREVALENCE: RESULTS FROM THE ROME FOUNDATION GLOBAL EPIDEMIOLOGY STUDY. 164:s-281-s-282. 2023
Sa1112 COMPARISON OF THE PREVALENCE AND IMPACT OF DISORDERS OF GUT-BRAIN INTERACTION IN THE FRENCH- AND DUTCH-SPEAKING POPULATIONS IN BELGIUM. 164:s-285. 2023
Sa1941 HIGH-RESOLUTION HYPERSPECTRAL IMAGING IN MOUSE COLITIS MODEL. 164:s-489. 2023
Su1555 THE EFFECTIVENESS OF PEG 3350 COMPARED TO LACTULOSE FOR THE TREATMENT OF ACUTE HEPATIC ENCEPHALOPATHY IN ADULT CIRRHOTIC PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. 164:S-1329. 2023
Tu1296 A MODEL-BASED META-ANALYSIS OF THE RELATIONSHIP BETWEEN PH CONTROL AND EROSIVE ESOPHAGITIS HEALING RATES. 164:s-1025-s-1026. 2023
Tu1368 SIMILAR RATE OF POST-COVID-19 SYMPTOMS IN PATIENTS WITH CELIAC DISEASE AND NON-CELIAC POPULATION: RESULTS OF AN INTERNATIONAL CROSS-SECTIONAL STUDY. 164:s-1033-s-1034. 2023
Tu1369 THE RATE OF ADVERSE EVENTS AFTER COVID-19 VACCINATION IS SIMILAR IN PATIENTS WITH CELIAC DISEASE AND NON-CELIAC POPULATION: RESULTS OF A LARGE INTERNATIONAL CROSS-SECTIONAL STUDY. 164:S-1034. 2023
Tu1613 ROLE OF GUT MICROBIOTA IN SYMPTOM EPISODES OF IRRITABLE BOWEL SYNDROME. 164:S-1057. 2023
Tu1624 EFFECTS OF CHANGES IN THE DIAGNOSTIC CRITERIA FOR IRRITABLE BOWEL SYNDROME (IBS) ON GLOBAL PREVALENCE RATES-RESULTS FROM THE ROME FOUNDATION GLOBAL EPIDEMIOLOGY STUDY. 164:s-1061-s-1062. 2023
Tu1627 BLOATING IN THE GLOBAL POPULATION: RESULTS FROM THE ROME FOUNDATION GLOBAL EPIDEMIOLOGY STUDY. 164:s-1063. 2023
Tu1633 IRRITABLE BOWEL SYNDROME (IBS) IS MORE SEVERE IN INDIVIDUALS SATISFYING ROME IV CRITERIA THAN THOSE WITH ROME III CRITERIA IN JAPANESE POPULATION IN THE ROME FOUNDATION GLOBAL EPIDEMIOLOGICAL STUDY. 164:s-1066. 2023
Tu1654 MICROBIAL PHOSPHOLIPIDS AS TRIGGERS OF VISCERAL HYPERALGESIA IN IRRITABLE BOWEL SYNDROME. 164:S-1075. 2023
Tu1668 GLOBAL PREVALENCE OF FUNCTIONAL ANORECTAL PAIN SYNDROMES. 164:s-1075. 2023
Tu1887 EFFECTS OF THE NEXT GENERATION PROBIOTIC, AKKERMANSIA MUCINIPHILA, ON INTESTINAL INFLAMMATION AND BARRIER FUNCTION. 164:S-1153. 2023
Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis. 164:619-629. 2023
Negative Impact of Disorders of Gut-Brain Interaction on Health-Related Quality of Life: Results From the Rome Foundation Global Epidemiology Survey. 164:655-668.e10. 2023
Unfermented β-fructan Fibers Fuel Inflammation in Select Inflammatory Bowel Disease Patients. 164:228-240. 2023
Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn’s Disease. 163:1364-1376.e10. 2022
Biogeographic Variation and Functional Pathways of the Gut Microbiota in Celiac Disease. 163:1351-1363.e15. 2022
Long-Term Impact of Helicobacter pylori Eradication Therapy on Gastric Cancer Incidence and Mortality in Healthy Infected Individuals: A Meta-Analysis Beyond 10 Years of Follow-Up. 163:754-756.e1. 2022
Mediterranean-Like Dietary Pattern Associations With Gut Microbiome Composition and Subclinical Gastrointestinal Inflammation. 163:685-698. 2022
Gastroenterology: A New Editorial Team Coming to You From Around the World. 163:1-2. 2022
Rio de Janeiro Global Consensus on Landmarks, Definitions, and Classifications in Barrett’s Esophagus: World Endoscopy Organization Delphi Study. 163:84-96.e2. 2022
Ozanimod for the Treatment of Ulcerative Colitis. 162:2104-2106. 2022
1086: COMPARISON OF TRADITIONAL TOOLS AND FECAL GLUTEN IMMUNOGENIC PEPTIDE DETECTION TO INVESTIGATE GLUTEN-FREE DIET ADHERENCE IN CELIAC DISEASE.. 162:S-253. 2022
1090: ADDING DEAMIDATED GLIADIN PEPTIDE TO TISSUE TRANSGLUTAMINASE ANTIBODIES DOES NOT INCREASE CELIAC DISEASE DETECTION RATES IN IMMUNOGLOBULIN A (IGA) SUFFICIENT PATIENTS.. 162:S-255. 2022
EP1240: THE ASSOCIATION BETWEEN DIET AND DISORDERS OF GUT-BRAIN INTERACTION: ANALYSES FROM THE ROME FOUNDATION GLOBAL EPIDEMIOLOGY STUDY.. 162:s-1075. 2022
EP1370: LYMPH NODE HARVEST AS A PREDICTOR OF SURVIVAL FOR COLON CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS. 162:s-1385-s-1386. 2022
EP1371: LYMPH NODE RATIO AS A PREDICTOR OF SURVIVAL FOR COLON CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS. 162:S-1386. 2022
EP1375: VERY LOW ENERGY DIETS PRIOR TO NON-BARIATRIC SURGERY: A SYSTEMATIC REVIEW. 162:S-1387. 2022
Mo1080: THE BURDEN OF PAIN IN ROME IV GASTROINTESTINAL DISORDERS: A ROME FOUNDATION GLOBAL STUDY. 162:s-688-s-689. 2022
Mo1407: FACTOR ANALYSIS CONFIRMS GLOBAL VALIDITY OF ROME IV CRITERIA FOR MAJOR DISORDERS OF GUT-BRAIN INTERACTION (DGBI). 162:s-760-s-761. 2022
Mo1409: GUT MICROBIOTA MODULATES CGRP PRODUCTION BY DRG NEURONS IN FEMALE MICE. 162:S-761. 2022
Mo1425: COMORBID DISORDERS OF GUT-BRAIN INTERACTIONS IN INDIVIDUALS WITH SEVERE PSYCHOLOGICAL DISTRESS AND SOMATIC SYMPTOMS: RESULTS FROM A GLOBAL EPIDEMIOLOGY INTERNET STUDY. 162:s-766-s-767. 2022
Mo1440: PROCEDURAL INTERVENTION FOR THE MANAGEMENT OF CONSTIPATION FOLLOWING ANTEGRADE ENEMA INSERTION: A POPULATION-BASED STUDY. 162:s-773-s-774. 2022
Mo1661: GASTROINTESTINAL EFFECTS OF CANNABINOIDS: RELATIONSHIP WITH SODIUM CHANNEL FUNCTION. 162:s-845-s-846. 2022
Sa1255: OPTIMIZING STOOL GLUTEN IMMUNOGENIC PEPTIDE TESTS FOR THE MONITORING OF ADHERENCE TO THE GLUTEN-FREE DIET. 162:S-356. 2022
Sa1260: EVALUATION OF QUALITATIVE LATERAL FLOW IMMUNOASSAY FOR DETECTING GLUTEN IMMUNOGENIC PEPTIDES IN CELIAC PATIENTS FOLLOWING A HABITUAL GLUTEN-FREE DIET.. 162:S-358. 2022
Sa1475: WORLDWIDE PREVALENCE AND BURDEN OF GASTROPARESIS-LIKE SYMPTOMS AS DEFINED BY THE EUROPEAN GASTROPARESIS CONSENSUS: ANALYSIS USING THE ROME FOUNDATION GLOBAL EPIDEMIOLOGY STUDY DATABASE. 162:s-387-s-388. 2022
Su1591: THE USE OF URINE METABOLOMICS TO DIFFERENTIATE PEDIATRIC ULCERATIVE COLITIS, CROHN'S DISEASE AND FUNCTIONAL GASTROINTESTINAL DISORDERS - THE NEAT STUDY (DIAGNOSING GASTROINTESTINAL DISEASES THROUGH URINE). 162:S-644. 2022
Tu1343: PREVALENCE AND ASSOCIATED FACTORS OF BLOATING AND DISTENTION SYMPTOMS IN THE GENERAL POPULATION: FINDINGS OF A SURVEY IN THREE COUNTRIES. 162:s-924-s-925. 2022
Tu1391: THE IMPACT OF ANTEGRADE ENEMA INSERTION ON HEALTHCARE UTILIZATION IN PEDIATRIC PATIENTS: A POPULATION-BASED COHORT STUDY. 162:S-948. 2022
Global Prevalence and Impact of Rumination Syndrome. 162:731-742.e9. 2022
Proton Pump Inhibitor Use: A Risk Factor for Inflammatory Bowel Disease or an Innocent Bystander?. 161:1789-1791. 2021
Anti-Microbial Antibody Response is Associated With Future Onset of Crohn’s Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic Risk. 161:1540-1551. 2021
Co-factors, Microbes, and Immunogenetics in Celiac Disease to Guide Novel Approaches for Diagnosis and Treatment. 161:1395-1411.e4. 2021
Host Genetic Determinants Associated With Helicobacter pylori Eradication Treatment Failure: A Systematic Review and Meta-analysis. 161:1443-1459. 2021
Uniting the Global Gastroenterology Community to Meet the Challenge of Climate Change and Non-Recyclable Waste. 161:1354-1360. 2021
Does a High-inflammatory Diet Increase the Risk of Inflammatory Bowel Disease? Results From the Prospective Urban Rural Epidemiology (PURE) Study: A Prospective Cohort Study. 161:1333-1335.e1. 2021
AGA Rapid Review and Guideline for SARS-CoV2 Testing and Endoscopy Post-Vaccination: 2021 Update. 161:1011-1029.e11. 2021
Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)—Part 1: Live Vaccines. 161:669-680.e0. 2021
Results of the First Pilot Randomized Controlled Trial of Fecal Microbiota Transplant In Pediatric Ulcerative Colitis: Lessons, Limitations, and Future Prospects. 161:388-393.e3. 2021
Ethnicity Associations With Food Sensitization Are Mediated by Gut Microbiota Development in the First Year of Life. 161:94-106. 2021
Reply. 160:2633-2635. 2021
245 THE ORAL TISSUE TRANSGLUTAMINASE INHIBITOR ZED1227 PREVENTS GLUTEN-INDUCED ENTEROPATHY IN A TRANSGENIC MOUSE MODEL OF CELIAC DISEASE. 160:s-53-s-54. 2021
393 ASSOCIATION OF PROCESSED FOOD INTAKE WITH RISK OF INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY. 160:s-81. 2021
425 RESULTS OF THE FIRST PILOT RANDOMIZED CONTROLLED TRIAL OF FAECAL MICROBIOTA TRANSPLANT FOR PEDIATRIC ULCERATIVE COLITIS. 160:S-89. 2021
735 DORSAL ROOT GANGLIA (DRG) NEURONAL RESPONSES AND SUBSTANCE P PRODUCTION ARE HIGHER IN MALE MICE AND SIMILAR BETWEEN CONVENTIONAL AND GERM-FREE MICE.. 160:S-148. 2021
99 COLONIC DYSMOTILITY, AUTONOMIC DYSFUNCTION AND ABNORMAL DEFECATION REFLEXES IN PATIENTS WITH CHRONIC CONSTIPATION. 160:S-22. 2021
Fr444 EFFECTS OF SACRAL PHOTOBIOMODULATION ON THE AUTONOMIC NERVOUS SYSTEM IN PATIENTS WITH COLONIC DYSMOTILITY. 160:S-320. 2021
Fr490 PREVENTIVE EFFECTS OF SAFFRON'S ANTI-INFLAMMATORY PROPERTIES IN A COLITIS MOUSE MODEL ARE LIKELY VEHICULATED THROUGH THE GUT MICROBIOME MODULATION. 160:S-329. 2021
Reply. 160:2207-2208. 2021
Sa479 INTESTINAL ULTRASOUND USE IN DETECTING POST-OPERATIVE RECURRENCE OF CROHN'S DISEASE: A DIAGNOSTIC TEST ACCURACY REVIEW AND META-ANALYSIS. 160:s-514-s-515. 2021
Sa596 PROINFLAMMATORY EFFECT OF HIGH SALT DIET AND UC MICROBIOTA IN GNOTOBIOTIC MICE. 160:s-566-s-567. 2021
Novel Fecal Biomarkers That Precede Clinical Diagnosis of Ulcerative Colitis. 160:1532-1545. 2021
From Birth to Overweight and Atopic Disease: Multiple and Common Pathways of the Infant Gut Microbiome. 160:128-144.e10. 2021
Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. 160:99-114.e3. 2021
Increased Intestinal Permeability Is Associated With Later Development of Crohn’s Disease. 159:2092-2100.e5. 2020
AGA Institute Rapid Review and Recommendations on the Role of Pre-Procedure SARS-CoV-2 Testing and Endoscopy. 159:1935-1948.e5. 2020
Assessment of Evidence Quality in Inflammatory Bowel Disease Guidance: The Use and Misuse of GRADE. 159:1209-1215. 2020
Association Between Inflammatory Bowel Diseases and Celiac Disease: A Systematic Review and Meta-Analysis. 159:884-903.e31. 2020
AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders. 159:697-705. 2020
AGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders. 159:708-738.e4. 2020
Probiotics Reduce Mortality and Morbidity in Preterm, Low-Birth-Weight Infants: A Systematic Review and Network Meta-analysis of Randomized Trials. 159:467-480. 2020
Spotlight: Probiotics Guidelines. 159:707-707. 2020
Peppermint Oil in Irritable Bowel Syndrome. 159:395-396. 2020
1123 ARYL HYDROCARBON RECEPTOR LIGAND PRODUCTION BY THE GUT MICROBIOTA IN CELIAC DISEASE. 158:S-217. 2020
166 LAPAROSCOPIC HEPATECTOMY IS SAFE AND EFFECTIVE FOR COLORECTAL LIVER METASTASES IN A POPULATION-BASED ANALYSIS IN ONTARIO, CANADA.. 158:S-1492. 2020
616 RESULTS OF THE FIRST PAEDIATRIC RANDOMIZED-CONTROLLED TRIAL OF FAECAL MICROBIOTA TRANSPLANT FOR ULCERATIVE COLITIS. 158:S-132. 2020
715 SACCHAROMYCES BOULARDII CNCM I-745 IMPROVES GUT-BRAIN AXIS DYSFUNCTION IN A HUMANIZED MOUSE MODEL OF IRRITABLE BOWEL SYNDROME WITH CO-MORBID ANXIETY. 158:S-150. 2020
808 FECAL CALPROTECTIN FOR DETECTING POUCHITIS FOLLOWING ILEAL POUCH ANAL ANASTOMOSIS IN ULCERATIVE COLITIS PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. 158:s-1532-s-1533. 2020
Development of the Microbiota and Associations With Birth Mode, Diet, and Atopic Disorders in a Longitudinal Analysis of Stool Samples, Collected From Infancy Through Early Childhood. 158:1584-1596. 2020
Mo1010 SOMATOSTATIN AND ANALOGUES FOR ACUTE NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING: A SYSTEMATIC REVIEW AND METAANALYSIS OF RANDOMIZED TRIALS. 158:s-753-s-754. 2020
Mo1141 SQUALAMINE, AN AMINOSTEROL POTENTIALLY USEFUL IN TREATING PARKINSON'S DISEASE, ACTIVATES THE AFFERENT VAGUS NERVE VIA ACTION ON THE ENTERIC NERVOUS SYSTEM. 158:S-801. 2020
Mo1321 THE UTILITY OF GLUCOSE HYDROGEN BREATH TEST IN IRRITABLE BOWEL SYNDROME: A SYSTEMATIC REVIEW. 158:s-848-s-849. 2020
Mo1570 THE INTESTINAL MICROBIOTA FROM A PATIENT WITH IBS-C SLOWS MOUSE COLONIC TRANSIT BY DISRUPTING INTERSTITIAL CELL OF CAJAL NETWORK. 158:s-899-s-900. 2020
Mo1906 FEASIBILITY OF THE FIRST PAEDIATRIC RANDOMIZED CONTROLLED PILOT TRIAL OF FAECAL MICROBIOTA TRANSPLANT FOR ULCERATIVE COLITIS. 158:S-972. 2020
Su1218 EVALUATION OF GUT MICROBIOTA COMPOSITION IN NAFLD WITH UC PANCOLITIS IN CLINICAL REMISSION: A PILOT STUDY. 158:s-547-s-548. 2020
Su1234 THE INFLUENCE OF SEX AND THE GUT MICROBIOTA ON VISCERAL SENSITIVITY IN MICE. 158:S-553. 2020
Su1835 WHAT IS THE INCIDENCE OF HERPES ZOSTER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE COMPARED TO THE GENERAL POPULATION: A SYSTEMATIC REVIEW AND META-ANALYSIS. 158:S-668. 2020
Su1853 CHARACTERISTICS OF SKIN LESIONS ASSOCIATED WITH ANTI-TUMOR NECROSIS FACTOR THERAPY OR OTHER BIOLOGIC AGENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY. 158:s-675-s-676. 2020
Tu1006 THE ASSOCIATION BETWEEN INFLAMMATORY BOWEL DISEASE AND CELIAC DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS. 158:s-1002-s-1003. 2020
Tu1459 SYMPTOMATIC AND ASYMPTOMATIC CELIAC DISEASE PATIENTS ON LONG-TERM GLUTEN-FREE DIET EXHIBIT DIFFERENCES IN FECAL MICROBIAL TAXA. 158:S-1116. 2020
Tu1460 BIFIDOBACTERIUM INFANTIS NLS-SS SHIFTS FECAL MICROBIOTA IN SYMPTOMATIC CELIAC PATIENTS ON LONG-TERM GLUTEN-FREE DIET.. 158:S-1116. 2020
Tu1938 PROBIOTICS FOR CELIAC DISEASE: A SYSTEMATIC REVIEW AND METAANALYSIS OF RANDOMIZED CONTROLLED TRIALS. 158:S-1225. 2020
Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review. 158:930-946.e1. 2020
Reply. 158:1175-1176. 2020
Uptake of Colorectal Cancer Screening by Physicians Is Associated With Greater Uptake by Their Patients. 158:905-914. 2020
AGA Clinical Practice Guidelines on Management of Gastric Intestinal Metaplasia. 158:693-702. 2020
AGA Technical Review on Gastric Intestinal Metaplasia—Epidemiology and Risk Factors. 158:732-744.e16. 2020
AGA Technical Review on Gastric Intestinal Metaplasia—Natural History and Clinical Outcomes. 158:705-731.e5. 2020
Advancing the Science in Gastric Pre-Neoplasia: Study Design Considerations. 158:751-759. 2020
Histologic Subtyping of Gastric Intestinal Metaplasia: Overview and Considerations for Clinical Practice. 158:745-750. 2020
Interpreting Reported Risks Associated With Use of Proton Pump Inhibitors: Residual Confounding in a 10-Year Analysis of National Ambulatory Data. 158:780-782.e3. 2020
Spotlight: Gastric Intestinal Metaplasia. 158:704-704. 2020
Controversies Around Measuring Drug Toxicity: US Food and Drug Administration and Gastrointestinal Perspectives. 158:22-27. 2020
Reply. 158:285-286. 2020
Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells. 157:1584-1598. 2019
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin. 157:682-691.e2. 2019
Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn's Disease. 157:320-348. 2019
Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial. 157:403-412.e5. 2019
Gut Microbiota and Irritable Bowel Syndrome. 157:1-1. 2019
Gut Microbiota in Patients With Irritable Bowel Syndrome—A Systematic Review. 157:97-108. 2019
Lactobacilli Degrade Wheat Amylase Trypsin Inhibitors to Reduce Intestinal Dysfunction Induced by Immunogenic Wheat Proteins. 156:2266-2280. 2019
1018 – Translational Studies of Lactobacillus Gasseri Effects on Trpv1 and Motility, and Therapeutic Value in Women with Chronic Constipation. 156:S-221. 2019
1053 – Uptake and Patient Outcomes of Laparoscopic Liver Resection for Colon Cancer Liver Metastases. A Populationbased Analysis. 156:S-1433. 2019
1153 – Critical Role of Toll-Like Receptor 2 in Mediating Serotonin Production in Gut. 156:S-247. 2019
460 – Effects of Proton-Pump Inhibitors in Patients Receiving Clopidogrel-Based Antithrombotic Therapy for Cardiovascular Prevention: A Systematic Review and Meta-Analysis of Randomized Trials. 156:S-97. 2019
596 – Real Life Patterns of Gluten-Free Diet Adherence in Celiac Patients Using Gip Excretion. 156:S-117. 2019
599 – Effect of Bifidobacterium Infantis Nsl Super Strain in Highly Symptomatic Celiac Disease Patients on Long-Term Glutenfree Diet. A Pilot Study. 156:S-119. 2019
819 – Metabolism of Wheat Amylase Trypsin Inhibitors by Lactobacilli Ameliorates Gut Dysfunction Induced by Wheat Proteins. 156:s-174-s-175. 2019
877 – Microbiota Plays a Key Role in Formation of Normal Intestinal Motor Patterns. 156:S-198. 2019
Mo1296 – Proton Pump Inhibitor Treatment Initiated Prior to Endoscopy Ic Diagnosis in Upper Gastrointestinal Bleeding: An Updated Cochrane Collaboration Systematic Review and Meta-Analysis of Randomized Controlled Trials. 156:S-751. 2019
Sa1930 – Fecal Microbiota Transplantation: Perceptions and Experiences in a Pediatric Ulcerative Colitis Population (Pedifetch Trial). 156:S-458. 2019
Sa2038 – Lack of Experimental Reproducibility in Preclinical Research May Be Influenced by the Nutritional Profile of Standard Rodent Chows. 156:S-481. 2019
Su1147 – Bleeding and Thrombosis Risk in Crtically Ill Patients with Acute Or Chronic Liver Failure: A Systematic Review and Meta-Analysis. 156:S-515. 2019
Su1580 – A Longitudinal Study Examining the Effect of Altering Fodmap Intake on the Metabolome and Pain Signalling in IBS Patients. 156:s-570-s-571. 2019
Su1895 – Targeting Ampkβ1 As a Novel Strategy to Ameliorate Colitis. 156:S-652. 2019
Tu1642 – Validation of the Bristol Stool Chart and the Bliss Stool Classification System in the Intensive Care Unit. 156:S-1073. 2019
Tu1859 – Altering Dietary Fermentable Carbohydrate (FODMAP) Content Shifts Fermentation Patterns But Does Not Impact Inflammation in Preclinical Models of Ibd. 156:s-1149-s-1150. 2019
An Interactive Web-Based Educational Tool Improves Detection and Delineation of Barrett’s Esophagus–Related Neoplasia. 156:1299-1308.e3. 2019
Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome. 156:46-58.e7. 2019
Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis. 155:1753-1763. 2018
Clinical Practice Guideline on Screening for Colorectal Cancer in Individuals With a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus. 155:1325-1347.e3. 2018
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease. 155:687-695.e10. 2018
1018 - Microbiota from Ibs-D Patients Induces Dysregulation of Innate Immunity. 154:S-193. 2018
1068 - Clinical Practice Guideline on Screening for Colorectal Cancer in Individuals with a Family History of Nonhereditary Colorectal Cancer or Adenoma: the Canadian Association of Gastroenterology Banff Consensus. 154:S-205. 2018
1109 - Resumption of Anticoagulant Therapy after Anticoagulantrelated Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis. 154:S-220. 2018
916 - Gut Microbiota-Diet Interactions in a Humanized Mouse Model of IBS: The Role of Intestinal Mast Cells. 154:S-182. 2018
Mo1039 - The Prevalence of Celiac Disease is Increased in Patients with Barrett's Esophagus and is Associated with Early Development of Dysplasia. 154:S-680. 2018
Mo1957 - Characterizing Microbiota Composition and Function that Precede Development of Clinically Relevant Inflammation in UC Patients. 154:S-864. 2018
Sa2010 - Influence of Maternal Ssri Exposure on the Development of the Enteric Nervous System and Enterochromaffin Cells. 154:S-446. 2018
Su1168 - Microbial Proteases Increase Sensitivity to Dietary Antigen Through Par-2 Signaling. 154:s-491-s-492. 2018
Su1175 - Gluten Immunogenic Peptide (GIP) Excretion Shows Evidence of Dietary Transgressions in Asymptomatic Treated Celiac Disease Patients. 154:S-494. 2018
Su1658 - Gut Microbiota Defines Host Responses to Dietary Fermentable Carbohydrates in IBS: The Role of Bacterial Histamine. 154:S-565. 2018
Su1775 - Overall and Disease-Free Survival in Colorectal Cancer Patients Receiving Adjuvant Chemotherapy with Biologic Agent: A Systematic Review and Meta-Anaylsis. 154:S-1313. 2018
Tu1576 - Incidence of Delayed Venous Thromboembolic Events in Patients Undergoing Abdominal and Pelvic Surgery for Cancer, a Systematic Review. 154:S-1347. 2018
Tu1965 - High Definition Tethered Capsule Optical Coherence Tomography Endomicroscopy Device for Improved Esophageal Imaging. 154:S-1067. 2018
Signature Celebration of Gastroenterology , Colorectal Cancer. 154:767-770. 2018
Reply. 154:764-765. 2018
Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome. 153:448-459.e8. 2017
Safety of Adding Oats to a Gluten-Free Diet for Patients With Celiac Disease: Systematic Review and Meta-analysis of Clinical and Observational Studies. 153:395-409.e3. 2017
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials. 153:113-122. 2017
Antigliadin Antibodies Predict the Symptomatic Response to Gluten-Free Diet and Improvement in Gastrointestinal Motility in IBS Patients. 152:S45-S45. 2017
No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease. 152:787-798.e2. 2017
American Gastroenterological Association Institute Technical Review on Initial Testing and Management of Acute Liver Disease. 152:648-664.e5. 2017
Clinical Practice Guidelines for the Use of Video Capsule Endoscopy. 152:497-514. 2017
Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases. 152:351-361.e5. 2017
Reply. 152:303-304. 2017
Duodenal Bacteria From Patients With Celiac Disease and Healthy Subjects Distinctly Affect Gluten Breakdown and Immunogenicity. 151:670-683. 2016
Concurrent Lower Gastrointestinal Bleeding Risk and Myocardial Ischemic Risk: Resume Aspirin or Not?. 151:222-225. 2016
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. 151:51-69.e14. 2016
Fundamentals of Neurogastroenterology: Basic Science. 150:1280-1291. 2016
Development and Validation of the Patient-Provider Relationship Scale among Patients with Irritable Bowel Syndrome. 150:S900-S901. 2016
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy. 150:734-757.e1. 2016
American Gastroenterological Association Institute Guideline on the Role of Upper Gastrointestinal Biopsy to Evaluate Dyspepsia in the Adult Patient in the Absence of Visible Mucosal Lesions. 149:1082-1087. 2015
American Gastroenterological Association Institute Technical Review on the Role of Upper Gastrointestinal Biopsy to Evaluate Dyspepsia in the Adult Patient in the Absence of Visible Mucosal Lesions. 149:1088-1118. 2015
Reply. 149:826-826. 2015
Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients. 149:379-388. 2015
Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study. 149:340-349.e2. 2015
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. 149:102-109.e6. 2015
Larazotide Acetate for Persistent Symptoms of Celiac Disease Despite a Gluten-Free Diet: A Randomized Controlled Trial. 148:1311-1319.e6. 2015
Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus. 148:1035-1058.e3. 2015
73 Adrenergic Innervation Regulates Intestinal Microbiota Diversity and Richness via Cholinergic Th17 Lymphocytes. 148:S-20. 2015
American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Asymptomatic Neoplastic Pancreatic Cysts. 148:819-822. 2015
American Gastroenterological Association Technical Review on the Diagnosis and Management of Asymptomatic Neoplastic Pancreatic Cysts. 148:824-848.e22. 2015
Management of Pancreatic Cysts in an Evidence-Based World. 148:692-695. 2015
Mo1263 Anxiety and Depression Increase in a Step-Wise Fashion in Parallel With Multiple FGIDs. 148:S-654. 2015
Mo1326 Increased Risk of Functional Gastrointestinal Disorders (FGIDs) in Obesity Patients. 148:s-672-s-673. 2015
Sa1295 Reflux Symptoms in Patients With Celiac Disease Are Associated With Alkaline or Weakly Acid Reflux. 148:S-284. 2015
Tu1829 Discovery of an Epithelial Form of Elastase in the Intestine That Participates to Mucosal Inflammation in IBD. 148:s-913-s-914. 2015
Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett’s Esophagus. 148:367-378. 2015
Development and Validation of a Symptom-Based Activity Index for Adults With Eosinophilic Esophagitis. 147:1255-1266.e21. 2014
The Origins of Irritable Bowel Syndrome: Experience of a Lifetime. 147:18-20. 2014
24 The Critical Role of Gut Microbiota in Determining Behavioral Changes and Susceptibility to Inflammation in a Model of Depression. 146:S-7. 2014
29 The Effect of High Fat Diet on Human Microbiota Transfer Into Gnotobiotic Mice. 146:s-8-s-9. 2014
81 Transplantation of Dysbiotic Microbiota Derived From UC Patients Promotes a Pro-Inflammatory Phenotype and Increased Susceptibility of Gnotobiotic Mice to Colitis. 146:S-23. 2014
850b The intestine switches between propulsion and segmentation through a nutrient-or neurally-induced transient pacemaker. 146:S-145. 2014
929b Larazotide Acetate, a First In-Class, Novel Tight Junction Regulator, Meets Primary Endpoint and Significantly Reduces Signs and Symptoms of Celiac Disease in Patients on a Gluten-Free Diet: Results of a Multicenter, Randomized, Placebo Controlled Trial. 146:S-159. 2014
929c A randomized, placebo controlled trial of fecal microbiota therapy in active ulcerative colitis.. 146:S-159. 2014
Mo1197 Dermatological Complications of Anti-TNF-a Therapy in Crohn's Disease. 146:S-583. 2014
Role of the Microbiome in Energy Regulation and Metabolism. 146:1525-1533. 2014
Sa2007 Colonic Motor Patterns in Patients With Chronic Constipation Assessed by High Resolution Manometry. 146:S-353. 2014
Sa2019 Squalamine Reverses Age and Loperamide Associated Dysmotility in a Mouse Biomarker Model of Constipation. 146:S-356. 2014
Sa2042 Dependence of Colonic Motor Patterns on 5-HT3 and 5-HT4 Receptor Activation in the Rat. 146:s-361-s-362. 2014
Su1444 Increased Prevalence of Gluten Related Disorders in Patients With Barrett's Esophagus: The Impact on the Development of Dysplasia. 146:s-470-s-471. 2014
Su1855 Morbidity and Morality Rates After Bariatric Surgery in a Regionalized Surgical Care Program: the Ontario Experience. 146:S-1053. 2014
Tu1749 Gluten-Induced Responses in NOD/DQ8 Mice Are Influenced by Bacterial Colonization. 146:S-833. 2014
Tu1778 Faecalibacterium prausnitzii Prevents Irritable Bowel Syndrome-Like Symptoms in Both Murine Low Grade Chronic Inflammation and Acute Stress Models. 146:s-840-s-841. 2014
Tu1797 The Adoptive Transfer of Anxiety and Gut Dysfunction From IBS Patients to Axenic Mice Through Microbiota Transplantation. 146:S-845. 2014
Tu1869 Patients With Active Celiac Disease Have Altered Intercellular Spaces and Tight Junction Structure of the Lower Esophagus That May Explain the High Prevalence of Reflux Symptoms in These Patients. 146:S-860. 2014
Tu2033 Investigating the microbiome pre and post fecal microbiota therapy from active ulcerative colitis patients in a randomized placebo controlled trial. 146:S-902. 2014
The Rome III Criteria for the Diagnosis of Functional Dyspepsia in Secondary Care Are Not Superior to Previous Definitions. 146:932-940.e1. 2014
Combination Therapy With Methotrexate in Inflammatory Bowel Disease: Time to COMMIT?. 146:608-611. 2014
Consensus Statements on the Risk, Prevention, and Treatment of Venous Thromboembolism in Inflammatory Bowel Disease: Canadian Association of Gastroenterology. 146:835-848.e6. 2014
Validation of the Rome III Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care. 145:1262-1270.e1. 2013
14 Endogenous Microbiota Influence the Postnatal Development of Intestinal Motility. 144:S-4. 2013
177 Suppression of Gluten-Induced Enteropathy by the Copolymer Bl-7010 in NOD/DQ8 Transgenic Mice, an Animal Model of Celiac Disease (CD). 144:S-42. 2013
Sa1261 A Quantitative Assessment of Psychological Distress in Celiac Disease Patients At the Time of Diagnosis. 144:S-245. 2013
Sa1266 The Long-Term Impact of the Gluten-Free Diet on the Psychological Distress of Celiac Disease Patients. Results of a Prospective Longitudinal Study. 144:S-246. 2013
Sa1343 Can Prophylactic PPI Help Reduce Marginal Ulcers After Gastric Bypass Surgery? A Systematic Review and Meta Analysis. 144:S-269. 2013
Sa2017 Blocking Peripheral Serotonin Synthesis by Telotristat Etiprate Reduces the Severity of Both Chemical- and Infection-Induced Intestinal Inflammation. 144:S-360. 2013
Tu1973 Bifidobacterium Infantis Nls Super Strain Reduces Expression of Alpha-Defensin-5, a Marker of Innate Immunity, in the Mucosa of Untreated Celiac Patients. 144:S-894. 2013
Tu1974 Bifidobacterium Breve NCC2950 Induces Expression of Antimicrobial Regiii in Colonic Epithelial Cells Through MYD88-Ticam Pathway. 144:s-894-s-895. 2013
Tu1980 Optimization of the Use of Probiotics to Prevent and Treat Colitis. 144:S-896. 2013
Tu1988 Impact of the Commensal Bacterium Faecalibacterium prausnitzii in a Non Active Inflammation Murine Model. 144:s-897-s-898. 2013
Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process. 143:336-346. 2012
1042 “Experts” Assess the Accuracy of Celiac Disease Diagnosis Performed in the Community Setting. 142:S-183. 2012
1091 Antimicrobial-Induced Dysbiosis Excerbates Colitis in NODl-/-;NOD2-/- Mice. 142:S-196. 2012
308 Immediate Effects of Infliximab Infusion on Mood in Patients With Inflammatory Bowel Disease. 142:S-69. 2012
410 Postnatal Patterning of the Enteric Nervous System is Dependent on the Presence of Endogenous Microbiota. 142:s-90-s-91. 2012
Sa2061 Protective and Curative Effect of Faecalibacterium prausnitzii in a Chronic DNBS-Induced Murine Colitis. 142:S-392. 2012
Su1607 Risk of Serious Upper Gastrointestinal (UGI) Complications With Concomitant use of Non-Selective NSAIDs and Clopidogrel for at Least 4 Weeks: A Series of Systematic Reviews of Randomized Controlled Trials (RCT), Cohort Studies and Case Control Studies. 142:S-463. 2012
Su1614 Risk of Serious (UGI) Complications With Concomitant use of Non-Selective NSAIDs and Low-Dose Aspirin: A Series of Systematic Reviews of Randomized Controlled Trials (RCT), Cohort Studies and Case Control Studies. 142:S-464. 2012
Su1771 Risk of Serious Upper Gastrointestinal (UGI) Complications With Concomitant Non-Selective NSAID and Anticoagulation Therapy for at Least 4 Weeks: A Series of Systematic Reviews of Randomized Controlled Trials (RCT), Cohort Studies and Case Control Studies. 142:S-499. 2012
Su1776 Risk of Serious Upper Gastrointestinal (UGI) Complications in Patients Receiving Multiple Non-Selective NSAIDs for at Least 4 Weeks: A Series of Systematic Reviews and Meta-Analyses of Randomized Controlled Trials (RCT), Cohort and Case Control Studies. 142:S-501. 2012
Su1777 Risk of Serious Upper Gastrointestinal (UGI) Complications With use of Non-Selective (NS) NSAIDs for at Least 4 Weeks Among Patients With a History of Peptic Ulcer (PU) or PU Complications: A Series of Systematic Reviews and Meta-Analyses. 142:S-501. 2012
Su1990 The Role of Microbiota in the Maternal Separation Model of Depression. 142:S-554. 2012
Tu1997 A Novel In Vivo Method to Measure Gastrointestinal Transit in Mice. 142:S-897. 2012
The Copolymer P(HEMA-co-SS) Binds Gluten and Reduces Immune Response in Gluten-Sensitized Mice and Human Tissues. 142:316-325.e12. 2012
Correction. 142:186-186. 2012
A Clinical Prediction Rule and Platelet Count Predict Esophageal Varices in Children. 141:2009-2016. 2011
Proton Pump Inhibitors Exacerbate NSAID-Induced Small Intestinal Injury by Inducing Dysbiosis. 141:1314-1322.e5. 2011
Dietary Intake and Nutritional Deficiencies in Patients With Diabetic or Idiopathic Gastroparesis. 141:486-498.e7. 2011
The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice. 141:599-609.e3. 2011
Interferon-λ Mediates Oral Tolerance and Inhibits Antigen-Specific, T-Helper 2 Cell–Mediated Inflammation in Mouse Intestine. 141:249-258.e2. 2011
Cellular Changes in Diabetic and Idiopathic Gastroparesis. 140:1575-1585.e8. 2011
Characterizing the Neural Pathways of Communication Within the Microbiota-Gut-Brain Axis. 140:S-362. 2011
Critical Role of Gliadin for Both Enteropathy and Insulitis Development in NOD-DQ8 Mice. 140:S-641. 2011
Influence of Interleukin-13 in 5-HT Synthesis and Severity of Experimental Colitis. 140:S-26. 2011
Inhibition of 5-HT Signaling by Blocking 5-HT7 Receptor Function Alleviates Colitis. 140:S-26. 2011
Microbial Perspectives in Very Low Birth Weight Infants Expressing High Calprotectin Levels. 140:S-78. 2011
Narcotic Bowel Syndrome: Characterization of 30 Patients and Preliminary Results After Detoxification. 140:s-465. 2011
Origin of Rhythmic Calcium Transients in the ICC-MP of the Mouse Small Intestine. 140:S-375. 2011
Proton Pump Inhibitors and Low-Dose Aspirin Markedly Exacerbate NSAID-Induced Small Intestinal Injury: A Link to Dysbiosis?. 140:S-87. 2011
The Intestinal Microbiota Determines Mouse Behavior and Brain BDNF Levels. 140:S-57. 2011
The Role of Intestinal Bacteria and Bifidobacterium Breve NCC2950 in Barrier Homeostasis and Intestinal Injury in NOD1 and 2 Knockout Mice. 140:S-847. 2011
Reply. 140:728-729. 2011
Analysis of Administrative Data Finds Endoscopist Quality Measures Associated With Postcolonoscopy Colorectal Cancer. 140:65-72. 2011
Type of CFTR Mutation Determines Risk of Pancreatitis in Patients With Cystic Fibrosis. 140:153-161. 2011
Chronic Gastrointestinal Inflammation Induces Anxiety-Like Behavior and Alters Central Nervous System Biochemistry in Mice. 139:2102-2112.e1. 2010
1007 Incidence of Inflammatory Bowel Disease Following the Walkerton Outbreak of Waterborne Bacterial Gastroenteritis. 138:S-145. 2010
904 Partner Burden in Irritable Bowel Syndrome (IBS). 138:s-128. 2010
Altered Brain Structure in Irritable Bowel Syndrome: Potential Contributions of Pre-Existing and Disease-Driven Factors. 138:1783-1789. 2010
M1691 Is There a Relationship Between H. pylori Prevalence and Overweight? A Systematic Review of Observational Studies. 138:S-399. 2010
Meta-analysis Shows That Detection of Circulating Tumor Cells Indicates Poor Prognosis in Patients With Colorectal Cancer. 138:1714-1726.e13. 2010
Mucin Gene Deficiency in Mice Impairs Host Resistance to an Enteric Parasitic Infection. 138:1763-1771.e5. 2010
Prevalence of Uninvestigated Dyspepsia 8 Years After a Large Waterborne Outbreak of Bacterial Dysentery: A Cohort Study. 138:1727-1736. 2010
S2040 Risk of Fracture After Diagnosis of Celiac Disease is Comparable to That of Control Population. 138:S-307. 2010
S2041 Improved Performance of Celiac Disease-Related Serology Tests in Predicting the Degree of Patients' Compliance With Long-Term Gluten-Free Diet. New Cut-Offs are Necessary. 138:S-307. 2010
S2042 A Prospective Study to Assess Comorbid Gastroesophageal Reflux Symptoms at Diagnosis of Celiac Disease and Effect of Treatment With the Gluten-Free Diet. 138:S-308. 2010
S2069 Developmental Associations Between Vagal Afferent Intramuscular Arrays and Interstitial Cells of Cajal. 138:S-313. 2010
T1029 The Utility of the Digital Rectal Exam (DRE) Amongst Physicians and Students: A Multi-Center Study. 138:s-472. 2010
T2021 Mouse Myenteric Ah Cells Sense Lactobacillus reuteri Within Minutes of Their Application to the Epithelial Layer, Ex Vivo. 138:S-615. 2010
T2037 Treatment With Probiotic Bacteria During Enteric Parasite Infection Upregulates Goblet Cell Hyperplasia and Promotes Host Defense. 138:S-618. 2010
T2052 Adoptive Transfer of Macrophage From Mice With Depression-Like Behavior Confers Susceptibility to Colitis in Naive Mice. 138:S-621. 2010
W1006 Conjoint Analysis of Patient Preferences for 5ASA Maintenance Therapy in Ulcerative Colitis. 138:S-630. 2010
W1378 Patients With IBS Commonly use Narcotics. 138:s-711. 2010
W1379 Predictors of Satisfaction With Care Among Patients With Irritable Bowel Syndrome (IBS). 138:s-711. 2010
W1386 Pain and Abuse History Predict Days in Bed and Physician Visits in African American Women With Functional Bowel Disorders (FBD). 138:s-712-s-713. 2010
W1387 Preliminary Study on Predictors of Health Status in African-Americans With Functional Bowel Disorders (FBD) Using an NIH Funded Database. 138:s-713. 2010
Genetic Risk Factors for Post-Infectious Irritable Bowel Syndrome Following a Waterborne Outbreak of Gastroenteritis. 138:1502-1513. 2010
The American College of Gastroenterology Irritable Bowel Syndrome Monograph: Translating Systematic Review Data to Clinical Practice. 138:789-791. 2010
Physiology, Injury, and Recovery of Interstitial Cells of Cajal: Basic and Clinical Science. 137:1548-1556. 2009
Serotonin Has a Key Role in Pathogenesis of Experimental Colitis. 137:1649-1660. 2009
Prospective Study of the Long-Term Effects of Bariatric Surgery on Liver Injury in Patients Without Advanced Disease. 137:532-540. 2009
Reactivation of Inflammatory Bowel Disease in a Mouse Model of Depression. 136:2280-2288.e4. 2009
1001 Fine Mapping of the Genetic Risk Factors for Post-Infectious Irritable Bowel Syndrome (PI-IBS) in the Walkerton Outbreak of Waterborne Gastroenteritis (GE). 136:A-155. 2009
194 Psychological Factors Are More Important Than Disease Activity in Determining Health Status in Celiac Disease. 136:a-36. 2009
363 Post-Infective Dyspepsia Eight Years After the Walkerton Outbreak of Waterborne Gastroenteritis (GE). 136:A-59. 2009
404 Validation of Genetic Risk Factors for Post-Infectious Irritable Bowel Syndrome (IBS) in Patients with Sporadic IBS. 136:A-68. 2009
996 Netrin Biosynthesized By Enteric Neurons Mediates the Attraction of Vagal Sensory Axons to the Fetal Gut. 136:A-154. 2009
M1222 Episodes of Irritable Bowel Syndrome - A Quantitative Examination of IBS-D, C & M Symptoms Using Ecological Momentary Assessment. 136:a-375-a-376. 2009
M1229 Pain and Bloating Symptoms Decrease After Bowel Movements in IBS: A Reaffirmation of ROME Criteria. 136:a-377. 2009
M1624 Role of Serotonin in Immune Activation and Inflammation in Experimental Colitis. 136:A-397. 2009
M2029 The DGP/tTG Screen Assay Can Detect Celiac Disease Among Anti-Tissue Transglutaminase Seronegative Gluten-Dependent Patients. 136:A-470. 2009
S1616 IL-13 Plays a Critical Role in Development of Enterochromaffin Cell Hyperplasia and Production of Serotonin. 136:A-235. 2009
S1790 Role of Enterochromaffin Cells in Regulation of Gut Inflammation and Host Defense in Enteric Infection. 136:A-271. 2009
S1801 Neonatal Stress Induces Changes in the Enteric Nervous System and Gut Microflora. 136:A-273. 2009
T1767 Examination of the Depressed Gut Reveals Changes in Microbiota and Serotonin Levels. 136:A-575. 2009
T1778 Reciprocal Modulation of Smooth Muscle Cell Contractility in TH1 and Th2 Dominant Environments Using Murine Model of Early Post Inflammatory Gut Dysfunction. 136:A-578. 2009
T2051 Prognosis of Post-Infectious Irritable Bowel Syndrome (PI-IBS) Eight Years After the Walkerton Outbreak of Waterborne Gastroenteritis (GE). 136:A-629. 2009
T2061 Development and Validation of a Risk Score for Post Infectious Irritable Bowel Syndrome. 136:A-631. 2009
The Relationship Between Intestinal Microbiota and the Central Nervous System in Normal Gastrointestinal Function and Disease. 136:2003-2014. 2009
W1029 Information Needs of Digestive Disease Patients: the Patient Education Needs Survey (PENS). 136:A-638. 2009
W1035 Long-Term Prospective Assessment of Quality of Life in Celiac Disease Patients. Deterioration At Four-Years On Treatment. 136:a-639-a-640. 2009
W1618 Early Depression-Like Behaviour in Maternal Separation Mice Is Associated with Altered Microbiota. 136:A-703. 2009
W2031 Antibiotic-Induced Intestinal Dysbiosis Results in Altered Behavior in BALB/C Mice. 136:a-776-a-777. 2009
Polymeric Binders Suppress Gliadin-Induced Toxicity in the Intestinal Epithelium. 136:288-298. 2009
1002 Role of Intestinal Barrier Modulation By Non-Steroidal Anti-Inflammatory Drugs in Gluten-Induced Epithelial Damage in HLA-Dq8/Hcd4 Transgenic Mice. 134:A-151. 2008
1057 Depression Reactivates Inflammatory Bowel Disease in Mice. 134:a-158-a-159. 2008
64 Role of Acetylcholine and Serotonin Receptors in the Maintenance of Muscle Hypercontractility in a Murine Model of Post-Inflammatory Irritable Bowel Syndrome. 134:A-9. 2008
694 Effects of Probiotics On Gut-Brain Axis During Chronic H. pylori Infection. 134:A-97. 2008
698 Critical Role of the Alpha-7 Nicotinic Acetylcholine Receptor in the Development of Colitis. 134:A-98. 2008
842 Genetic Risk Factors for Post-Infectious IBS in the Walkerton Outbreak of Waterborne Gastroenteritis. 134:A-122. 2008
M1511 A Population-Based Study of Surgical Treatment of Colon Cancer in Ontario, Canada. 134:A-863. 2008
M1783 The Relative Effects of Clinical and Psychosocial Factors On Health Care Utilization and Disability in Women with Functional Bowel Disorders. 134:a-417. 2008
Progenitor Cells of Interstitial Cells of Cajal: On the Road to Tissue Repair. 134:1252-1254. 2008
S1284 An Essential Role of 5-HT in Pathogenesis of Experimental Colitis. 134:A-218. 2008
T1269 Effects of Synthetic Zot Peptide Analog AT-1002 and Inhibitor AT-1001 On Gluten Induced Alterations in Barrier Function and Macrophage Recruitment in HLA-HCD4/DQ8 Mice. 134:a-519-a-520. 2008
W1035 Very High Rate of Misdiagnosis of Celiac Disease in Practice. 134:a-619-a-620. 2008
W1324 The Development of IBS, Abdominal Pain and Constipation Following Elective Hysterectomy. 134:a-680. 2008
W1377 Altered Intestinal Paracellular Permeability in H. pylori Infected Mice Is Restored By Bacterial Eradication and Probiotic Treatment. 134:A-691. 2008
W1742 Guidance of Vagal Sensory Axons in the Fetal Gut: Long-Range Netrin-Mediated Attraction Terminated By Laminin in the Target Microenvironment. 134:A-706. 2008
W1927 Low Dose Aspirin Affects the Small Bowel Mucosa. Results of a Pilot Study Using a Multidimensional Assessment. 134:A-736. 2008
Development of Abdominal Pain and IBS Following Gynecological Surgery: A Prospective, Controlled Study. 134:75-84. 2008
TIM-4 Expressed by Mucosal Dendritic Cells Plays a Critical Role in Food Antigen–Specific Th2 Differentiation and Intestinal Allergy. 133:1522-1533. 2007
Natural History of Functional Gastrointestinal Disorders: A 12-year Longitudinal Population-Based Study. 133:799-807.e1. 2007
Development, Validation, and Evaluation of a Pediatric Ulcerative Colitis Activity Index: A Prospective Multicenter Study. 133:423-432. 2007
The Development and Validation of an Endoscopic Grading System for Barrett’s Esophagus: The Prague C & M Criteria. 131:1392-1399. 2006
The Vagus Nerve: A Tonic Inhibitory Influence Associated With Inflammatory Bowel Disease in a Murine Model. 131:1122-1130. 2006
Incidence and Epidemiology of Irritable Bowel Syndrome After a Large Waterborne Outbreak of Bacterial Dysentery. 131:445-450. 2006
Limited Value of Alarm Features in the Diagnosis of Upper Gastrointestinal Malignancy: Systematic Review and Meta-analysis. 131:390-401. 2006
Antidepressants Attenuate Increased Susceptibility to Colitis in a Murine Model of Depression. 130:1743-1753. 2006
CD4+ T-Cell Modulation of Visceral Nociception in Mice. 130:1721-1728. 2006
Fundamentals of Neurogastroenterology: Basic Science. 130:1391-1411. 2006
A Community Screening Program for Helicobacter pylori Saves Money: 10-Year Follow-up of a Randomized Controlled Trial. 129:1910-1917. 2005
American Gastroenterological Association Technical Review on the Evaluation of Dyspepsia. 129:1756-1780. 2005
Explaining Divergent Results of Meta-Analyses on Proton Pump Inhibitor Treatment for Ulcer Bleeding. 129:1804-1805. 2005
CD23-Mediated IgE Transport Across Human Intestinal Epithelium: Inhibition by Blocking Sites of Translation or Binding. 129:928-940. 2005
Mechanisms Underlying the Maintenance of Muscle Hypercontractility in a Model of Postinfective Gut Dysfunction. 129:131-141. 2005
Helicobacter pylori “Test and Treat” or Endoscopy for Managing Dyspepsia: An Individual Patient Data Meta-analysis. 128:1838-1844. 2005
A prospective assessment of bowel habit in irritable bowel syndrome in women: Defining an alternator. 128:580-589. 2005
Nonulcer dyspepsia and proton pump inhibitors. 128:805-805. 2005
Reply. 128:805-806. 2005
The efficacy of proton pump inhibitors in nonulcer dyspepsia: A systematic review and economic analysis. 127:1329-1337. 2004
Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction. 127:826-837. 2004
Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction. 127:179-187. 2004
Helicobacter pylori and gastric cancer. 126:1927-1927. 2004
Reply. 126:1927-1928. 2004
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. 126:693-702. 2004
Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. 126:576-585. 2004
Meta-analysis of the relationship between cagA seropositivity and gastric cancer. 125:1636-1644. 2003
Meta-analysis of the relationship between cagA seropositivity and gastric cancer. 125:1636-1644. 2003
Gastric neurostimulation for gastroparesis: time to pick up the pace1 1Gastric electrical stimulation in intractable symptomatic gastroparesis.Digestion 2002;66:204–212.. 125:979-981. 2003
Reply. 125:981-981. 2003
Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders 1 1This study was registered with ClinicalTrials.gov (trial registry no. NCT00006157).. 125:19-31. 2003
A multi-center randomized trial of cognitive-behavioral treatment (CBT) vs. education (EDU) in moderate to severe functional bowel disorder (FBD). 124:a530. 2003
A multi-center randomized trial of desipramine (DES) vs. placebo (PLA) in moderate to severe functional bowel disorder (FBD). 124:a30. 2003
Is clinical response to tricyclic antidepressants in functional bowel disorders related to dosage?. 124:a223. 2003
High-conductance chloride channels generate pacemaker currents in interstitial cells of Cajal. 123:1627-1636. 2002
Chronic stress induces mast cell–dependent bacterial adherence and initiates mucosal inflammation in rat intestine. 123:1099-1108. 2002
Immune-mediated neural dysfunction in a murine model of chronic Helicobacter pylori infection. 123:1205-1215. 2002
A case for an immunological basis for irritable bowel syndrome. 122:2078-2080. 2002
Evolving pathophysiologic models of functional gastrointestinal disorders. 122:2032-2048. 2002
Using and Understanding Medical Statistics. 122:835-836. 2002
Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the west. 122:588-590. 2002
Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. 121:1120-1126. 2001
Enhanced transepithelial antigen transport in intestine of allergic mice is mediated by IgE/CD23 and regulated by interleukin-4. 121:370-381. 2001
Role of immunologic factors and cyclooxygenase 2 in persistent postinfective enteric muscle dysfunction in mice. 120:1729-1736. 2001
Altered and distinct cardioautonomic responses to esophageal stimulation (ES) in patients with GERD or with non-cardiac chest pain (NCCP). 120:A632-A632. 2001
Cancer risk and Crohn's disease in a Canadian population. 120:A445-A446. 2001
Characterization of early and late cerebral evoke responses (CEP) to stimulation of afferent esophageal pathways in humans. 120:A630-A630. 2001
Chronic H. pylori interaction induces functional and morphological changes in the neural system. 120:A235-A235. 2001
Cortical evaked petential response (EP) to esophageal stimulation (ES) in healthy controls and patients with GERD or non-cardiac chest pain (NCCP). 120:A222-A222. 2001
Evidence for cytokine-induced activation of signal transducer and activator of transcription 6 (STAT6) in human intestinal muscle cells. 120:A315-A315. 2001
Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I (SR-BI)-deficient mice. 120:A65-A65. 2001
Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I (SR-BI)-deficient mice. 120:A65-A65. 2001
In Vivo motility disturbances in a model of post-infective IBS. 120:A71-A71. 2001
Low frequency presynaptic stimulation selectively excites S neurons with descending axons in the guinea pig ileum. 120:A332-A332. 2001
Neuro-immune interactions in the stomach of H. pylori infected mice: Role of lymphocytes. 120:A535-A535. 2001
Rectal pain thresholds are higher, not lower in IBS patients with history of sexual/physical abuse. 120:a638. 2001
Sustained increase of the pseudoaffective visceromotor response (VMR) to colorectal distention (CRD) in NIH/SWISS mice (NIH/SWISS) following Trichinella spiralis (Tsp.) enteritis. 120:A331-A331. 2001
“Test and treat” strategy for management of uninvestigated dyspepsia: A meta-analysis. 120:A89-A89. 2001
Development of interstitial cells of Cajal in a full-term infant without an enteric nervous system. 120:561-567. 2001
Organization of intestinal pacemakers. 120:319-320. 2001
Organization of intestinal pacemakers - Reply. 120:320-321. 2001
Reply. 120:320-321. 2001
Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. 119:1740-1744. 2000
Interstitial cells of Cajal and inflammation-induced motor dysfunction in the mouse small intestine. 119:1590-1599. 2000
Molecular identification and functional characterization of Mdr1a in rat cholangiocytes. 119:1113-1122. 2000
Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women. 119:631-638. 2000
Quantitative analysis of intestinal motor patterns: Spatiotemporal organization of nonneural pacemaker sites in the rat ileum. 119:386-394. 2000
Stress reactivation colitis and the role of the autonomic nervous system (ANS). 118:A882-A882. 2000
Cigarette smoke aggravates experimental colitis in rats. 117:877-883. 1999
An evidence-based approach to gastroenterology diagnosis. 116:1230-1237. 1999
Neurotransmitters modulate cytokine-stimulated interleukin 6 secretion in rat intestinal smooth muscle cells. 116:346-353. 1999
T cell–mediated exocrine pancreatic damage in major histocompatibility complex class II–deficient mice. 115:978-987. 1998
An evidence-based approach to gastroenterology therapy. 114:1318-1325. 1998
Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. 114:1169-1179. 1998
In vivo modulation of the hepatic acute phase response after injury by hepatocyte growth factor. 114:A1152-A1152. 1998
Interstitial cells of Cajal direct normal propulsive contractile activity in the mouse small intestine. 114:724-736. 1998
Gastric pacing as a treatment for intractable gastroparesis: Shocking news?. 114:598-601. 1998
Gastric pacing improves emptying and symptoms in patients with gastroparesis. 114:456-461. 1998
Reflux esophagitis and H. pylori.. 113:2020-2021. 1997
Therapeutic placebo in ulcerative colitis: fact or fiction?. 113:2021-2022. 1997
What Role Does Helicobacter pylori Play in Dyspepsia and Nonulcer Dyspepsia? Arguments For and Against H. pylori Being Associated With Dyspeptic Symptoms. 113:S67-S77. 1997
What role does Helicobacter pylori play in dyspepsia and nonulcer dyspepsia? Arguments for and against H. pylori being associated with dyspeptic symptoms.. 113:S67-S77. 1997
Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice. 113:1224-1232. 1997
Rapid transepithelial antigen transport in rat jejunum: Impact of sensitization and the hypersensitivity reaction. 113:856-864. 1997
Cytokine modulation of T-lymphocyte activation by intestinal smooth muscle cells. 112:1986-1995. 1997
Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis. 112:1798-1810. 1997
The magnitude of the central response to esophageal electrical stimulation is intensity dependent. 112:1137-1146. 1997
The mechanism of altered neural function in a rat model of acute colitis. 112:156-162. 1997
Previous inflammation alters the response of the rat colon to stress. 111:1509-1515. 1996
The immunomodulation of enteric neuromuscular function: Implications for motility and inflammatory disorders. 111:1683-1699. 1996
Helicobacter pylori infection and omeprazole efficacy. 111:1401-1403. 1996
Leukemia inhibitory factor mediates cytokine-induced suppression of myenteric neurotransmitter release from rat intestine. 111:674-681. 1996
The endoscopic assessment of esophagitis: A progress report on observer agreement. 111:85-92. 1996
Activation of T lymphocytes by syngeneic murine intestinal smooth muscle cells. 110:1456-1466. 1996
Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. 110:725-732. 1996
Involvement of eicosanoids and macrophage-like cells in cytokine-mediated changes in rat myenteric nerves. 109:1852-1862. 1995
Experimental colitis alters myenteric nerve function at inflamed and noninflamed sites in the rat. 109:718-722. 1995
How selective are the cholecystokinin antagonists in the dog?. 108:1953-1953. 1995
Interleukin 1β induces the expression of interleukin 6 in rat intestinal smooth muscle cells. 108:1720-1728. 1995
Plurichemical transmission and chemical coding of neurons in the digestive tract. 108:554-563. 1995
Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. 108:65-74. 1995
A patient with primary sclerosing cholangitis ponders pulse: Methotrexate paper. 107:1570-1571. 1994
Synergism between interleukins 1β and 6 on noradrenergic nerves in rat myenteric plexus. 107:993-1001. 1994
Expression of cytokines in the longitudinal muscle myenteric plexus of the inflamed intestine of rat. 107:691-700. 1994
Origins of motility patterns in isolated arterially perfused rat intestine. 106:649-657. 1994
Quality of life: A valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. 106:287-296. 1994
Interleukin 1β-induced increase in substance P in rat myenteric plexus. 105:1754-1760. 1993
Anti-immunoglobulin E-stimulated ion transport in human large and small intestine. 105:764-772. 1993
Altered small intestinal smooth muscle function in Crohn's disease. 104:1692-1699. 1993
Human recombinant interleukin 1β suppresses acetylcholine release from rat myenteric plexus. 104:1648-1654. 1993
On the specificity of altered muscle function in experimental colitis in rats. 104:1049-1056. 1993
Gastrointestinal food hypersensitivity: Basic mechanisms of pathophysiology. 103:1075-1095. 1992
Increased levels of substance P in the myenteric plexus of Trichinella-infected rats. 102:1913-1919. 1992
The effect of continuous enteral nutrition on gastric acidity in humans. 102:1506-1515. 1992
Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: A meta-analysis. 102:139-148. 1992
Galanin inhibition of vasoactive intestinal polypeptide release and circular muscle motility in the isolated perfused canine ileum. 101:1471-1476. 1991
Quality of life of patients with ulcerative colitis preoperatively and postoperatively. 101:1307-1313. 1991
LYMPHOCYTE-T MODULATION OF INTESTINAL MUSCLE FUNCTION IN THE TRICHINELLA-INFECTED RAT. 101:31-38. 1991
T-lymphocyte modulation of intestinal muscle function in the Trichinella-infected rat. 101:31-38. 1991
Reproducibility of long-term ambulatory esophageal combined pH/manometry. 100:1630-1637. 1991
Meta-analysis workshop in upper gastrointestinal hemorrhage. 100:1481-1482. 1991
Relationship between ulcer healing and acid suppression. 100:1482-1482. 1991
Reply. 100:1482-1483. 1991
Macrophage engulfment of mucosal mast cells in rats treated with dexamethasone. 100:929-937. 1991
Airway responsiveness to inhaled methacholine in patients with irritable bowel syndrome. 100:68-74. 1991
Impaired sympathetic nerve function in the inflamed rat intestine. 100:675-682. 1991
Bundles of smooth muscle, interstitial cells of Cajal (ICC) and nerves are interspersed with skeletal muscle and generate pacemaker activity in canine esophagus. 99:1215-1215. 1990
Ouabain-induced excitation of smooth muscle due to block of K conductance by intracellular sodium. 99:1215-1215. 1990
The effect of naloxone on lipid-induced pyloric motor response in humans. 99:930-934. 1990
Is there an optimal degree of acid suppression for healing of duodenal ulcers?. 99:345-351. 1990
Allergic reactions of rat jejunal mucosa. 99:74-82. 1990
Ion transport abnormalities in inflamed rat jejunum. 98:561-567. 1990
Effect of dietary fiber on symptoms and rectosigmoid motility in patients with irritable bowel syndrome. 98:66-72. 1990
Jejunal circular muscle motility is decreased in nematode-infected rat. 98:59-65. 1990
Psychoneuroimmunology: Interactions of the central nervous system and the intestinal immune system. 97:230-230. 1989
A new measure of health status for clinical trials in inflammatory bowel disease. 96:804-810. 1989
Initial Therapy and Relapse of Duodenal Ulcer: Possible Acid Secretory Mechanisms. 96:632-639. 1989
Effect of immunologic reactions on rat intestinal epithelium. 94:1368-1375. 1988
Omeprazole (20 mg daily) versus cimetidine (1200 mg daily) in duodenal ulcer healing and pain relief. 94:1130-1134. 1988
Neurohormonal regulation of gastrointestinal immunity. 93:1431-1434. 1987
Patients with irritable bowel syndrome have greater pain tolerance than normal subjects. 93:727-733. 1987
Measurement of upper esophageal sphincter pressure. 93:526-532. 1987
Altered calcium-handling properties of jejunal smooth muscle from the nematode-infected rat. 91:1462-1469. 1986
COMPARISON OF METHODOLOGIES FOR THE MEASUREMENT OF ANTRODUODENAL MOTOR-ACTIVITY IN THE DOG. 91:547-553. 1986
Comparison of methodologies for the measurement of antroduodenal motor activity in the dog. 91:546-553. 1986
ELECTRICAL BASIS OF EXCITATION AND INHIBITION OF HUMAN COLONIC SMOOTH-MUSCLE. 90:1197-1204. 1986
Electrical basis of excitation and inhibition of human colonic smooth muscle. 90:1197-1204. 1986
Electrophysiologic control of motility in the human colon. 88:500-511. 1985
Effect of Intestinal Anaphylaxis on Gut Function in the Rat. 86:391-397. 1984
Reliability of Symptoms in Assessing Control of Gastric Acid Secretion in Patients With Zollinger-Ellison Syndrome. 84:108-113. 1983
Proglumide is a specific antagonist of the action of cholecystokinin on isolated smooth muscle cells from guinea pig stomach. 82:1035. 1982
Studies of intragastric acidity and nocturnal acid secretion in cimetidine nonresponders. 82:1068. 1982
Impaired Na⁺-dependent brush border D-glucose transport in experimental viral diarrhea. 80:1191. 1981
Intravenous oxmetidine is a more potent inhibitor of meal-stimulated acid secretion than cimetidine. 80:1233. 1981
Long-term medical therapy in Zollinger-Ellison syndrome (ZES). 80:1227. 1981
The potency and duration of action of ranitidine and cimetidine on meal-stimulated acid output. 80:1311. 1981
Gastric secretory studies in humans with impromidine (SK&F 92676)—a specific histamine H2 receptor agonist. 78:505-511. 1980
Initiation of duodenal acid-induced motor complexes. 77:1217-1224. 1979
Comparisons of 24-hour intragastric acidity in duodenal ulcer patients on high dose antacid or cimetidine. 76:1204. 1979
Gastric secretory responses in man to a specific histamine H2 receptor agonist. 76:1158. 1979
Inhibition of VIP-stimulated intestinal secretion and cyclic AMP production by somatostatin in the rat. 74:726-730. 1978
EFFECTS OF THE NEXT GENERATION PROBIOTIC, AKKERMANSIA MUCINIPHILA, ON INTESTINAL INFLAMMATION AND BARRIER FUNCTION 2023

Gastroenterology Journal

Overview

publication venue for

has subject area

Identity

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)